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Salmonella is a leading bacterial pathogen, causing a significant number of human 
infections and deaths every year in the United States.  Recently, the increase in the 
prevalence of ceftriaxone and azithromycin resistance among human Salmonella isolates 
became a serious public health threat since both are used for the empirical treatment of 
salmonellosis.  Analogs of these antibiotics (ceftiofur and tulathromycin, respectively) are 
widely used in beef cattle, which could be contributing to this problem, since beef products 
are one of several major sources of Salmonella outbreaks.  A randomized controlled 
longitudinal field trial was designed to determine the effects of single-doses of ceftiofur 
and tulathromycin metaphylactic treatment on Salmonella prevalence, quantity and 
serotype distribution among cattle feces, sub-iliac lymph nodes, and hide samples.  Beef 
cattle (n = 134) were divided 4 blocks consisting of three pens each.  One pen in each 
block received either ceftiofur, tulathromycin, or else no antibiotic (i.e., negative control 
group) on Day 0.  Feces (during the feeding period and at slaughter), sub-iliac lymph nodes 
and hide swabs (at slaughter) were collected from each animal, during periods before and 
after the treatment.  Salmonella was isolated, quantified and tested for phenotypic 
antibiotic resistance using standard methods.  Serotypes, sequence types, antibiotic 
resistance genes, and plasmids of Salmonella isolates were determined from whole-
genome sequencing data.  Phylogenetic analyses were performed to measure evolutionary 
distances between Salmonella comparing pens, source, days, sample types across the study 
period. 
Data analyses indicated no significant effects (P > 0.05) of metaphylactic antibiotic 





(P < 0.05) day (period) effect observed in both measures of Salmonella occurrence, 
increasing significantly from early spring through mid-summer.  Salmonella isolates were 
mostly pan-susceptible and this was not affected by the antibiotic treatment.  Serotypes 
found in cattle samples strongly clustered within pens and dynamically shifted their 
dominance over time; importantly, suggesting a strong interaction of this pathogen with the 
local ambient cattle pen environment.  Further analyses are needed to understand the 
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1.1.   Overview of Salmonella  
The genus Salmonella was first discovered by Karl Joseph Eberth in 1880, then 
identified by Theobald Smith and named by Daniel Elmer Salmon in 1886 [1, 2].  
Salmonella is a gram-negative, generally motile through the flagella, non-lactose 
fermenting, gas-producing, 2-3 µm in length, and facultative anaerobic bacillus genera 
found in the Enterobacteriaceae family.  Salmonella is a persistent microorganism that can 
grow in temperature ranges from 6 to 48°C with optimal growth observed between 32-37 
°C.  The optimal pH-level required for Salmonella is between 6.5-7.5 [2, 3].  The genus 
Salmonella is divided into two main species that consist of 6 subgenera (I-VI), these are 
based on DNA differences observed in 16S rRNA sequences.  When these differences 
were further analyzed by a DNA-DNA hybridization method, those subgenera were 
subgrouped as follows: Salmonella enterica (I, II, III, IV, and VI) and Salmonella bongori 
(V) [4]. 
Furthermore, these subgenera are divided into serotypes that currently result in 
more than 2,600 identified serotypes of the genus Salmonella.  Within the same DNA-
DNA hybridization study, these serotypes reported showing more than 80% genetic 
similarity.  A minor portion of these serotypes (n = 23) belong to the Salmonella bongori 
species, and the remaining serotypes are  members of the Salmonella enterica species.  S. 
enterica is further subdivided into six subspecies based on their DNA, biochemistry, and 






These subspecies (with given subgenera numbers in parentheses) are listed as 
follows: S. enterica subspecies enterica (I), S. enterica subspecies salamae (II), S. enterica 
subspecies arizonae (IIIa), S. enterica subspecies diarizonae (IIIb), S. enterica subspecies 
houtenea (IV), and S. enterica subspecies indica (VI) [5]. 
 
Figure 1.  Overview of the Salmonella subspecies and serotypes 





1.2.   Clinical significance  
S. enterica subsp. enterica is the largest subspecies within the Salmonella genus, 
consisting of 1,547 serotypes.  The majority of these serotypes (99%) have the ability to 
infect or proliferate in warm-blooded animals, whereas the remainder of the subspecies 
usually cause infections and proliferate in cold-blooded animals [6]. Salmonella species are 
highly adapted microorganisms that can be also found in various niches of the ambient and 
built environment [6].  Salmonella serotypes that cause infections both in humans and 
animals are further divided into two groups according to their disease-specific syndromes. 
Four S. enterica serotypes (S. Typhi, S. Paratyphi A, S. Paratyphi B dTar-, and S. 
Paratyphi C) cause typhoid and paratyphoid fever only in humans; therefore, members of 
this group are also called “typhoidal Salmonella”.  The remaining serotypes belong to the 
“non-typhoidal Salmonella” group that may cause either symptoms of gastroenteritis that 
may be self-limiting, or can lead to invasive (bacteremia) or extra-intestinal symptoms 
(Figure 1).  These symptoms can be followed by local infections and more diffuse 
bacteremia and septicemia.  More than 1,500 serotypes belong to the non-invasive group 
that mostly cause self-limiting symptoms, such as diarrhea, abdominal cramps, and nausea 
in both humans and animals [5].  
1.3.   Research background 
Each year in the United States, approximately 9.4 million foodborne illnesses occur 
due to exposure to foodborne pathogens [7].  Salmonella enterica subsp. enterica 
(hereafter referred to as simply Salmonella or non-typhoidal Salmonella) is one of the 





hospitalizations, and 450 deaths every year in the United States [7, 8].  According to the 
U.S. Centers for Disease Control and Prevention (CDC) National Outbreak Reporting 
System (NORS), a total of 1,833 Salmonella related outbreaks were calculated to have 
occurred in the United States between 2009 and 2017.  Of these outbreaks, 1,186 (64.7%) 
were attributed to the consumption of contaminated food products while 35.3% of cases 
were attributed to direct animal contact, environmental sources, person-to-person contact, 
or various unknown reasons (publicly accessible national outbreak data are available at 
NORS dashboard [9]).   
Most of the food-related clinical Salmonella infections are attributed – in order of 
importance – to ingestion of contaminated seeded vegetables, eggs, poultry, and beef 
products, respectively [10, 11].  Beef products are considered as one of the major sources 
of the Salmonella outbreaks, since the majority of Salmonella infections are attributed to a 
few important serotypes that mainly found in cattle [12, 13].  Equally important, non-meat 
sources of outbreaks are inevitably traced by to contamination by fecal matter from 
animals; very often, from food producing animals such as cattle, pigs, and poultry or else 
from wildlife. 
Cattle are usually exposed to Salmonella in feedlots via the ingestion of 
contaminated feed and water [14].  Salmonella becomes a persistent problem in the 
feedlots because cattle that are exposed to Salmonella shed the microorganism through 
their fecal waste to the feedlot environment [2].  Salmonella also can be found in the 
digestive tract and the lymph nodes of healthy cattle [15, 16].  Hide and fecal origin 
Salmonella may be introduced to cattle carcasses at slaughter during the skinning process 





subsequently lead to dissemination through the food chain and remain in or on the final 
beef products.  In addition to fecal and hide origin Salmonella, cattle lymph nodes 
harboring Salmonella have also been reported as a potential contamination source for 
ground meat products.  Cattle lymph nodes are embedded in fat tissue; later, this trim 
product contributes extensively to the fat content in ground beef products.  During the 
grinding process, lymph nodes harboring Salmonella can be incorporated into the ground 
meat products [15, 19, 20]. 
Salmonella mostly causes self-limiting infections in adults, characterized by mild 
gastrointestinal symptoms, such as diarrhea, abdominal cramps, and nausea.  These 
infections are often limited to the intestinal lumen and do not require antibiotic treatments.  
However, children 5 years of age or younger, adults 65 years of age or older, and adults 
with impaired immunity are high-risk groups to develop invasive Salmonella infections 
that can migrate from the intestinal lumen to the bloodstream, the lymphatic system, and 
other body sites.  These infections – often requiring antibiotic treatment along with 
hospitalization – are characterized by positive blood culture and bacteremia, and include 
acute symptoms such as severe and bloody diarrhea, fever, and septicemic shock.  The 
failure of the antibiotic treatment can result in patient death [21, 22].  Antibiotics used for 
the treatment of the human invasive (extra-intestinal) Salmonella infections include 
ceftriaxone (a 3rd generation cephalosporin), ciprofloxacin (a fluoroquinolone), and 
azithromycin (a macrolide) [22, 23].  Among these treatments, ceftriaxone and 
azithromycin are often the primary choices for empirical therapy of pediatric, obstetric, and 
recently also for adult cases of salmonellosis due to some adverse side effects of 





Antimicrobial resistance among human Salmonella isolates became a global 
concern due to the observed increase of cephalosporin- and fluoroquinolone-resistance 
resulting in the failure of these antibiotics to treat human Salmonella infections [8, 27, 28].  
In addition to clinically defined resistance, reduced susceptibility to fluoroquinolones (e.g., 
ciprofloxacin) – mainly induced by a plasmid-mediated resistance has also become an 
emerging problem [29, 30].  Based on the CDC Antibiotic Resistance Threat Report 
published in 2013, multidrug-resistant (MDR) Salmonella was classified as one of the 
serious-level public health threats causing 100,000 infections and 40 deaths annually in the 
United States [8].  According to this report, antibiotic-resistant (AR) Salmonella that show 
a pattern of resistance to at least one antibiotic is recovered from an estimates 100,000 
patients annually.  Of these recovered isolates, 66,000 are found to be resistant to at least 
five classes of antibiotics.  Many of these AR Salmonella strain-related outbreaks were 
attributed to certain Salmonella serotypes such as Salmonella Enteritidis, followed by 
Salmonella Typhimurium, and Salmonella Newport serotypes [31]. 
In recent years, the CDC's concern about the increasing number of AR human 
Salmonella isolates was mainly focused on increasing ceftriaxone and ciprofloxacin 
resistance, both of which are the antibiotics that are used to treat human Salmonella 
infections (Figure 2).  The CDC underlined the increases observed of the levels of 
ceftriaxone and ciprofloxacin resistance found in human Salmonella isolates between 1996 
and 2015.  According to this report, AR trends of Salmonella show levels of ceftriaxone 
resistance found in human Salmonella isolates gradually increased from 0.2% to 4.4% 
from 1996 to 2003.  These levels have not dropped under the level of 2.4% from 2003 until 





0.5%  to 3% by the year 2011 [8].  In addition to resistance, reduced susceptibility to these 
antibiotics was also increasingly observed in Salmonella isolates [32].  
 
Figure 2.  Ceftriaxone- and ciprofloxacin-resistant human Salmonella isolates from 1996-
2011 
Adapted from the CDC Antibiotic Resistance Threat Report [8]. 
The National Antimicrobial Resistance Monitoring System (NARMS) began 
monitor azithromycin resistance among human Salmonella isolates in 2011.  One of the 
recent NARMS Human Isolates Surveillance Report published in 2018 also highlighted the 
increasing prevalence of azithromycin resistance in human Salmonella isolates (Figure 3).  
Although resistance to azithromycin is currently at low levels, the trends observed [32] for 





from 2012 to 2013 and then dropped to 0.0% by 2014.  This level reached the highest 
resistance level (0.3%) in 2015 [32].  
 
Figure 3.  Azithromycin-resistant human Salmonella isolates from 2011-2015 
Adapted from the NARMS Human Isolates Surveillance Report, 2018 [32]. 
Antibiotics are widely used in beef cattle for disease treatment, metaphylaxis 
(disease control), and prophylaxis (disease prevention) purposes.  Metaphylaxis is 
commonly used to control infectious bacterial diseases in cattle herds during the onset and 
early stages of an outbreak.  One of the major challenges of the cattle feedlot industry is 
bovine respiratory disease (BRD; also known as shipping fever) caused by pulmonary 
pathogens and stress factors that emerge upon arrival after transportation from the cow-
calf/backgrounder/stocker industries or auction markets to the feedlots.  BRD is the most 
common health problem of beef cattle causing both high morbidity and mortality[33].  
BRD is estimated to affect 16.2% of cattle arriving to U.S. feedlots.  More than half (60%) 
of the U.S. cattle population receive metaphylaxis to reduce the incidence of BRD in 
feedlots [34].  Following the initial metaphylactic treatments for BRD, cattle are not 





period that may take three to ten months until the cattle reach the desired slaughter weight 
[35]. 
It has been also documented that antibiotics that are used for BRD in beef cattle for 
any therapeutic  purpose (i.e. treatment, control, prevention) may significantly or 
transiently increase the number of AR bacteria among enteric populations recovered from 
cattle [36-45].  There are also other studies showing lesser effects of antibiotic use in 
enteric bacterial populations [46-51]. 
Ceftiofur crystalline-free acid (CCFA; also referred herein simply as ceftiofur) and 
tulathromycin are two antibiotics that are approved and commonly used to control BRD in 
cattle herds [34, 52, 53].  Ceftiofur (an analog of ceftriaxone) – as crystalline-free acid – is 
a long-acting 3rd generation cephalosporin formulation that  was approved to treat BRD 
infections in both dairy and beef cattle in 2003; in addition, its label extends to the 
metaphylaxis of BRD in beef cattle.  Tulathromycin (an azalide subclass of macrolide) is 
an analog of azithromycin that is also in the same subclass and was approved for use in 
beef cattle for BRD in 2005.  Both ceftriaxone and azithromycin belong to two of five 
antibiotic classes that are listed as the highest priority critically important antimicrobials 
for human medicine by the World Health Organization (WHO) [54]. 
Beginning with the fact that BRD antibiotics can select for bacterial resistance, it is 
crucial to determine the selection effects of ceftiofur and tulathromycin on the resistant 
bacterial population in food-producing animals; that is, selection pressure that may 





1.4.   Research significance  
Salmonella is one of the most important bacterial foodborne pathogens, causing a 
significant number of human infections and deaths every year in the United States.  Cases 
of salmonellosis attributed to MDR Salmonella infections may not be responsive to 
antibiotic treatment.  Macrolides and 3rd generation cephalosporins play a critical role in 
the treatment of human Salmonella infections.  Trends show increasing numbers of 
ceftriaxone- and azithromycin-resistant Salmonella recovered from human isolates.  
Ceftiofur and tulathromycin are analogs of these antibiotics, both of which are widely used 
in cattle herds to control BRD infections.  Since antibiotic use in beef cattle may result in 
the selection of resistant bacterial populations in cattle, studies aiming to measure the 
direct effects of ceftiofur and tulathromycin use for BRD metaphylaxis in cattle are 
necessary.  
Even though there are several epidemiologic observational and case-control studies 
existing in the literature aimed at understanding associations between antibiotic use and 
selection pressure for AR Salmonella in cattle, longitudinal randomized and controlled 
field trials are superior to these study designs; that is, they provide direct measurement of 
the effects of the antibiotic treatments on the bacterial population distributions of 
susceptible and resistant strains by controlling the environmental- and the host-related 
factors impacting the ecology – and consequently affecting the epidemiology – of 
antibiotic resistance.  There are only a few longitudinal randomized controlled cattle trials 
that have measured the effects of these antibiotics on E. coli (an organism that is widely 
accepted as one of the indicator microorganism for AR profiles of gram-negative bacteria 





While a few of these studies reported a significant or transient effect of the antibiotic 
treatment on the resistance of enteric bacteria in cattle  [36-41], the remaining studies 
tended to report little or no effects on these populations following antibiotic administration 
[46, 47, 51].  Among those, only Ohta et.al (2017) examined the direct effects of ceftiofur 
treatment in beef cattle on enteric Salmonella populations [36].  There are no existing 
studies in the literature measuring the effects of tulathromycin treatment on cattle 
Salmonella populations.  The existing studies measuring the effects of tulathromycin on 
enteric bacterial populations in cattle were limited to metagenomic populations [46, 51].  
These studies listed above explored the dynamics of the effects of these treatments for a 
maximum 28 days after the metaphylaxis; therefore, the potential public health risks of the 
treatments remained unknown until the slaughter age (90+ days).  In addition, the focus of 
all these randomized controlled field trials was restricted to fecal samples.  Therefore, no 
information was provided for the lymph node and hide origin Salmonella populations 
following the treatments.  
The significance of this study was to utilize an epidemiological approach to fill two 
research gaps in the literature in order to understand the potential public health risks of 
ceftiofur and tulathromycin administration on the Salmonella populations in feedlot cattle.  
The first need was to determine the long (90+ days) term effects of these antibiotics at 
slaughter after they were administered early in the feeding period.  The second need was to 
measure the effects of these antibiotics not only in fecal samples but also in the lymph 
nodes and on the hides, each of which can be a potential source of beef contamination at 
slaughter.  For this study, sampling the feces throughout the feeding period is important to 





A main focus of this study was examining specifically the sub-iliac lymph nodes 
that are in the flank region of cattle.  The extensive fat tissue mass surrounding the lymph 
node means these are more likely to be introduced into ground beef products than with 
other lymph nodes.  To understand the pen/environment-related contributions to the 
Salmonella population, we also aimed to examine hide swabs collected from the brisket 
area of the cattle that were less likely to reflect animal-animal contamination.  This region 
is most likely to reflect the environmental Salmonella carriage because of continuous 
contact of the brisket region with the pen floors during periods of rest. 
Filling these gaps provides us an accurate and realistic approach to understanding 
the potential risk factors related to the consumption of AR Salmonella contaminated beef 
products obtained from the beef cattle that received BRD metaphylaxis upon arrival to the 
feedlot (at an early stage of feeding.  In addition to filling the gaps listed above, this study 
also provides the serotype and phenotypic distribution of the Salmonella populations found 
in the cattle, since serotype and antibiotic resistance profiles tend to ne highly correlated in 






1.5.   Research objectives 
The main objective of this study was to determine the effects of ceftiofur and 
tulathromycin treatments on the population dynamics of Salmonella in feedlot cattle from 
early in the feeding period until slaughter.  The specific aims of the study were as follows:  
1. To compare the prevalence, quantity, and phenotypic antibiotic resistance of 
Salmonella from feces collected before and after antibiotic treatments throughout 
the cattle feeding period, and to provide these comparisons among the feces, lymph 
nodes, and hides at slaughter age. 
2. To evaluate the population structure and serotype distribution of Salmonella across 






2.   LITERATURE REVIEW 
2.1.   Cattle origin Salmonella  
Salmonella in cattle are considered a serious food safety and animal health issue 
that cause significant negative impacts to the feedlot industry [55].  Cattle are usually 
exposed to Salmonella through ingestion of contaminated feed and water [14, 56].  
Salmonella-infected cattle became carriers and shed Salmonella through their feces to the 
feedlot environment where Salmonella can became a persistent problem [2].  The risk 
factors for developing Salmonella infections in cattle include the number of cattle in the 
herd, feed and water quality, levels of pasture/pen contamination, fertilizer contamination, 
duration in pen, the density of Salmonella shedding of pen mates, and excessive numbers 
of rodents or wild animals on farms [2, 55]. 
The majority of Salmonella serotypes can reside in the intestinal tract of healthy 
cattle without causing disease in their host.  However, a mostly cattle-specific serotype (S. 
Dublin, which also became associated with human infections recently) can result in acute 
(clinical) infections and other non-specific serotypes (e.g., S. Typhimurium, S. Enteritidis, 
S. Newport, and S. Cerro) can result in acute and sub-acute clinical infections in cattle [57].  
Cattle infections caused by the S. Dublin serotype can be epidemic and highly contagious 
in dairy cattle herds resulting in high morbidity.  On the other hand, S. Typhimurium 
outbreaks can be more sporadic but also with high mortality [58].  In recent years, S. 
Newport and S. Cerro serotypes also have been associated with Salmonella outbreaks in 
dairy cattle [59, 60].   
The prognosis of salmonellosis in cattle depends on host immunity, the virulence 





Salmonella infections in cattle usually appear 5-7 days after the exposure and symptoms 
can vary from fever, depression, severe diarrhea (watery or bloody), abortion, respiratory 
disease (specifically, in calves) to septicemia and death [2, 55, 61].  On the other hand, 
sub-clinical infections usually progress without apparent clinical signs, but may cause local 
infections in cattle lymph nodes, spleen, or liver.  These animals become latent carriers or 
intermittent shedders and consequently shed Salmonella through their feces after the initial 
infection and for a long-time period [2, 61].  
Other Salmonella serotypes that are simply members of the commensal 
gastrointestinal microbiota of cattle are ubiquitous.  These serotypes, that generally are not 
pathogenic to cattle, can also proliferate in the feedlot environment.  However, these 
serotypes may be pathogenic for humans, causing gastrointestinal tract infections [62, 63].  
Therefore, the ecology and epidemiology of Salmonella in cattle and their production 
environments needs to be better understood to assess the possible public health risks of 
Salmonella contamination in beef products and other cattle-related sources.  In the 
literature, there are various detection, identification, and quantification methods available 
to evaluate the ecology and epidemiology of Salmonella in cattle feces, lymph nodes, and 
on hides, and in the cattle environment.  
2.1.1.   Detection of Salmonella 
Salmonella isolation from various sample types, such as feces, tissues, soil, 
feedstuffs, food, and other environmental samples may take up to 5-7 days using various 
microbiological and molecular techniques and methods [3, 64].  The combination of both 





Salmonella from samples that harbor various bacterial species in the microbiota such as 
fecal, lymph node, and hide samples [3, 65].  Non-selective pre-enrichment broth, such as 
buffered peptone water (BPW) or tryptic soy broth (TSB), provide the main nutrients and 
chemicals – such as casein, peptone, sodium chloride, phosphate, glucose, and water – that 
are required for Salmonella growth, and are usually utilized as the initial step to increase 
the total number of target bacteria – including Salmonella – found in a sample.  Following 
non-selective enrichment, a Salmonella-specific (selective) enrichment broth usually is 
utilized to increase the numbers of Salmonella.  These specific enrichment broths, such as 
tetrathionate (TT), Rappaport-Vassiliadis R10 (RV), and selenite cystine, provide a 
selective media environment for Salmonella by inhibiting other microorganisms found in 
the sample.  The majority of these selective features of Salmonella specific agars are 
combined with the compounds that Salmonella is naturally more resistant to than other 
members of Enterobacteriaceae.  These compounds include – but are not limited to –  
selenite, tertigol, bile salts, iodine, brilliant green, and malachite green [2, 66].  The 
selectively enriched suspensions are further inoculated on a selective agar plate, such as 
xylose lysine deoxycholate agar, Hektoen enteric agar, bismuth sulfite agar, and brilliant 
green agar (BGA) to distinguish Salmonella from other microorganisms that can survive 
throughout these passages, and are further selected based on their standard colony 
morphologies [64, 67-69]. To increase the specificity of Salmonella isolation and eliminate 
false-positive Salmonella results, combining the pre-enrichment, specific enrichment broth 
and selective agar is highly recommended.  Even though performing these methods can be 





media processed in the aforementioned sequence is accepted as the gold standard for 
highly sensitive and specific Salmonella detection and determination [3, 64]. 
Even though these combinations are generally enough to isolate Salmonella, they 
are often not successful in eliminating Citrobacter spp. and Proteus spp. that are 
commonly found in the environments that Salmonella inhabit; most often, this is due to 
similarities observed among the morphologies and/or indicative biochemical reactions.  
Essentially, selective enrichment media are often not enough to eliminate such 
microorganisms from samples for which the aim is to isolate Salmonella.  For example, 
Salmonella is known to be naturally resistant to novobiocin up to a minimum inhibitory 
concentration (MIC) of 2,400 µg/ml; on the other hand, Proteus spp. are susceptible and 
inhibited at concentrations between 25-400 µg/ml [70].  Therefore, a selective medium 
combined with ≥ 25 µg/ml novobiocin (i.e., TT- novobiocin, RV- novobiocin, BGA- 
novobiocin) may be preferred due to its ability to suppresses the growth of Proteus spp. 
and to  reduce Citrobacter spp. growth by up to 50% [16, 71, 72]. 
The conventional culturing methods listed above are standard methods to detect 
Salmonella in samples of animal origin.  However, it should be noted that the sensitivity 
and specificity limits of non-selective and selective enrichment methods, and the effects of 
incubation parameters for detection or isolation of Salmonella, have been studied by few 
researchers [65, 73].  Significant (P < 0.05) differences in performance of five different 
culture methods used to isolate Salmonella in swine feces have previously been reported 
[65]. According to that study, initial selection by tetrathionate broth, followed by RV 
broth, was found to be superior to using only one single specific enrichment step.  These 





serotypes [74-76].  For example, adding novobiocin to the enrichment broth  and then 
following this with inoculation of the suspension onto BGA plates improved the 
probability of selecting S. Dublin versus using an XLD plate [76], and when compared to 
the other methods.  Gorski et al. (2012) [74] tested if certain media enrichments would 
favor certain serotypes or serogroups.  They tested 10 serotypes that belong to 4 
serogroups (B, C1, C2, and E) by using either TSB enrichment, TSB enrichment followed 
by RV, or else RV containing soy peptone broth.  Among all methods tested, they found 
that mainly serogroup C2 and E isolates were selected compared to the remaining 
serogroups; of concern, serogroup B was detected at the lowest numbers. 
One of the limitations of these microbiological methods is that they only provide 
the opportunity to detect Salmonella at the species or subspecies-level.  Therefore, for the 
further discernment and identification of Salmonella, additional biochemical, serological, 
and molecular techniques are required.  
2.1.2.   Identification and characterization of Salmonella 
Several traditional biochemical reaction tests are used for the initial identification 
of Salmonella.  The principle of these biochemical tests is typically based on an active 
enzymatic reaction catalyzed for a biochemical compound that helps to differentiate 
Salmonella at the subspecies-level, except for a few serotypes.  These biochemical reaction 
tests include, but are not limited to, glucose fermentation, negative urease reaction, 
hydrogen sulfide (H2S) production, and negative indole tests [3].  For example, non-
typhoidal Salmonella can ferment lactose, whereas the remaining subspecies cannot.  On 





(thus, they can grow in a simple medium that contains glucose and ammonium ions), they 
are not easily distinguishable using biochemical reaction tests.  However, several host-
specific serotypes (e.g., S. Typhi, S. Gallinarum, and S. Abortusovis) require certain 
growth factors that are associated with host-specificity, and these can be distinguished by 
their biochemical reactions.  For instance, S. Typhi A fails to produce H2S; on the other 
hand, other non-typhoidal Salmonella serotypes can produce H2S to decarboxylate the 
lysine [2].  
In addition to these biochemical methods, whole-cell matrix-assisted laser 
desorption ionization (MALDI), time of flight (TOF) mass spectrometry (MS) has become 
an alternative novel cost-effective technology commonly used for rapid identification of 
ribosomal protein compositions (ribosomal fingerprints) of Salmonella species and 
subspecies [77, 78]. This method can successfully discriminate the soluble proteins at the 
mass range of 2000-20,000 Da (Dalton); that is, those usually belonging to the ribosomal 
proteins in a bacterial cell.  The principle of this method is based on the desorption of 
bacterial cells on a matrix surface by nitrogen laser beams and then measuring the flight 
time of the ionized proteins by a spectrometer.  The protein patterns of the molecules are 
recorded in a format calculated by the mass (m) amount divided by the electrical molecule 
charge (z).  Later, the m/z result is compared with the main spectra protein database and 
presented as an output with confidence scores.  This method produces highly accurate, 
rapid, cost-effective and reliable results and has been widely used in many clinical 





2.1.2.1.   Identification of subtypes 
The majority of Salmonella outbreaks have been found to be subtype dependent 
[12].  Therefore, identification of Salmonella at the subtype-level plays an important role 
in the investigation and understanding of the possible source and distribution of an 
outbreak.  There are numerous subtyping methods that have been developed, both at 
culture- and molecular-level.  The subtyping methods of Salmonella include, but are not 
limited to: serotyping, bacteriophage typing, pulsed-field gel electrophoresis (PFGE), and 
multi-locus sequence typing (MLST) [80].   
Salmonella serotyping is one of the oldest subtyping methods and is based on 
serologic cell component characteristics of Salmonella.  In recent years, Salmonella 
serotyping has gained importance due to fact that the majority of human Salmonella 
outbreak cases are usually traced back to several (<100) known human Salmonella 
serotypes [12, 62, 63].  There are several serological and molecular techniques available 
for Salmonella serotyping.  
The serum slide-agglutination test is one of the traditional serological tests used for 
Salmonella identification at the serotype-level.  The principle of the slide-agglutination test 
is based on agglutination reactions observed to occur between the polyvalent antisera and 
Salmonella specific antigenic components using commercial antiserum kits.  These 
components consist of 1) bacterial surface (somatic O), 2) flagellar (H1 and H2), and 3) 
capsular (Vi) antigens.  All members of Salmonella serotypes express somatic and at least 
one flagellar antigen.  However, the capsular antigen is only expressed by S. Typhi, S. 
Paratyphi C, and S. Dublin serotypes.  The antigenic formulae of Salmonella serotypes 





identified serotypes are updated by the WHO Collaborating Centre for Reference and 
Research on Salmonella at the Pasteur Institute, Paris, France [81, 82].  This test (now 
named by some as: Kauffman-White-Le Minor) is widely used and accepted as a gold 
standard for preliminary identification of Salmonella species, subspecies, and serotypes 
[3].  However, the results of the test are heavily dependent on the decision of the observer, 
and thus can vary within and among laboratories.  Furthermore, obtaining the specific 
antisera for more than 2,600 Salmonella serotypes and testing the isolate of interest against 
each antiserum is laborious, time-consuming, and costly for researchers. 
There is also a molecular approach targeting the genes encoding the same specific 
antigenic cellular components in non-typhoidal Salmonella using whole-genome 
sequencing (WGS) and bioinformatic tools [83].  The serotypes of Salmonella are 
identified by the genomic variations observed in these components.  Currently, there are 
two standardized, reliable, and generally accepted in silico tools available for Salmonella 
serotyping using high-throughput sequencing data: Salmonella in silico Typing Resource 
(SISTR) [84] and  SeqSero [85].  Both tools determine wzx and wzy genes and rfb gene 
clusters, which are specific for somatic (O) antigens, as well as fliC and fljB gene alleles, 
which are specific for flagellar (H1 and H2, respectively) phases.  These tools scan and 
determine the unique gene sequences in WGS data that are matched in certain Salmonella 
serotype classifications recognized in the Kauffmann-White-LeMinor Scheme [81].  A 
study comparing SeqSero with traditional serotyping found that the traditional serotyping 
method failed to identify 36 isolates where they were all identified using SeqSero.  
However, SeqSero was also reported to provide incorrect calling of antigenic determinants 





to SISTR due to providing an opportunity to determine the serotypes from the raw 
sequencing reads, rather than relying on assemblies [83].  Even though using in silico tools 
has several advantageous over traditional serotyping methods, one of the major 
deficiencies is the fact that these tools are fully dependent on the prior-defined sequences 
already existing in the serotype database.  Therefore, it is highly important to identify 
serotypes using the most updated databases and using traditional methods for unidentified 
strains in order to be able to recognize newly emerging strains.  
It has been shown that serotyping Salmonella is not enough when various 
homology or lineage differences can be observed within a single-serotype.  For example, 
outbreak data collected from S. Enteritidis strains showed that traditional molecular 
serotyping methods were not enough to determine the lineages observed within these 
serotype-specific strains found in different locations and settings [86].  Therefore, other 
high-resolution subtyping methods have also gained importance to fully identify the 
lineages and homology characteristics of an outbreak strain.   
One of the most common and traditional molecular identification methods is the 
PFGE.  PFGE detects the genetic characteristics (DNA fingerprints) of bacterial isolates 
using restriction enzymes (endonucleases) to cut DNA into large fragments; later, these 
fragments are placed into a gel and exposed to an electrical field that is constantly 
changing voltage and direction.  The electrical field separates the DNA fragments 
according to their sizes and creates strain-specific DNA patterns that can be compared.  
PFGE has highly standardized protocols that are widely accepted and applied in broad-
spectrum pathogens; perhaps surprisingly, the results are comparable both domestically 





it is highly dependent on the choice of restriction enzymes (e.g., xbaI, BlnI, SpeI) used, 
conditions of the electrophoresis gel, and the skills of the technician.  It has been shown 
that PFGE also has low sensitivity for differentiating some Salmonella subtypes because of 
those varieties and lineages that have been observed within serotype-level that are not 
detectable with these restriction enzymes [80].  Up until 2014, this method was accepted as 
the gold standard by the U.S. national reference laboratory at the CDC (e.g., PulseNet) for 
bacterial molecular pathogen typing due to its high reliability, reproducibility, and 
accuracy. 
Due to extensive labor and other limitations of the PFGE method, and the 
comparatively reduced costs of WGS methods (when factoring in other data that are 
provided), PulseNet and the national reference laboratories started to use WGS data for 
Salmonella typing since 2014.  The WGS approach has not only replaced PFGE by 
providing higher accuracy and reproducibility, but also is preferred due to providing a 
wealth of genomic data about other genetic characteristics; these include – but are not 
limited to, antibiotic resistance genes (ARGs), genomic islands, virulence genes, non-
synonymous and regulatory effectors (e.g., single-nucleotide polymorphic regions), and 
plasmids.  WGS also provides an opportunity to perform genotypic comparisons to analyze 
the phylogenetic relationships across/among different species, subspecies, and subtypes.  
WGS data obtained from researchers are deposited in online databases, which gives 
scientists around the world the opportunity to obtain WGS data from various domestic and 
international laboratories and to perform comparisons [87].  The WGS method is proven to 
provide more robust phylogenetic inferences with a high epidemiological correlation for 





numerous WGS bioinformatics tools have been developed to perform in silico analyses of 
Salmonella using WGS data [5, 84, 85, 87].   
MLST is one of the molecular subtyping methods using bacterial WGS data that 
was first proposed as a replacement for non-typhoidal  Salmonella serotyping by Achtman 
et al. (2012) [5].  This method detects the SNP (single-nucleotide polymorphism) 
variations in the genomic sequences and gene clusters based on the similarities observed in 
DNA sequences; furthermore, these sequences are matched with previously identified 
MLST gene groups deposited in the MLST database to provide information on subtype 
groups [5].  The gene sequences that are utilized through MLST are based on the level of 
genes such as: ribosomal (rMLST), core genome (cgMLST), whole-genome (wgMLST), 
and legacy MLST.  Legacy MLST is based on a concept that determines SNPs in the 
housekeeping genes, which are found to be specific for each sequence type (ST).  For the 
Salmonella legacy MLST analysis, there are seven housekeeping gene fragments used: 1) 
aroC (chorismate synthase), 2) dnaN (DNA polymerase III, β-subunit), 3) hemD 
(uroporphyrinogen III synthase), 4) hisD (histidinal dehydrogenase), 5) purE 
(phosphoribosylaminoimidazole carboxylase), 6) sucA (2-oxoglutarate dehydrogenase 
decarboxylase), and 7) thrA (aspartokinase I) [5].  The ST types are determined based on 
unique sequence variants found in the non-typhoidal Salmonella MLST database curated 
from public databases for molecular typing and microbial genome diversity platform 
(PubMLST; www.pubmlst.org).  
Even though protein-level Salmonella typing at species- and subspecies- level has 
been explored by MALDI-TOF MS, this method was not successful in identifying 





belonging to the same subspecies groups [77].  However, a study conducted by Dieckmann 
et al. (2011) showed that MALDI-TOF MS can successfully identify the five most 
common human Salmonella serotypes (S. Enteritidis, S. Typhimurium, S. Virchow, S.  
Hadar, and S. Infantis) observed in European countries by using the biomarkers for unique 
proteins prior to the MALDI-TOF MS process [78].  Serotyping using MALDI-TOF MS 
may well become a promising approach in the future by developing unique spectra 
databases, biomarkers, and different measurement parameters for the identification of an 
entire group of Salmonella serotypes. 
2.1.2.2.   Characterization of antibiotic resistance profiles 
One of the most important aspects of Salmonella characterization for public health 
is determining the ARG traits at microbiological (phenotypic) and molecular (genotypic) 
levels.  Phenotypic antimicrobial susceptibility testing (AST) can be determined based on 
colony growth observed under different concentrations of antibiotic-containing media.  E-
tests, disc-diffusion, agar dilution, and the broth (both macro- and micro-) dilution methods 
are traditional and widely used methods for the identification and characterization of 
phenotypic antibiotic resistance [88].  While disc diffusion method only can provide 
binary-coded data (resistant or susceptible), other methods can provide quantitative, semi-
quantitative, or categorical data that are related to the MIC of an antibiotic; that is, by 
testing the growth of the target microorganisms under various concentrations of different 
antibiotics and antibiotic combinations.   
Among those methods, the broth microdilution method is widely used in clinical 





customized plates [89].  The results of phenotypic antibiotic resistance tests are mainly 
interpreted by the guidelines established by two major organizations: the Clinical 
Laboratory Standards Institute (CLSI) located in the United States [90] and the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST) located in Europe [91].  
One of the major differences among these organizations is the additional clinical 
interpretation classification of “intermediate resistance” that is defined in CLSI guidelines 
but not in EUCAST guidelines.  This class refers to the MIC values that fall in the range 
between the MIC value of susceptible and resistant.  Besides this difference, the way of 
each organization interpretations of MIC values for classification of resistance is also 
different.  For example, the EUCAST uses the epidemiologic cut-off values, which are 
determined by the difference between the MICs of the wild-type strain (that are sensitive to 
the antibiotic tested) and those strains with acquired resistance.  On the other hand, the 
CLSI uses clinically interpreted cut-off values for resistance that are based on the likely 
treatment success of the antibiotic for a given strain in the clinics.  This incorporates both 
microbiological, pharmacological, and physiological parameters.  These differences may 
result in slightly different interpretations of the antibiotic resistance for any tested 
microorganism and antibiotic [92].   
In addition to these AST methods, using molecular techniques, the determination of 
ARGs in bacteria is also important to understand the molecular insights of antibiotic 
resistance mechanisms and their relation to phenotypic resistance  [93].   
Molecular methods to identify the ARGs are utilized either using standard PCR 
(polymerase-chain reaction) methods, which are usually performed with designed ARG 





species [95]. The ARGs can also be determined by using next-generation sequencing 
methods along with the bioinformatic tools applied on to WGS data that rely on comparing 
gene sequences against given ARG nucleotide or protein sequence databases [96].  
Recently, WGS has become a cost-effective and robust method that is preferred to detect 
tall he ARGs from bacterial genomes.  In addition to the ARGs, this method provides a 
large amount of other bacterial WGS related information [93, 97].  The most commonly 
used ARG databases include, but are not limited to, ResFinder [98], the Comprehensive 
Antibiotic Resistance Database (CARD) [99], and the Antibiotic Resistance Gene-
Annotation (ARG-ANNOT) database [100].   
Salmonella can acquire antibiotic resistance by chromosomal mutations that can 
cause rapid changes in bacterial populations to reduce the susceptibility to an antibiotic 
that originally either limits the growth of the bacterial cell or else destroy the bacterial 
cells.  However, viable chromosomal mutations are considered as rare events in Salmonella 
[101, 102].  Another acquired resistance mechanism in Salmonella is through horizontal 
gene transfer that occurs via plasmids, bacteriophages, and transposons [103].  
Conjugation events that are orchestrated by the plasmids are the most common horizontal 
transfer events in Salmonella and can result in the transfer of the up to seven or more 
antibiotic resistance elements at one time [104].  These transfers are often coordinated by a 
mobile DNA element that can be harbored in a plasmid located in the bacterial cell, or else 
or can be inserted into the bacterial chromosome as genomic islands, integrons, and 
insertion elements [105, 106].  Moreover, these resistance plasmids can be shared inter- 





Therefore, understanding the plasmidal relations of the ARGs in Salmonella 
provides insights into the epidemiology of AR Salmonella and their related sources [108].  
Besides the ARG encoding plasmids, there are also different types of plasmids identified in 
Salmonella.  These plasmids can either harbor virulence genes that are specific for 
Salmonella subspecies or serotypes, or else harbor the biological function genes to reduce 
the fitness cost of those genes for the bacterial DNA [109].  The plasmidal profiles of 
bacterial strains can be determined by a bioinformatic tool called PlasmidFinder.  It 
matches the WGS data with a nucleotide-based plasmid database curated from PubMLST 
using plasmid MLST (pMLST) consisting of previously identified plasmidal DNA 
sequences [110]. 
Even though ARGs provide more accurate genetic information, from a public 
health perspective phenotypic resistance is still the most important outcome of the 
antibiotic resistance and is required to be determined along with the ARG information 
from the bacterial isolates.  Currently, prediction of phenotypic resistance using WGS data 
became a popular and important research subject pursued by some utilizing machine 
learning [111].  The focus of such an approach is to develop phenotypic antibiotic 
resistance predictions accurately and  to understand the patterns of antibiotic gene 
expressions using a large data set that contains both WGS data and isolate-specific MIC 
values [97, 112].  Even though this method provides an “idealistic” approach to identify 
the features of antibiotic resistance, the necessity of microbiological methods remains 





2.1.3.   Quantification of Salmonella 
Quantification of Salmonella is important to determine for estimating the potential 
risks of Salmonella shedding in the feedlots and the potential risks of causing Salmonella 
infections in humans through carcass and environmental contamination.  Therefore, 
Salmonella quantification in cattle feces, which is the primary source of shedding in the 
feedlots has been evaluated by researchers [69, 113].  Specifically, quantification of 
Salmonella in the feces, lymph nodes and on hide surfaces is important to better estimate 
the risks of human Salmonella infections that are proven to be related to the dose of 
exposure.  The dose of human infection for Salmonella is reported to vary from <102 to 
1010 [114], though it is ethically nearly impossible to update these risk estimates in the 
present day.  
Determining the estimated quantity of Salmonella colonies in samples is often not 
simple and is inaccurate due to the detection or quantification (low- or high-) limits of the 
techniques, only a subset of a sample being tested, complex background microbiota, and 
uneven distribution of Salmonella in the samples.  There are numerous cultural or 
molecular methods available for Salmonella enumeration from cattle sources [15, 67, 113, 
115-118].  The most probable number (MPN, the results are expressed as MPN per weight 
or area of the sample) and viable plate count (the results are expressed as colony-forming 
units [CFU] per weight or area of the sample) are the two commonly used microbiological 
methods to quantify cattle origin Salmonella from feces [69, 113], lymph nodes [15, 118], 
hide [67, 69].  The direct plating method is one of the traditional culture-based Salmonella 
enumeration methods, which is based on serially diluting and plating the various 





or area by back-calculating the starting concentration, the direct plating method can be 
useful for the quantification of low concentrations of Salmonella in samples [119].  
However, direct plating is a time- and material-consuming laborious method to obtain CFU 
counts from a high number of samples, and it is highly dependent on the pipetting accuracy 
of the technician.  An automated spiral plating technique [119] provides the opportunity to 
spread the multiple dilutions of a bacterial inoculum on a single-agar plate. After the 
incubation of these plates, an automated plate reader also can be utilized to obtain the CFU 
counts of Salmonella.  Using the spiral plater and plate reader together reduces time, cost 
and errors related to the human factors.  This method is also commonly used to quantify 
CFUs of Salmonella from feces, lymph nodes and hides [117, 120, 121]. 
In addition to culture-based methods, a quantitative PCR based (qPCR) method can 
also be utilized by quantifying Salmonella-specific genes such as members of the inv/spa 
gene complex with specific primers [15, 67, 122].  Combining the PCR method with a 
selective pre-enrichment process can also decrease the lower limits of quantification (LLQ) 
of Salmonella when the density of Salmonella in the samples is expected to be low or 
variable in the samples.  This additional pre-enrichment step also provides necessary 
adaptation time for cells that might be stressed or damaged during transport and storage 
prior to the PCR-based quantification methods [115].  
However, the qPCR method is also laborious and can detect Salmonella at the 
gene-level, which also has limits of quantification.  In addition, this method can determine 
the Salmonella quantity based on the quantity of total DNA, which fails to reflect the 





2.2.   Salmonella in cattle and feedlots 
The fecal Salmonella population in cattle depends on various environmental (i.e., 
season, farm management, and quantity of Salmonella) and cattle- related (i.e., behavior, 
source of cattle, Salmonella shedding density and frequency, and age) factors [123-125].  
Cattle shed Salmonella to the pen environment through their fecal waste and consequently 
can contaminate other cattle housed in the same pen or feedlot [126].  This results in the 
contamination of cattle hide surfaces due to the direct contact with the pen floors.  Cattle 
hides can also be contaminated with pen- or environment-origin Salmonella during dust 
events or due to aerosolization of pen-floor material by hoof action [127].  Moreover, cattle 
behaviors (e.g., grooming, licking the farm equipment) can also cause repeating 
contamination between the environment and the digestive tract of the cattle.  Therefore, 
Salmonella in the feedlots builds and can become a persistent opportunistic pathogen over 
time.  
Carcass-level contamination via hides can directly occur during hide skinning and 
the evisceration processes or indirectly occur via contact with the slaughterhouse 
environment or equipment at the harvesting stage [19, 128, 129].  In addition to fecal and 
hide origin Salmonella, lymph node origin Salmonella may also be incorporated into 
ground beef products during the fat/lean trimming events in food-processing facilities [20, 
130, 131].  Cattle lymph nodes are embedded in fat tissue that is highly valued for 
improving the fat content of ground beef products.  Since these lymph nodes are relatively 
small in size compared to the fat tissue that surrounds them, they can be difficult to 
identify and eliminate during the trimming events.  Specifically, the massive fat tissues 





(superficial cervical) and prefemoral (sub-iliac) lymph nodes are considered as being of 
high-risk for incorporation into these beef products [20].  It has been shown that even 
healthy cattle can have Salmonella in their lymph nodes [132].  Salmonella in lymph nodes 
have also been found to be associated with host status, the route of transmission, inoculum 
amount, and serotype [121, 133-135].  In addition to cattle origin, the lairage environment 
was also reported as a possible origin of Salmonella contamination [122].   
Clearly, the cattle feces, lymph nodes, and hides are commonly perceived as the 
primary contaminants of cattle origin Salmonella found on carcass surfaces and in beef 
products.  Therefore, to estimate the public health risks of cattle origin Salmonella, there 
have been numerous studies conducted to determine the prevalence, quantity, serotype, and 
antibiotic resistance profile distribution of Salmonella in ready-to-harvest healthy beef 
cattle [15, 68, 69, 132].  These studies have been mainly observational studies conducted 
to analyze the possible risk factors (e.g., geographical, feedlot related, and seasonal) of 
fecal, lymph nodes and hide origin Salmonella populations in cattle presented for 
slaughter.  
Vikram et al. (2017) collected fecal samples from cattle raised conventionally (n= 
360) and without (n = 359) antibiotics from large slaughter plants located throughout the 
United States from February 2014 to January 2015 [136].  Overall, Salmonella prevalence 
was estimated at 13.8%, which did not statistically differ (P = 0.42) between cattle raised 
without antibiotics versus conventionally.  However, the Salmonella prevalence in these 
cattle was significantly (P < 0.01) higher in summer (38.3%) when compared to fall 
(9.4%), winter (5.6%), and spring (1.7%) months.  Salmonella prevalence in the feces of 





tested Salmonella isolates for phenotypic resistance to a 3rd generation cephalosporin 
(cefotaxime) and to nalidixic acid.  Among all Salmonella isolates, only one isolate 
showed phenotypic cefotaxime resistance and no isolate was resistant to nalidixic acid, 
suggesting no reduced susceptibility was observed against ciprofloxacin.  They also 
analyzed the abundance of ARGs among the conventionally and raised-without-antibiotic 
cattle samples.  They found a significant increase (P < 0.01) in tetracycline, 
aminoglycoside, and macrolide resistance genes among conventionally raised cattle 
samples when compared to the samples from cattle raised without antibiotics.  The ARGs 
encoding for 3rd generation cephalosporins were at low-abundance and did not differ 
between the two groups.  However, in their study the antibiotic use information was not 
available for the cattle that were raised conventionally; this lack of differentiating 
information needs to be carefully considered before deriving any conclusions from this 
study about the selection effects of antibiotic use on antibiotic resistance observed in beef 
cattle feces.  
A cross-sectional year-long observational study conducted by Kunze et al. (2008) 
involved collecting hide swabs (n = 1,081) from the perineal region of cattle at four 
slaughterhouses along with fecal samples (n = 600) from pen floors of six feedlots holding 
harvest-ready cattle in the southern United States [69].  Within this study, Salmonella 
prevalence and quantity, along with serotype and phenotypic antibiotic resistance profile of 
isolates, from hide and feces were determined.  In their study, the Salmonella prevalence 
was reported higher in hide (69.6%) compared to fecal samples (30.3%).  Furthermore, 
they also analyzed seasonal effects on the prevalence but did not report any significant 





as 1.73 log10/100 cm2 for hide and 0.71 log10/g for feces.  The serotype identification of 
762 isolates recovered from this study showed that the most common serotypes isolated 
from hide and feces were S. Anatum (22.9% and 32.5%, respectively), S. Montevideo 
(22.9% and 19.6%, respectively), and S. Mbandaka (10.0% and 14.7%, respectively).  S. 
Cerro (14.9%) was more prevalent on the hides than in the feces (4.3%), whereas S. 
Kentucky was more prevalent in the feces (16.0%) than in the hide samples (5.7%).  The 
majority of Salmonella isolates were pan-susceptible (51.1%) or else singly resistant 
(33.1%) to either tetracycline or sulfisoxazole.  The ACSSuT (ampicillin, 
chloramphenicol, streptomycin, sulfisoxazole, and tetracycline) and the MDR-AmpC 
phenotypes were almost exclusively observed in 73.7% and 66.7% of S. Reading isolates, 
respectively.  These isolates were recovered from 4.9% of the feces and 1.8% of the hide 
samples.  In their research, a strong serotype and phenotypic resistance association were 
reported. 
Gragg et al. (2013) also investigated the within animal diversity of Salmonella from 
feces, hides (over the foreshank region), and four different types of lymph nodes 
(mandibular, mesenteric, mediastinal, and sub-iliac) of 68 feedlot cattle at a slaughterhouse 
in Mexico [68].  Their study was conducted in early fall and the fecal and hide Salmonella 
prevalences were reported as 94.1% and 100%, respectively.  The highest Salmonella 
prevalence found in lymph nodes was in mesenteric lymph nodes (91.2%) followed by 
sub-iliac lymph nodes (76.5%).  Among 91 isolates, the most prevalent serotypes were S. 
Kentucky (15/91), S. Anatum (26/91), and S. Reading (15/91).  In addition to these 
serotypes, S. Meleagridis, S. Cerro, S. Muenster, S. Give, and S. Mbandaka were also 





serotypes.  According to their results, certain serotypes may be better adapted to either 
lymph nodes or hides rather than feces illustrating that S. Meleagridis was more likely to 
be recovered from lymph nodes than hide and feces.  In contrast, S. Kentucky was more 
likely to be recovered from feces and hides than from lymph nodes.  Approximately 60.0% 
of isolates were susceptible to all antibiotics tested.  Tetracycline resistance was observed 
in 22.0% of the isolates.  MDR was observed for 13.2% of the isolates.  The overall results 
are somewhat confounded by the fact that Salmonella isolation methods used for lymph 
nodes versus hides and feces were different, which may favor some serotypes over others 
(and as the authors stated in their conclusion).  In contrast to Kunze et al. (2008), 
phenotypic antibiotic resistance was not fully associated with certain serotypes; rather, 
AMR phenotypes were associated with certain PFGE subtypes suggesting the feedlot 
origin of these cattle may have been in different regions and with different antibiotic use 
history.  However, this information was not provided.  It is also not known if there were 
any cluster effects of cattle in these data.  Furthermore, the sampling frequency also was 
not provided to eliminate any effects of sampling period factors on the Salmonella 
population.  Therefore, given the relatively small sample size (n = 68), conclusions from 
these data need to be carefully derived. 
The same study group of Gragg et al. (2013) conducted another observational 
cross-sectional study to assess seasonal and regional effects on Salmonella prevalence, 
quantity, and phenotypic antibiotic resistance profiles in bovine sub-iliac lymph nodes at 
harvest [15].  The samples in this study (n = 3,327) were collected from slaughter plants in 
three different regions (i.e., southern, western, and northern United States) and during three 





significantly higher (P = 0.0304) Salmonella prevalence was observed in summer/fall 
months compared to winter/spring.  Also, Salmonella prevalence was significantly higher 
(P = 0.0198) among cattle in slaughterhouses located in the southern United States when 
compared to more northern locations.  Salmonella enumeration from the subset (33.0%) of 
Salmonella-contaminated lymph nodes revealed CFU values ranging from 1.9 to 3.8 log10 
CFU per gram of lymph node tissue.  Serotyping results of the isolates showed that the 
major serotypes were S. Montevideo (44.0%) and S. Anatum (24.8%) among 24 serotypes 
recovered from the total of 266 tested isolates.  Again, in their study, the majority of 
Salmonella isolates were found to be pan-susceptible (86.1%); on the other hand, 8.3% of 
Salmonella isolates were resistant to at least three classes of antibiotics.  The MDR- AmpC 
resistance profile was mostly serotype dependent, and was observed in S. Reading, S. 
Newport, S. Dublin, and S. Typhimurium serotypes.  Since this study had a much larger 
sample size and footprint compared to the previous study (10) and focused on different 
geographical plants in the United States with more extensive sampling (i.e., 76 lymph 
nodes per day with two days for each season), several potential confounding factors were 
likely to be eliminated.  However, as the authors also stated in their conclusion, 11 of the 
13 S. Reading serotypes in this study were from a single sample collection day (and thus, a 
single plant) in the summer months.  This result shows a temporal and likely geographical 
clustering effect observed within their findings. 
Another cross-sectional study was recently published by Webb et al. in 2017, 
evaluating Salmonella prevalence in the sub-iliac lymph nodes of healthy cattle at harvest 
collected during a one-year period from three different regions (i.e., western, southern, and 





collected from 12 commercial slaughterhouses [132] and Salmonella were recovered from 
5.3% of the total (289/5,450).  The authors also reported an increase in prevalence in 
summer/fall (from June through October) months and in the southern  when compared to 
the western and midwestern regions of the United States.  Among positive samples, 
Salmonella CFUs ranged from 1.6 (limit of detection) to 4.9 log10 CFU per gram of lymph 
node.  S. Montevideo (26.9%), S. Lille (14.9%), S. Cerro (13.0%), and S. Anatum (12.8%) 
were found to be the most common four serotypes out of 22 serotypes identified in 376 
(i.e., with multiple isolates recovered from a subset of lymph nodes) Salmonella.  Again, 
many of these isolates were pan-susceptible (80.6%) or else resistant to two or more 
antibiotics (10.7%).  S. Dublin isolates recovered from this study were mostly (24/26) 
resistant to four or more classes of antibiotics.  Tetracycline, sulfisoxazole, streptomycin, 
and chloramphenicol were the most commonly observed antibiotic resistance phenotypes 
among Salmonella isolates.  In this study, the sample size may be sufficient to support a 
conclusion based on seasonal and regional differences, which were also forced into their 
statistical models as fixed effects, along with their interaction terms.  However, the 
seasonal differences observed in such distant geographical locations and the unknown 
spatial distance within and between facilities also need to be further evaluated.  
Estimating the nationwide Salmonella prevalence in feedlots is a challenging task 
due to a large number of feedlots and the wide distribution of these feedlots in various 
geographical locations throughout the United States.  In addition, the point prevalences 
obtained from different sampling seasons show confounding effects on reported the 
Salmonella populations.  Moreover, even though these three studies above (two in the U.S, 





methods can yield a bias when comparing results among laboratories [65]. Therefore, 
conducting a study, either a long-term study that can last for few years, or else collecting 
large nationwide data within a single-year, it is ideal to utilize a single-method to explore 
the actual locational and seasonal dynamics of Salmonella population among cattle and 
feedlots.   
The only up-to-date nationwide Salmonella prevalence survey was conducted by 
USDA (United States Department of Agriculture) -APHIS (Animal and Plant Health 
Inspection Service) and published in 2014 [137].  This survey was conducted based on 
samples collected from 12 U.S. states, which accounted for over 95.0% of the cattle 
inventory in large feedlots during the year of the survey.  From 68 large feedlots, three 
pens were randomly selected for Salmonella detection.  In total, 5,050 individual samples 
were collected from 202 pen floors (25 samples from each pen).  Their findings showed 
that 60.3% of the 68 feedlots had one or more samples that tested positive for Salmonella.  
The most common serotypes that were found in 50.4% of Salmonella recovered from those 
feedlots were S. Anatum (18.0%), S. Montevideo (17.2%), and S. Kentucky (15.2%).  
Phenotypic antibiotic resistance of these isolates was also tested against 14 antibiotics 
(amoxicillin/clavulanic acid, ampicillin, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, 
ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole, 
tetracycline, and trimethoprim/sulfamethoxazole).  Most Salmonella isolates were found to 
be pan-susceptible (74.6%) and the remaining resistance was observed as mostly singly 
resistance (15.9%).  Of these singly resistant isolates, the majority of isolates showed 





These results showed similar prevalence patterns to the previously conducted 
USDA-APHIS survey conducted between 1999 and 2000 [138]. In that survey, samples 
10,417 samples were collected from 73 feedlots from 11 States over the course of one year.  
Salmonella prevalence in different seasons and serotypes was determined.  The highest 
prevalence was observed in summer (11.4%), followed by spring (6.8%), autumn (4.0%) 
and winter (2.5%) based on a total of 654 Salmonella positive isolates.  The top five most 
common serotypes found in the earlier survey were: S. Anatum, S. Montevideo, S. 
Reading, S. Newport, and S. Kentucky.  
Haneklaus et al. (2012) examined the effects of feedlot source on Salmonella 
prevalence in bovine lymph nodes recovered from cattle from seven different feedlots in 
the Southern United States [16].  In their study, two types of lymph nodes (279 superficial 
cervical and 28 iliofemoral) were collected from healthy cattle at harvest.  The total 
Salmonella prevalence for both types of lymph nodes was found to be dramatically 
different among feedlots ranging from 0.0% to 88.2%, thereby, showing that feedlots are 
one of the key factors affecting the ecology and epidemiology of Salmonella found in the 
lymph nodes of cattle [16].  
The observational studies and surveys listed above showed that Salmonella in cattle 
at slaughter age show a wide range of diversity depending on sampling from different 
feedlots, sample types and season.  The key findings suggest that Salmonella prevalences 
during the summer were observed at higher levels when compared to other seasons.  The 
prevalence on hides was generally higher than in the feces and lymph nodes.  Most of the 
cattle origin Salmonella were pan-susceptible (74-80%) or else singly resistant to either 





Montevideo, S. Mbandaka, S. Cerro, and S. Kentucky.  The MDR profile was often 
serotype-specific and typically found in S. Reading isolates, though also other serotypes 
across different regions.  In addition to the cattle/feedlot origin Salmonella, it has been also 
reported that the hide surfaces can also be cross-contaminated with Salmonella during 
transportation to slaughter, further complicating our understanding of the original source of 
contamination at slaughter [122, 139]. 
2.3.   Salmonella in slaughterhouses 
Each year in the United States 30-33 million cattle are slaughtered in commercial 
slaughterhouses [140].  In order to reduce pathogen carriage in farm animals and carcasses 
at slaughterhouse and meat processing facilities, HACCP (Hazard Analysis and Critical 
Control Point) standards have been enforced in slaughterhouse and meat processing 
facilities by the USDA-Food Safety and Inspection Service (FSIS) since 1996 in the 
United States [141].  Salmonella has often been found at high prevalence on carcass 
surfaces and meat products by the Standard Salmonella surveys conducted by FSIS agency 
of the USDA [142].  To meet with the HACCP standards, slaughterhouse facilities often 
utilize carcass interventions such as physical and/or chemical applications at either post-
hide-removal or pre-chill stages.  The post-hide removal interventions include, but are not 
limited to: 1) carcass washing with cold, warm, or hot water, 2) chlorine wash, 3) caustic 
soda wash, 4) bacteriophage application, 5) de-hairing, and 6) lactic, acetic or peroxyacetic 
acid washes.  The interventions applied to beef carcasses at the pre-chill stage include, but 
are not limited to: 1) trimming, 2) hot water wash, 3) steam water wash, 4) lactic acid wash 





The latest Beef-Veal Carcass Baseline Survey published by FSIS in 2016 evaluated 
2,736 post-hide removal and pre-chilled swabs of beef carcasses from August 2014 to 
December 2015.  Post-hide removal swabs were collected when the carcass was de-hided 
and initial interventions were applied.  Pre-chill swabs were collected after the last 
interventions applied (closer to the consumer) before the carcass was placed into the 
coolers.  This survey, conducted by The Nationwide Microbiological Baseline Data 
Collection Program, showed that Salmonella prevalence was 27.1% (371/1,368) on the 
post-hide carcass and decreased to 3.3% (46/1,368) on the same carcasses after the pre-
chill stage [143]. The same survey also identified 46 different Salmonella serotypes on the 
post-hide carcasses and this number decreased to 20 serotypes on pre-chilled carcasses.  
The predominant  serotypes observed were as follows:  S. Montevideo (21.5%), S. Anatum 
(15.9%), and S. Cerro (10.7%) were the three most commonly isolated serotypes from 
post-hide removal carcasses, while S. Montevideo (17.3%), S. Muenchen (10.8%), and 
monophasic variant of Salmonella Typhimurium and S. Agona (both at 8.7%) were more 
prevalent among Salmonella positive pre-chill carcasses (Table 1).   
Studies conducted by Beach et al. (2002) [144] and Arthur et al. (2008) [122] also 
examined the potential contribution of cattle feces, hide and environment at slaughter.  
Both studies suggested environmental factors during transport and slaughterhouse 
contributed to the observed high-levels of Salmonella prevalence. 
Beach et al. (2002) examined the Salmonella prevalence, serotype, and antibiotic 
resistance profiles recovered from rectal swabs, hide swabs of pre- and post-transit cattle, 
and carcass swabs, as well as environmental swabs collected from the transport vehicle 





slaughterhouse were sampled before and after transportation (approximately 15 miles) 
from the same feedlot to the same slaughterhouse. 
Table 1.  Serotype frequency and diversity recovered from carcass surfaces at post-hide 
removal and pre-chill stages by FSIS in 2016 
Serotypes Post-hide removal Pre-chill 
Montevideo 80 8 
Anatum 59 0 
Cerro 40 0 
Muenster 18 0 
 Muenchen 17 5 
Agona 11 4 
I 4,[5],12:i: 0 4 
Give 0 3 
Infantis 15 3 
Newport 13 0 
Meleagridis 8 0 
Typhimurium  0 3 
Derby 0 2 
Kentucky  19 2 
Uganda 0 2 
Other 90 10 
Source: The Nationwide Microbiological Baseline Data Collection Program: Beef-Veal Carcass Survey August 2014- 
December 2015 FSIS databases [143]. 
Their study reported a significant (P < 0.05) Salmonella prevalence increase in hide 
samples immediately before (19.8%) and after (52.2%) transportation, which they reported 
as related to the transport vehicle.  Follow-up research conducted by the same authors 
examined the rectal, hide, carcass and  environmental samples obtained during the previous 
study [145] and showed that Salmonella prevalence was highest in environmental samples 
(47.4%), followed by hide (37.5%), carcass (19.0%), and fecal (4.0%) samples with an 
overall prevalence of 26.7% (281/1,050).  A subset (n = 120) of these isolates were further 





Among these, S. Anatum (18.3%), S. Kentucky (17.5%), S. Montevideo (9.2%), S. 
Senftenberg (8.3%), and S. Mbandaka (7.5%) were the most commonly identified 
Salmonella serotypes.  In the study, 78.3% of the isolates recovered from feedlot cattle 
were recorded as pan-susceptible or else singly resistant to tetracycline (21.7%).  The study 
showed only certain Salmonella serotypes (S. Anatum [16/26], S. Kentucky [5/26], S. 
Mbandaka [4/ 26], and S. Cerro [1/26]) had phenotypic tetracycline resistance profile.  In 
contrast to the previous studies [15, 69], in the study of Beach et al. (2002, serotype and 
phenotypic AR profiles were not strongly associated. 
Arthur et al. (2008) examined Salmonella carriage in cattle (n = 581) before leaving 
the feedlots and on arrival at one of three different slaughterhouses and after post-harvest 
stage to evaluate the potential origin of Salmonella contamination on carcass surfaces 
[122].  Cattle hide and fecal samples were samples at the feedlots a day before the 
transport to the slaughterhouse.  The transport vehicles were surface sampled before and 
after cattle load.  Lairage environment samples were collected from the lairage surface 
before cattle passing through each area.  In addition, hide samples were collected at the 
slaughterhouse (post-harvest stage) before and after applications of the hide wash 
procedures in the cabinets, whereas the carcass samples were collected after hide removal 
but before the carcass interventions applied on the carcass surfaces.  Results using PFGE 
analysis showed that 30.0% (15/50) of Salmonella found on carcasses, and 65.1% 
(656/1,007) of Salmonella recovered from hide samples at slaughter were attributed to the 
lairage environment.  The only Salmonella contamination found on the carcasses was 
found in one slaughterhouse that did not utilize carcass wash procedures . The remaining 





on carcass surfaces.  The authors concluded that carcass contaminations were mostly 
related with the lairage environment and that hide wash procedure significantly (P < 0.05) 
reduced Salmonella carriage in terms of prevalence and CFUs on the cattle hides. 
Overall, these findings suggest that when the serotypes found on carcass surfaces 
are examined, they show similarities to the serotypes that are commonly found in cattle 
feces, lymph nodes, and on hides.  These studies also suggest that when slaughterhouse 
interventions are regularly applied to hide and carcass surfaces, a reduction of Salmonella 
load and a shift in the population of dominant Salmonella serotypes can be observed  [122, 
143, 146].  However, these interventions are not enough to fully eliminate the public health 
risks of contamination resulting from cattle lymph nodes harboring Salmonella.   
2.4.   Salmonella in beef products  
One of the main human exposures to Salmonella is via the consumption of 
contaminated beef products [13].  Each year in the United States an estimated 26- 28 
billion pounds of beef products are produced and sold for human consumption [147].  
Salmonella contamination in beef products usually occurs at slaughter or at meat 
processing stages.  As described previously, contamination of carcass surfaces and 
inclusion of lymph nodes as fat trim in batches of ground meat may lead to the 
contamination of the final beef products.  Contaminated beef products further pose a risk 
for human Salmonella infections when they are handled or cooked improperly prior to 
consumption.  Salmonella is one of the leading concerns for the beef industry.  Cattle at the 
age of slaughter are transported to slaughterhouses from various feedlots.  After slaughter, 





human consumption are often blended into ground meat along with fat tissue masses 
surrounding lymph nodes.  Therefore, identification of a single animal or even a single 
feedlot as the point source of a beef-related Salmonella outbreak becomes exceedingly 
difficult.  According to the USDA-FSIS, Salmonella is not considered an adulterant of raw 
beef products, since good food handling practices such as application of the adequate 
cooking temperatures (approximately 160 °F [71 °C]) to these raw meat products before 
consumption can eliminate Salmonella [148]. 
Zhao et al. (2006) examined 1,522 ground beef samples, along with the other meat 
types (chicken, turkey, and pork), collected from eight FoodNet (Foodborne Disease 
Active Surveillance Network) sites in 2002-2003.  Among these ground beef samples, 
Salmonella prevalence was less than 2%; however, 6 of the 19 Salmonella ground beef 
isolates were resistant to ceftriaxone [149].   
Another research paper evaluated beef products and their contribution to beef-
related outbreaks  [13].  That study showed that 22.9% of the outbreaks were related to 
ground beef consumption, 27.0% were related to roast beef, and a further 31.2% were 
related to other beef products (e.g., steak, brisket, jerky, barbecued beef, barbacoa, beef 
blood, ribs, and tripe).  The remaining 18.7% was related to an unknown beef product 
among the total of 96 Salmonella-related outbreaks attributed to beef consumption between 
1973 and 2011.  Phenotypic antibiotic susceptibility profiles were examined only for 14 
beef-related outbreaks.  Their results showed that six of the 14 outbreak strains were pan-
susceptible, the remaining eight outbreaks were MDR strains and all were recovered from 
ground beef products.  These strains were mostly of the (5 of 8) S. Newport serotype.  The 





tetracycline, amoxicillin-clavulanic acid, and ceftriaxone phenotype [n = 2]) and ACSSuT 
(n = 1) were observed in the three of the five S. Newport strains.  The remaining three 
serotypes were S. Typhimurium and the other two had  MDR profiles similar to the MDR 
S. Newport. 
S. Montevideo isolates are known to be commonly isolated from ground beef 
samples but rarely cause human infections [32, 150, 151].  S. Newport and S. 
Typhimurium are two well-known serotypes that are most often associated with 
Salmonella outbreaks [31, 152, 153].   
Among the 17,161 ground beef samples collected by USDA-FSIS in 2013, a 
Salmonella prevalence of 1.6% (277/17,161) was reported in the ground beef samples.  
Among the Salmonella positive samples, the most common serotype was S. Montevideo 
(31.0%), followed by S. Typhimurium (6.8%), S. Meleagridis (6.4%) S. Dublin (6.4%), S. 
Newport (4.6%), S. Muenchen (4.3%), S. Kentucky (4.3%), S. Cerro (3.9%), and S. 
Anatum (3.2%).   
A recent Salmonella outbreak attributed to S. Newport serotype contaminated 
ground beef resulted in 403 reported cases in 30 states along with 117 hospitalizations but 
with no deaths reported in 2018 [154].  Even though S. Dublin serotype is highly adapted 
to cattle, human infections of S. Dublin are thankfully rare.  Those few outbreaks caused 
by S. Dublin serotypes show the highest rate of hospitalization, invasive infections and 
deaths when compared to the other serotypes [142]. S. Meleagridis is not a commonly 
isolated serotype from beef products and is not often found associated with human 





Clearly, beef products containing Salmonella are a public health risk for humans 
and pose a potential financial burden to the beef industry.  Certain Salmonella serotypes 
(e.g., S. Newport and S. Typhimurium) found in ground beef can cause severe human 
infections resulting in hospitalization [12].  Therefore, it is important to evaluate factors 
related to the serotype distribution in cattle, and specifically in lymph nodes, to fully 
address public health risks.  To summarize, Salmonella contamination of beef products 
sourced from cattle (feces, lymph nodes and hides) needs to be better understood in order 
to decrease the public health impacts.   
2.5.   The public health burden of Salmonella  
Foodborne pathogens in humans are one of the most important global problems due 
to their health and finance-related consequences.  Salmonella is a leading foodborne 
pathogen resulting in 75.5 million illnesses and more than 28,000 deaths in the world 
annually [155].  The total number of people affected by Salmonella is difficult to estimate, 
since most of the people affected by Salmonella develop mild symptoms and recover 
without antibiotic treatment, and especially since infected individuals most often do not 
present to health care facilities or hospitals.  Therefore, providing the exact numbers of 
people who are affected by Salmonella is difficult to estimate in both global and local 
settings.  In addition, the long incubation period of Salmonella (12-72 h post-exposure), 
and possible recall or selection biases of food exposure information obtained from people 
during epidemiologic investigations, can result in an unattributable outbreak,  especially 





efforts to solve the epidemiological problems in order to detect the source of an outbreak 
[156].  
Determining the source of an outbreak plays an important role in preventing the 
spread of a disease.  It requires collaborative networking and exchange of the data that are 
collected from hospitals, retail markets, and agriculture settings.  There are few countries 
that have established a collaborative surveillance agency to monitor the epidemiology of 
the foodborne pathogens.  These countries are mainly developed countries such as 
Denmark, the United States, Canada, the United Kingdom, and Colombia.  In the United 
States, the FoodNet of the CDC is the agency that routinely generates food-related 
outbreak reports through the collaboration of the United States Food and Drug 
Administration (FDA), USDA-FSIS, and outbreak reports collected from the health 
department of ten states.  FoodNet reports the laboratory-confirmed bacterial infections 
and estimates population-level parameters.  
Salmonella and Campylobacter are two of the leading foodborne zoonotic 
pathogens in the United States that are most often transmitted to humans via contaminated 
foods.  The number of laboratory-confirmed bacterial pathogens that were reported to 
FoodNet was 18,375 in 2015; of these, 7,719 were confirmed as Salmonella, followed by 
6,289 cases of Campylobacter [157].  In the same report, survey-based population-level 
incidence rate of salmonellosis was reported as 15.74 per 100,000 persons annually in the 
United States.  The hospitalization percentage of these 7,719 laboratory-confirmed 
Salmonella cases was reported as 27.3%.  The percentage of hospitalization rates increased 
by up to 58.3% among elderly individuals who in the age range of 60-85+.  Based on 





approximately 168,000 physician visits, 15,000 hospitalizations, and 400 deaths per year 
from 1996–1999 [158]. 
Besides the health-related consequences of Salmonella, salmonellosis is also a 
global financial problem all over the world due to expenses spent on medicine, loss of 
productivity, and related to deaths.  USDA-Economic Research Service (ERS) report on 
the medical costs resulting from Salmonella estimated total costs at $312,738,453, 
productivity losses due to Salmonella at $81,380,620, the cost of deaths related to the 
Salmonella at $3,272,480,959 and with the total cost estimated at $3,666,600,031 in 2013 
[159, 160].  In addition, there is a substantive cost resulting from the waste of food 
products when Salmonella-contaminated foods are recalled (these were not included in the 
ERS estimate).  For example, the recent Salmonella outbreak reported in ground beef 
products resulted in the recall of 6.4 million pounds of ground beef products in October 
2018, with an additional 5.2 million pounds of beef products recalled in December 2018 
[154]. 
Symptoms of Salmonella usually occur 12-72 h after the digestion of contaminated 
food products.  The incubation time of Salmonella in humans shows variability, which is 
mainly related to the intake dose of Salmonella and host immunity.  Salmonella infections 
in humans usually cause mild symptoms and are self-limiting.  These infections mainly 
result in gastroenteritis, which is often characterized by fever, acute watery diarrhea, 
nausea, vomiting and abdominal cramps [22].  The full recovery from salmonellosis in 
people may take from two to seven days and often does not require medical practitioner 
visits or medication.  If these mild infections persist in the patients, they may be admitted 





potassium, and chloride.  However, immunosuppressed people, including children younger 
than 5 years old and adults older than 65 years old, as well as HIV (human 
immunodeficiency virus) patients with impaired immunity, people who receive cytotoxic 
therapy or have malnutrition, and people who are diagnosed with hemoglobinopathy, 
cirrhosis, or P. falciparum malaria are considered at highest risk for developing invasive 
(systematic) Salmonella infections [23, 161, 162].   
Systemic Salmonella infections may occur following the migration of Salmonella 
from the intestinal lumen to the bloodstream and other body sites where the infection can 
cause life-threatening complications for patients.  Symptoms of systemic Salmonella 
infections may consist of high fever, bloody diarrhea, and septicemia.  These patients are 
admitted to hospitals and often require parental antibiotic treatments, which are known to 
have bactericide or bacteriostatic effects on Salmonella [163].  Historically, the 
recommended choice of antibiotics for the treatment of human Salmonella infections was 
ampicillin, chloramphenicol, or trimethoprim-sulfamethoxazole.  Due to emerging 
resistance in Salmonella against these antibiotics, today the recommended empirical 
treatment for salmonellosis in humans includes newer generation cephalosporins (e.g., 
ceftriaxone), fluoroquinolones (e.g., ciprofloxacin) and macrolides (e.g., azithromycin) 
[164].  Fluoroquinolone use is limited in children and pregnant women due to adverse side 
effects on the developing cartilage of juvenile animals [24].  In addition, the FDA recently 
announced a black-box warning regarding the use of fluoroquinolone in adults due to 
potentially serious side-effects such as aortic vessel rupture,  tendonitis, and neuropathy 
[26].  Therefore, ceftriaxone (100 mg/kg/day for two days) and azithromycin (20 





of pediatric, obstetric, and most adult cases [22, 23].  Therefore, these antibiotics are 
critically important for human medicine, since the failure of the antibiotic treatment may 
cause death of these patients [54, 165]. 
2.5.1.   Epidemiology of Salmonella in humans 
Salmonella colonies can resist environmental changes such as temperature, pH, 
moisture, and solar radiation, which increases the survival rate of Salmonella outside of the 
usual host enteric niche.  The ability of Salmonella to adapt to harsh conditions generates a 
persistent and complex problem for human exposure to Salmonella.  Salmonella can be 
found in the gastrointestinal tract of animals, which can disseminate to other animals via 
soil, water and air [166].  Therefore, the transmission dynamics of Salmonella is a complex 
issue, since human exposure to Salmonella can be attributed to many different routes such 
as animal contact, water, food, person-to-person, and other sources, and ultimately can 
spread from agricultural to kitchen settings [125] (Figure 4). 
Human exposure to Salmonella may occur via direct physical contact with 
Salmonella-colonized farm animals, handling contaminated farm equipment, and 
inhalation of contaminated aerosols at or near a farm environment.  Farm irrigation 
systems can also carry these pathogens to nearby surface waters and rivers.  Wastewater 
containing human feces, effluent from meat industries and wastewater from livestock can 
pose a potential risk factor for transmission of Salmonella despite treatments applied to 
reduce pathogen carriage [167].  Farm soil that is used as fertilizer for crop production can 





contamination can lead to contamination of vegetables, crops, water, and be widely spread 
across multiple regions [166]. 
 
Figure 4.  Epidemiology of zoonotic foodborne pathogens and associated antibiotic 
resistance 
Modified from Health Canada, 2002 [168]; earlier adapted from Linton,1977[169]. 
Wild animals and rodents also play a potential role to carry and spread Salmonella 
to different locations [170].  Also, during animal transport, aerosolized fecal materials may 
also spread along the route taken by these vehicles [171].  At slaughterhouses and meat 
processing facilities, workers can be exposed to these microorganisms via direct contact or 
through the air.  Offal products can pose an increased risk due to their reintroduction into 





commonly used as protein, fiber, calcium and fat sources in animal feed and pet foods, 
which can result in Salmonella exposure of farm animals and pets, respectively, and later 
to pet owners [172-174].  Handling exotic animals, especially reptiles has also been 
reported as a source of Salmonella infection in humans [170].  In addition to the routes 
described above, person-to-person Salmonella transmission may occur via fecal-oral 
transmission route due to a lack of hygiene practices in humans [175].  Animal origin food 
products may cause Salmonella outbreaks when these products are not entirely raised to 
the recommended temperatures to eliminate or reduce pathogen carriage of the products 
[148].  The consumption of uncooked vegetables, seed, and fruits that were contaminated 
with farm soil or water may also be sources of food-related Salmonella outbreaks [126].  
Additionally, kitchen surfaces and equipment such as cutting boards, countertops, knives, 
and utensils that came into contact with a raw animal origin food product, can contaminate 
other food products that are consumed as raw or else cooked at lower temperatures [176]. 
Population-based data collected from 7,895 cases of laboratory-confirmed 
Salmonella infections from 1996 to 1999 by the FoodNet revealed an estimate of 40.5% of 
these infections were caused by S. Typhimurium, S. Enteritidis, or S. Heidelberg serotypes 
[177]. 
Based on the most up-to-date FoodNet 2015 Surveillance Report, involving 10 
states and 20,098 laboratory-confirmed infections caused by foodborne pathogens, 
Salmonella was the most prevalent (15.7%) food-borne pathogen resulting approximately 
2,100 hospitalization and 32 deaths.  Among 7,220 Salmonella isolates that were 
serotyped, the most common serotypes were S. Enteritidis (19.2%), S. Newport (11.4%), 





S. Enteritidis and S. Newport was significantly higher (P < 0.05), while significantly lower 
(P > 0.05) for S. Typhimurium when compared to 1996-1998 data.  Salmonella infections 
were highest in summer (from July through October) [157].   
Approximately 80.3- 93.8 million human gastroenteric cases of salmonellosis that 
occur globally each year are attributed to the consumption of Salmonella contaminated 
food products [161].  Therefore, human consumption of animal food products is one of the 
most studied and most important routes of transmission of foodborne pathogens.  Beef 
products play an important role in Salmonella related outbreaks [10, 11].  The 
salmonellosis cases attributed to beef products globally were caused by multiple 
Salmonella serotypes that include, but are not limited to: S. Newport, S. Enteritidis, S. 
Heidelberg, S. Montevideo, S. Saintpoul, S. Berta, S. Infantis, S. Thompson, S. Agona, S. 
Anatum, S. Chester, S. Hadar, S. Reading, S. Agama, S. Bovismorbificans, S. Braenderup, 
S. Cerro, S. Derby, S. Hartford, S. Kiambu, S. Ohio, S. Oranienburg, S. Singapore, S. 
Schwarzengrund, and S. Senftenberg serotypes [13]. 
2.5.2.   Antibiotic resistance in Salmonella 
Antibiotic resistance observed in food-borne pathogens is an important public 
health problem due to a persistent increase in AR clinical cases worldwide [165, 178, 179].  
Antimicrobial therapies are mostly applied to patients diagnosed with Salmonella 
infections with clinical symptoms, especially to the patient group that is considered at 
highest risk to develop invasive Salmonella infections [180].  Even though antibiotic use 
can prolong Salmonella shedding in the patients, it is a lifesaving solution sometimes 





empirical treatment of salmonellosis shifted from aminopenicillins, phenicols, and folate 
pathway antagonists to fluoroquinolones, 3rd generation (extended-spectrum) 
cephalosporins, and macrolides due to the isolation of the AR bacteria emerging in human 
infections caused by chloramphenicol and trimethoprim-sulfamethoxazole-resistant 
Salmonella serotypes [181].  Since then, AR Salmonella have become a persistent public 
health threat due to emerged antimicrobial resistance and reduced susceptibility (i.e., MICs 
of 0.12– 1 μg/ml) against the fluoroquinolones, the 3rd generation cephalosporins (Figure 
2), and azithromycin (Figure 3) in human Salmonella isolates [8, 28, 182].  
NARMS has also been extensively tracking serotypes and phenotypical antibiotic 
resistance profiles of laboratory-confirmed human Salmonella isolates recovered from 
patients at the national-level since 1996.  The NARMS monitoring program was first 
started with a human population of 13 states; today, NARMS represents 50 states and the 
District of Columbia, which is almost the entire US population [28].  Within introduction 
of low-cost WGS methods, NARMS began to also monitor and report molecular insights 
of antibiotic resistance since 2014 [183].  Therefore, complete ARG information along 
with phenotypic antibiotic resistance profiles obtained from human Salmonella isolates is 
somewhat limited.   
The most up-to-date NARMS Annual Human Isolates Surveillance Report 
published in 2018 tested a subset of clinical human isolates (n = 2,364) for both phenotypic 
and genotypic antibiotic resistance [32].  In this report, Salmonella resistance against the 
antibiotics used for the treatment of salmonellosis in humans was extensively evaluated.  
According to this report, the majority (75.0% [1,775/2,364]) of the Salmonella isolates 





antibiotic.  Only 13 of the 1,775 phenotypic susceptible isolates demonstrated an identified 
an ARG and ARG mechanism corresponding to what should have been a resistance 
phenotype.  Perhaps this could have been due to cryptic ARGs, which are not directly 
responsible for the expression of a resistance mechanism [184] or else to a low-quality 
base-call of the genomic sequence data.  On the other hand, 64 of the phenotypic AR 
isolates did not harbor any resistance genes, which may be the result of the loss of a 
plasmid carrying ARGs during the storage or testing period or to unidentified ARGs, 
which are not yet available for searching in the ARG databases.  
Bacterial resistance to nalidixic acid, which is the oldest quinolone, is usually 
characterized by a decreased susceptibility to higher-level fluoroquinolones such as 
ciprofloxacin.  The observed decrease in susceptibility to fluoroquinolones is mainly 
observed in typhoidal Salmonella isolates, but also recently has become a concerning 
problem for non-typhoidal Salmonella [185].  The NARMS Human Isolate Reports used 
the MIC interpretation criteria for ciprofloxacin as:  ≤ 1 µg/ml for susceptible, 2-4 µg/ml 
for intermediate, ≥ 4 µg/ml for resistant until 2012.  Later, NARMS followed the new MIC 
interpretative criteria for ciprofloxacin as:  ≤ 0.06 µg/ml for susceptible, 0.12-0.5 µg/ml for 
intermediate, and ≥ 1 µg/ml for resistant, which was also updated by CLSI in 2012 [32].   
In the past, most of the quinolone resistance found in Salmonella was related to 
chromosomal mutations of the gyrA and parC genes [186].  However, during the last 
decade plasmid-mediated quinolone resistance (i.e., qnr gene-harboring plasmids) in 
Salmonella have become more prevalent [187, 188].  In the recently published NARMS 
Annual Human Isolates Surveillance Report [32], 5.8% [137/2364] of Salmonella isolates 





S. Enteritidis serotype.  Further, these isolates were examined for quinolone related ARGs.  
The majority of the plasmid-mediated quinolone-resistant isolates (n = 35) were found to 
be associated with a qnrB (n = 23) gene, followed by qnrS (n = 5), qnrA (n = 3), oqxAB (n 
= 3), and aac(6’)lb-cr (n = 1) genes.  In addition to the plasmid-mediated quinolone 
resistance, chromosomal mutations of the gyrA gene were observed in 64 isolates, whereas 
parC mutations were observed in only two isolates. 
CLSI applied a resistance interpretive criteria for ceftriaxone at an MIC  ≥ 64 μg/ml 
up until 2010; since then, the updated resistance interpretive criterion of ≥ 4 μg/ml has 
been used in the United States [189].  The most commonly observed ceftriaxone resistance 
mechanisms in Salmonella are the transferable plasmid-mediated AmpC β-lactamase gene 
(blaCMY) and the extended-spectrum β-lactamases genes (blaCTX-M and blaSHV) [190-192].  
In the literature, there are a large number of bla genes resistance genes that have been 
identified in Salmonella isolates; these bla genes include, but are not limited to: CARB, 
CMY, CTX-M, DHA, KPC, NDM, OXA, and SHV [192].  In the NARMS Human Isolates 
Surveillance Report published in 2018 [32], phenotypic ceftriaxone resistance was found 
in 2.7% (n = 65/2,364) of the total isolates.  Ceftriaxone resistance was mostly identified in 
the S. Dublin (66.7%) serotype, followed by S. Infantis (6.9%), S. 4,[5],12:i: (6.0%), S. 
Newport (4.7%), S. Heidelberg (4.4%), and S. Typhimurium (4.0%).  Ceftriaxone 
resistance genes were observed in a total of 57 Salmonella isolates.  Among those, the 
identified genes were blaCMY (n = 49), and in addition 8 isolates showed an extended-
spectrum β-lactamase (ESBL) phenotype and were harboring either the blaSHV-12/30 (n = 5) 





resistance due to the following genes: blaTEM, blaCMY, blaCARB, blaSHV, blaCTX-M, and 
blaOXA).  
In addition, three of seven ceftriaxone-resistant Salmonella outbreaks that have 
recently occurred have been attributed to the consumption of beef products between 2011 
and 2012 [190].  In those outbreaks, the ceftriaxone resistance gene (blaCMY) encoded on 
IncA/C or IncI1 plasmids were found in two S. Typhimurium and one S. Newport strains 
that were phenotypically resistant to ceftriaxone.  The full resistance phenotype observed 
in the S. Newport was MDR-AmpC (AmpC-ACSSuT) profile, which has commonly been 
associated with cattle and beef sourced outbreaks [150, 193]. 
In addition, there was an observed increased in the percentage of human Salmonella 
isolates resistant to ceftriaxone from 0.2% to 3.4% from 1996 to 2009 in the United States 
[28].  Among these resistant isolates, that were mostly MDR, the most common profile 
was the ACSSuT phenotype.  Ceftriaxone resistance in human strains is mostly found 
associated with this MDR profile and has been observed in S. Typhimurium, S. Newport, 
S. Heidelberg, S. 4, [5],12:i:–, and S. Dublin serotypes. 
At present, there are no clinical azithromycin breakpoints established for non-typhoidal 
Salmonella [189]; therefore S. Typhi breakpoints are used for the detection of phenotypic 
resistance in non-typhoidal serotypes. It has also been reported that non-typhoidal 
Salmonella and typhoidal Salmonella can show similar azithromycin MIC values [182].  
NARMS included azithromycin in their phenotypic susceptibility testing panels as a  
replacement for amikacin in 2011 due to emerging concerns about azithromycin resistance 
in Salmonella [194].  Azithromycin is a relatively new choice of antibiotics to treat 





genotypic AR data or evidence of azithromycin resistance that have been reported.  In 
Salmonella, there have been numerous ARGs of macrolide class antibiotics reported 
historically.  These genes are listed as: ere, erm, lnu, lsa, mef, mph, msr, and vga genes 
[192].  In the NARMS Human Isolates Surveillance Report published in 2015 [32], 
phenotypical azithromycin resistance was observed among 0.3% (n = 8/2364) of the total 
isolates.  Among these, 6 isolates were identified harboring the mphA (n = 5) gene and one 
isolate had co-existing mscE and mphE genes [32].   
Sjolund-Karlsson et al. (2011), investigated phenotypic and genotypic azithromycin 
resistance in 575 Salmonella randomly selected isolates (232 human isolates submitted to 
the CDC, 227 animal [chicken, turkey, cattle, or swine] isolates submitted to the USDA, 
and 116 ground meat [chicken, turkey, or beef] isolates submitted to the FDA) from a total 
of 2,379 Salmonella isolates in 2008 [182].  Among these isolates, the  majority were 
either S. Enteritidis or S. Typhimurium, whereas the animal origin serotypes were S. 
Kentucky, S. Heidelberg, and S. Montevideo serotypes, and the serotypes found in retail 
meat were either S. Heidelberg, S. Hadar or S. Typhimurium variant O:5—.  The highest 
MIC range for azithromycin was observed in human isolates (with MICs of 1-32 µg/ml) 
followed by retail meat (with MICs of 4-16 µg/ml), and animal origin  isolates (with MICs 
of 2-16 µg/ml) (Figure 5).  Among these, two Salmonella isolates that were resistant to 
azithromycin (with an MIC ≥ 32) were screened for ereA, ereB, ermB, mefA, mphA, 
mphB, and mphD genes using PCR.  The PCR results did not detect any of these macrolide 
resistance genes.  This result may be related to the specificity and sensitivity of the PCR 
method they used or the phenotypic resistance may be related to other unidentified and 






Figure 5.  Azithromycin MICs observed from human-, animal-, and ground-meat-origin 
Salmonella 
Adopted from Sjolund-Karlsson et al. (2011) [182] 
Before 2013, the CLSI streptomycin resistance breakpoint was defined as ≥ 64 
µg/ml, this was later updated to ≥ 32 µg/ml in 2014.  In the NARMS Human Isolates 
Surveillance Report published in 2018 [32], a total of 251 isolates  harbored a streptomycin 
resistance gene, among these isolates, the most common gene was the strA (n = 188), strB 
(n = 186), aadA (n = 84), aph(6)-Ic (n = 3), and armA (n = 1) genes.  In addition, 
gentamicin resistance genes (aac, aadB, and armA) were also identified in 40 isolates.  
Tetracycline resistance genes were the most prevalent resistance genes found in this study 





tetracycline resistance gene was tet(A) (n = 129), followed by the tet(B) (n = 123), tet(G) 
(n = 25), tet(M) (n = 7), tet(C) (n = 4), and tet(D) (n = 3).  The ARGs conferring resistance 
to either sulfisoxazole (sul1, sul2, and sul3) or trimethoprim-sulfamethoxazole (sul+dfrA.) 
were the second most prevalent (n = 264) ARGs.  Chloramphenicol resistance genes 
(either floR, cml, oqxAB, catA or catB) were harbored by 75 isolates. 
In the same NARMS Human Isolate Surveillance Report [32], 12.4% (293/2364) of 
Salmonella isolates that were MDR were mostly S. Dublin (91.7%), S. 4,[5],12:i:- I 
(68.8%), S. Typhimurium (18.3%), S. Infantis (15.3%), S. Newport (5.6%), or S. 
Enteritidis (4.2%) serotypes. The MDR Salmonella were mainly associated with the 
ACSSuT phenotype [192, 193, 195].  The ACSSuT profile corresponds to resistance 
against five CLSI classes of antibiotics as follows: aminopenicillins (ampicillin), phenicols 
(chloramphenicol), aminoglycosides (streptomycin), sulfonamides (sulfisoxazole), and 
tetracyclines (tetracycline).  However, in this report, the ACSSuT phenotype was not 
identified.  However, overall 5.0% of the isolates had the ASSuT phenotype (a phenotype 
similar to the ACSSuT but without chloramphenicol resistance) that was commonly 
observed though only in S. 4,[5],12:i:- I (59.1%) serotype.  Chloramphenicol has not been 
used in U.S. food animal agriculture since 1985, though florfenicol has been available 
since the 1990s. 
In recent years, a new MDR profile of Salmonella also has emerged by including 
amoxicillin-clavulanic acid and ceftriaxone resistance (the ACSSuTAuCx phenotype) to 
the ACSSuT phenotype, which shows phenotypic resistance to two additional classes of 
antibiotics.  In the NARMS report [32], 1.3% (31/2,364) of the isolates showed an 





followed by the S. Newport serotype (4.7%), S. monophasic Typhimurium I 4,[5],12:i:- I 
(2.7%), and S. Typhimurium serotypes (1.6%) [32].  Antibiotic resistance phenotypes that 
are commonly found in Salmonella are those against ampicillin, tetracycline, sulfisoxazole, 
streptomycin, and chloramphenicol.  These phenotypes are mainly encoded by blaCMY, 
blaTEM-1, tet(A), tet(B), sul1, sul2, and floR genes [192]. 
MDR Salmonella are a serious and threatening problem, since human cases related 
to these strains often result in a higher number of treatment failures, longer hospitalization 
periods, and higher mortality rates when compared to infections caused by antibiotic 
susceptible strains [165, 196, 197]. 
2.6.   Public health risks of antibiotic use in food-producing animals 
The use of antibiotics in food animals is commonly perceived as one of the key 
contributors to emerging antibiotic resistance problems in enteric commensal bacteria that 
might potentially pose a risk for public health [198-200].  Usually, antibiotic resistance 
found in foodborne pathogens is against tetracycline, streptomycin, and sulfamethoxazole, 
which are older antibiotics that were commonly used in the recent history of agriculture 
[31, 201].   
Antibiotic use in food-producing animals can select for resistant bacterial 
populations and can cause potential direct or indirect effects to the public health.  The risk 
of antibiotic use in food-producing animals is mainly dependent on dose, class, and 
duration of the antibiotics that are used [199, 202-205].  The direct effects of antibiotic use 
that can increase the risk of colonization of resistant bacterial populations in the human 





antibiotics (e.g., direct contact) [206, 207], and 2) consumption of AR bacteria-
contaminated food products [203, 207].  Human exposure to animal origin AR bacteria can 
be also caused indirectly as follows: 1) exposure to dust and air-particles carrying AR 
bacteria [171], 2) use of animal waste as fertilizer that can result in water contamination 
with AR bacteria [208, 209], 3) contact with contaminated domestic animal feed produced 
from by-products of food animals treated with antibiotics [174, 210, 211], and 4) 
horizontal gene transfer occurring in the human gastrointestinal tract via a mobile genetic 
element that harbor ARGs occurring between a non-pathogenic animal origin bacteria and 
a human pathogen  [212-214].  
There is abundance evidence suggesting that antibiotic use in animals contributes to 
the selection of antimicrobial resistance in Salmonella and other enteric populations, which 
potentially can transmit from animals to humans and pose a public health threat [203, 204, 
206, 215, 216].  
One of the oldest prospective field studies, conducted in 1976, showed evidence of 
transmission of antibiotic resistance from chickens to chickens and from chickens to 
humans [216].  When these chickens were fed tetracycline containing feeds, the authors 
showed an increased proportion of E. coli harboring tetracycline-resistant plasmids in the 
feces obtained from farm families, especially when compared to families living away  from 
the farm location.,.   
Among the older research projects on this subject published by Holmberg et al. in 
1984, revealed a direct link of cattle origin AR Salmonella causing serious human 
infections via consumption of meat products [203].  Identification of the plasmidal profiles 





Salmonella was transmitted to humans from beef cattle that were fed with chlortetracycline 
for growth promotion purposes in South Dakota.   
A case-control study related to a massive MDR S. Typhimurium outbreak 
attributed to milk products was published in 1987 [215].  This strain carried a unique 
antibiotic resistance pattern and plasmid; therefore, the outbreak was readily traced back to 
its origin.  Later, it was found that the contamination occurred in the milk plant and this 
strain repeatedly contaminated the milk products.  Even though this study proved the 
transmission of antibiotic resistance carrying Salmonella between animal origin food-
products to humans, the direct role of antibiotic use in dairy farms in this study remains 
unknown.   
Resistant-Salmonella transmission was also reported to have occurred between a 
child and a cow via direct psychical contact [206].  A 12-year-old boy that was infected 
with an MDR Salmonella was traced back and revealed to have had direct contact with a 
cow on a family farm in 2000.  The Salmonella that was isolated from the child was 
determined to be the identical strain of blaCMY-2 gene harboring ceftriaxone-resistant 
Salmonella that was found in a cow treated with ceftiofur.   
In parallel, the temporary withdrawal of antibiotics from animals has also shown a 
reduction in the AR Salmonella population [204].  Dutil et al. (2010) showed the 
relationship among ceftiofur resistant S. Heidelberg serotypes recovered from both poultry 
and human infections using the CIPARS (Canadian Integrated Program for Antimicrobial 
Resistance Surveillance) data during 2003–2008 [204].  Their finding showed a 
statistically significant (P< 0.05) and strong association among S. Heidelberg isolated from 





which were likely due to a large amount of in ovo ceftiofur use in hatcheries in Quebec, 
Canada.  This study also showed that the withdrawal of ceftiofur injection from chicken 
eggs significantly decreased the prevalence and incidence of AR Salmonella recovered 
chicken products and humans, respectively; however, once ceftiofur began to be 
administered once again, the situation reversed to previous levels. 
Due to existing evidence of antibiotic use in animals and their potential public 
health risk for selection of resistance, various countries and societies have enforced rules or 
given recommendations to limit/ban non-treatment purposes of antibiotic use in food 
animals.  The first report (also known as Swann Report) recommending the banning of 
important human antibiotics as growth promoters in food-producing animals was published 
by the Joint Committee on the Use of Antibiotics in Animal Husbandry and Veterinary 
Medicine in the United Kingdom in 1969.  This ban was proposed due to the observed 
increase of MDR Salmonella in human isolates that were found to be related to the large 
amount of antibiotic use as growth promoters in food-producing animals [217].  After this 
report, the growth promoter uses of medically important antibiotics were banned in the 
United Kingdom.  After the United Kingdom, other European countries (e.g., Sweden in 
1986 then Denmark in 1996) also banned the use of these antibiotics as growth promoters.  
In the United States, first regulation and prohibition were set for the extra (off)-label use of 
glycopeptides (vancomycin and avoparcin) and fluoroquinolones (danofloxacin and 
enrofloxacin) in 1997 and then cephalosporins (ceftiofur) in 2012 [218].  Additionally, the 
FDA proposed a voluntary withdrawal of all labels allowing medically important 
antibiotics in feed or water of food animals for production purposes and permitted the legal 





This voluntary withdrawal was fully implemented in 2017 [219].  This implementation 
ruled by the GFI (guidance for the industry) #213 was due to the increasing global threat of 
emerging antibiotic resistance against medically important antibiotics in pathogens found 
in food-animals [220].  
Reducing the use of antibiotics in food-producing animals has been characterized 
by the reduction in observed antibiotic resistance in both animal and human isolates.  For 
example, within the two years after the ban of avoparcin (a glycopeptide that is used as a 
feed additive in food animals in Europe) in 1997, a decrease in vancomycin-resistant 
enterococci isolated from both humans and animals was widely observed in many 
countries [221].  Similarly, a significant reduction of extended-spectrum cephalosporinase-
producing E. coli in pigs and pork meat was observed after a voluntary ban of 
cephalosporin use in Denmark in 2010 [222].   
Considering antibiotics are the most efficient treatment to combat bacterial 
infections in human, it is urgent and necessary to explore the consequences of antibiotic 
administrations, and prudently use these antibiotics in food-producing animals. 
2.7.   Antibiotic use in cattle 
Antibiotics are widely used for the treatment of clinical infections, control 
(metaphylaxis), and prevention (prophylaxis) of common infectious diseases in feedlot 
cattle.  Antibiotics are mainly administered to individual cattle to treat a clinically 
diagnosed infection.  On the other hand, herd-level (i.e., groups of cattle) administrations 
are applied to prevent an expected disease or else to control the spread of infection in a 





accurately assess the associations between antibiotic resistance found in food-producing 
animals and antibiotic use in animal agriculture, it is essential to collect detailed 
information on the amount of medically important antibiotics used in food-producing 
animals.   
In the United States, annual reports reporting the mass of antibiotics (kg of active 
ingredient/drug class) sold or distributed for use of food-producing have been routinely 
monitored and published by the FDA for approximately one decade.  Based on the most 
up-to-date FDA data collected in 2016, an estimated 8,356,340 kg of medically important 
antibiotics were used in food-producing animals for the treatment, prophylaxis, 
metaphylaxis, and growth promotion purposes [223]. Since the beginning of 2017 (after 
the FDA’s GFI #213), medically important antibiotics have only been used for animal 
health-related purposes, which yielded a complete cessation (5,770,655 kg [ 2016] to 0 kg [ 
2017]) of the sale of these antibiotics for growth promotion purposes [223, 224].  Before 
the middle of 2016, these data included only the sales and distribution of antibiotics among 
the classes of food-producing and domestic animals.  However, due to the variations of 
antibiotics used in different food-producing animal species, this approach was not found to 
be enough to determine the drivers of the antimicrobial resistance in certain animal species 
and humans in relation to antibiotic use.  Therefore, starting from the mid-2016, FDA 
started to require sponsors to provide estimates of sales to four major food-producing 
animals: cattle, chickens, turkey, and swine [225].   
Based on the latest FDA report published in 2018, domestic sales and distribution of 
antimicrobials approved for use in food-producing animals decreased by 33% from 2016 





was used in food-producing animals.  Approximately 2,349,271 kg (42%) of these 
antibiotics were used in cattle.  The divided mass of major medically important antibiotics 
used for cattle was of tetracyclines (66%), followed by macrolides (11%), sulfonamides 
(8%), aminoglycosides (5%), penicillins (4%) and then cephalosporins and 
fluoroquinolones (less than 1%), respectively (Table 2).  
In 2017, the major sales of antibiotics for cattle were observed in tetracyclines, 
followed by macrolides, sulfonamides, aminoglycosides, penicillins, amphenicols, 
cephalosporins, and fluoroquinolones.  When these numbers are compared to the previous 
year (2016), the sales of the majority of the antibiotic classes largely decreased (between 
16%-45%); this decrease was small for penicillin and cephalosporin class antibiotics (≤ 
5%).  However, the macrolides and fluoroquinolones sold for cattle use had increased by 






Table 2.  Medically important antibiotics sold for cattle use between 2016-2017 
 
Antibiotic class Antibiotic 




In 2016 In 2017 2016-17 
Aminoglycosides 
Dihydrostreptomycin, gentamicin,  
hygromycin B, neomycin, 
spectinomycin 
161,646 124,675 -23% 
Amphenicols Florfenicol - 49,321 N/A 
Cephalosporins Ceftiofur, cephapirin 24,677 23,512 -5% 




tulathromycin tylosin, tylvalosin 
194,811 274,479 41% 
Penicillins Amoxicillin, ampicillin, cloxacillin, penicillin 99,935 96,936 -3% 
Sulfonamides Sulfadimethoxine, sulfamethazine 234,955 196,902 -16% 
Tetracyclines Chlortetracycline, oxytetracycline, tetracycline 2,840,519 1,560,542 -45% 
*No animal species-level data present, the data include cattle, swine, and other species.  Source: 2017 Summary Report 
on Antimicrobials Sold or Distributed for Use in Food-Producing Animals, FDA [224]. 
2.8.   Metaphylaxis of BRD 
The two most common infectious diseases that were reported to occur in 3,214 
cattle feedlots located in the 13 major cattle-on-feed states in the United States are BRD 
(97% of feedlots) followed by lameness (93% of feedlots)  [34].  BRD is reported to occur 
in all of the feedlots in the United States [34].  BRD is a complex disease of cattle that is a 
co-infection of both viral and bacterial pathogens.  The viral pathogens usually cause 
primary infections resulting in immune suppression in the host and with mild clinical signs 
such as decreased appetite, depression, nasal and ocular discharge, and coughing.  Viral 
pathogens of BRD include bovine herpesvirus type 1 (BHV-1), parainfluenza-3 virus 
(PI3), bovine respiratory syncytial virus (BRSV), and bovine viral diarrhea virus (BVDV).  





respiratory tract and cause infection and disease when immunity is impaired [226, 227].  
The bacterial pathogens associated with BRD are Mannheimia haemolytica, Mycoplasma 
bovis, Pasteurella multocida, and Histophilus somni.  M. haemolytica, P. multocida and H. 
somni  are normally present in the cattle nasopharyngeal microbiome.  The immune status 
of cattle and exposure to pathogens are two drivers of BRD.  The immunity of cattle is 
often related to environmental stress factors such as transportation (loading and unloading, 
duration of transport), dramatic climatic changes, and weaning [53, 228].  After the 
inclusion of both viral and bacterial pathogens in the disease complex, these cattle show 
severe clinical symptoms such as high fever, septicemia, and finally BRD can cause death 
[226, 227].   
BRD is also known as shipping fever, since the clinical signs of BRD usually occur 
shortly after arrival to the feedlot from cow-calf, backgrounder, stocker industries or 
auction markets.  Cattle are at a higher risk for BRD when they first arrive at feedlots from 
backgrounding/stockers or cow-calf sectors due to transport and environment-related stress 
factors.  BRD is a major cause of morbidity, mortality, and economic loss in cattle 
industries affecting 16.2% of cattle arriving at feedlots.  It is reported that metaphylactic 
antibiotic treatments significantly reduce the incidence of BRD [34, 53].  Therefore, an 
estimated 60% of cattle receive BRD metaphylaxis upon arrival to the feedlot [33, 34, 
229].   
The decision of BRD antibiotic administration at the feedlot is taken based on the 
health condition of the cattle upon arrival (e.g., weight, prior vaccination statue, history of 
exposure, source), shipping distance, or any other environmental stress factors such as 





antibiotics that are used to control BRD in cattle are available in both injectable and oral 
forms.  Injectable products are mostly preferred due to providing accurate dosing per 
animal weight, regardless of appetite or thirst.  There were eight injectable antibiotics 
approved for metaphylactic use for BRD as of 2011: amoxicillin, ceftiofur, florfenicol,  
gamithromycin, tilmicosin, oxytetracycline, penicillin, and tulathromycin [34, 230], 
enrofloxacin was also approved for control use in 2012.  Among these, ceftiofur is the only 
cephalosporin class antibiotic, whereas gamithromycin, tilmicosin and tulathromycin are 
the macrolide class antibiotics.    
Based on the most up-to-date USDA-APHIS-NAHMS (National Animal Health 
Monitoring System) Feedlot 2011, Part IV: Health and Health Management on U.S. 
Feedlots with a Capacity of 1,000 or more Head Report published in 2011, tilmicosin was 
used by 57.6% of feedlots, followed by tulathromycin (45.3%), ceftiofur (39.7%), 
oxytetracycline (17.4%), florfenicol (9.2%), and gamithromycin (4.3%)  [34]. Therefore, 
according to this report, tilmicosin, ceftiofur, and tulathromycin are the top three most 
commonly used antibiotics in the feedlots for BRD metaphylaxis.  Among these 
antibiotics, tulathromycin (Draxxin®) and ceftiofur (Excede®) are two antibiotics that are 
preferred by farmers to treat or control BRD in feedlots because of their long-acting 
formulations and clinical effectiveness [34, 52].   
Tulathromycin is a semi-synthetic long-acting azalide that was approved for use of 
beef cattle, but not dairy cattle, in 2005 [231].  It is mainly indicated to treat or control 
BRD of beef cattle and also to treat bovine foot rot disease and pinkeye.  A single 
subcutaneous dose of 2.5 mg/kg tulathromycin by injection is recommended for 





withdrawal period for the meat before the slaughter.  Tulathromycin is the second most 
commonly used BRD metaphylaxis for cattle over 317 kg in the United States [34].  
Tulathromycin was also reported as the most common BRD metaphylaxis used for cattle 
under 317 kg [34]. 
CCFA is a long-acting third-generation cephalosporin that was approved to treat 
BRD infections in both dairy and beef cattle in 2003; later, its name was changed to 
Excede® [232].  It is mainly indicated to treat or control BRD in cattle and to also treat 
bovine foot rot.  A single subcutaneous dose of 6.6 mg/kg ceftiofur by injection is 
recommended for metaphylaxis of BRD in cattle upon arrival to the feedlots.  Ceftiofur has 
a 13-day slaughter withdrawal period prior to slaughter.  Ceftiofur is the third most 
commonly used antibiotic to control BRD in feedlots located in the United States [34]. 
2.9.   Possible cross-selection risks of antibiotics for resistance 
To address the relationship between the emerging cephalosporin and macrolide-
resistant human Salmonella cases and antibiotic use in cattle, it is important to evaluate the 
cephalosporin and macrolide class antibiotics used in beef cattle and their potential for 
cross-selection for ceftriaxone and azithromycin resistance. 
2.9.1.   Cephalosporins 
Ceftiofur and cephapirin are the only two approved cephalosporins that are available 
for cattle use [224].  Cephapirin is an older, 1st generation cephalosporin antibiotic and not 
used for metaphylaxis of BRD in cattle.  However, ceftiofur, which like ceftriaxone is a 3rd 





cattle.  Ceftiofur has selection potential for ceftriaxone-resistant Salmonella largely 
because both antibiotics are in the same sub-class of cephalosporins and with very similar 
molecular structures [233] (Figure 6). 
Even though it has been proposed that ceftiofur is degraded or inactivated in the bovine 
intestinal tract by facultative and obligate anaerobic bacterial species [234], in the 
literature, there have been numerous randomized controlled field trials that have reported 
significant, transient, or else no effects of metaphylactic ceftiofur treatments on phenotypic 
or genotypic ceftriaxone and/or ceftiofur resistance profiles of enteric bacteria in beef 
cattle populations, especially on Salmonella [36], E. coli [38, 39], or more broadly the 
fecal microbiome found in the cattle feces [37, 41, 47].  
 
Figure 6.  Chemical structure of ceftiofur and ceftriaxone 
Source: Open chemistry database (PubChem) at the National Institutes of Health (NIH) [233]. 
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Studies measuring the effects of ceftiofur use on Salmonella populations in feedlot 
cattle are limited.  Only Ohta et al. (2017) conducted a 26-day longitudinal randomized 
controlled cattle field trial to monitor the prevalence, phenotypic antibiotic resistance, and 
serotype distribution of Salmonella following a single-dose (6.6 mg/kg) of subcutaneous 
CCFA injection [36].  This study explored the effects of ceftiofur treatment (or no 
treatment) on fecal Salmonella populations in beef cattle.  The trial was conducted in the 
research feedlot facility at West Texas A&M University, Canyon, TX.  The antibiotic was 
administered to all animals in two pens (approximately 22 cattle) for two replicates (total 
of four pens, 44 cattle, 11 cattle in each pen) on Day 0 for the treatment group, the same 
number of animals were included in the control group with one of 11 cattle in each of 4 
pens receiving the CCFA treatment, the fecal samples were collected before and after the 
antibiotic administration (on Days 0, 4, 8, 14, 20, and 26).  According to this study, 
Salmonella prevalence significantly decreased (P < 0.004) by Days 4 and 8 in the ceftiofur 
treated group, but a recovery was observed after Day 8 until the end of the study.  The 
ceftiofur treatment also selected for MDR Salmonella compared to the non-treated group, 
but this was not statistically significant (P > 0.05), since the Salmonella population that 
was found before the antibiotic treatment was pan-susceptible.  However, after the 
treatment, 26.7% and 22.7% of the population exhibited the MDR phenotype in cattle that 
received ceftiofur on days 4 and 8, respectively.  Interestingly, the MDR prevalence 
dropped to 3.2% and 3.6% by Days 14 and 20 and increased back to 12.9% by the end of 
the study (Day 26).  In contrast, the control group, with only one ceftiofur treated steer, 
had the highest overall Salmonella prevalence.  In this group, the MDR Salmonella was 





14.  By Day 20, 5.7% decreased to 3.8%.  There were no MDR Salmonella observed in 
this group on Day 26 (Figure 7).  
This study clearly showed that the ceftiofur treatment selected for MDR Salmonella 
starting 4 days after the treatment and continued selecting for MDR Salmonella in the 
feces by the end of the study.  Ohta et al. (2017) also explored the serotype distribution of 
these Salmonella isolates using WGS data with SeqSero and MLST databases.  The 
serotypes and matching ST types found in this study as listed from the most prevalent to 
least as: 1) S. Mbandaka (ST 413), 2) S. Kentucky (ST 198), 3) S. Montevideo (ST 138), 4) 
S. Give (ST 654), 5) S. Reading (ST 1628), and 6) S. Anatum (ST 64). 
 
Figure 7.  MDR Salmonella prevalence after single-dose ceftiofur treatment from Ohta 
et.al (2017) 
Grey: the proportional size of the total samples tested, green: the proportional size of the pan-susceptible Salmonella, red: 
the proportional size of the MDR Salmonella.  Adapted from Ohta et al.(2017) [36]. 
The molecular insights of this study also showed that the MDR profile of 
Salmonella was strongly associated (P < 0.05) with the serotype S. Reading.  This serotype 
had the ACSSuT + Cef resistance profile and was first recovered after Day 4 in both 





remained in the ceftiofur treated group until the end of the study, whereas in the control 
group it was always detected at low-numbers and was not detected on Day 26.  
Interestingly, this serotype was not identified on Day 0; however, S. Reading was likely 
present in the feces or environment but was not prevalent without the selection pressure of 
the antibiotic and therefore was not identified.  
Other serotypes isolated from this study were mostly pan-susceptible.  That study 
was the only published longitudinal controlled field study that measured the direct effects 
of ceftiofur on fecal Salmonella populations during 26 days following the antibiotic 
treatment.  Due to the time limitation of this study, the dynamics of the MDR Salmonella 
population observed on Day 26 remained unknown at slaughter, which typically takes 90 
or more days.  
Within the same cattle study of Ohta et al. (2017), Kanwar et al. (2013) explored 
the effects of ceftiofur treatment on the E. coli population focusing on the phenotypic 
antibiotic resistance profiles along with the blaCMY-2 gene, both before and after treatment 
on Days 0, 4, 12, and 24 [38].  The results of the studies published by Kanwar et al. (2013), 
showed that ceftiofur had a moderate selective pressure for MDR E. coli by reducing the 
proportion of ceftiofur or ceftriaxone susceptible strains against the resistant E. coli 
population especially on Day 4; however, this recovered back to the initial levels starting 
from Day 7, and a total recovery was observed by Day 26.  This study also found that the 
ceftiofur treatment significantly increased the likelihood of an isolate being phenotypically 
resistant to five to ten antibiotics.  The majority of the ceftiofur/ceftriaxone resistant 
isolates carried the blaCMY-2 gene that was mainly found among isolates with phenotypic 





Within the same study, the effects of ceftiofur were also investigated focusing on 
the fecal microbiome population and blaCMY-2, blaCTX-M, and 16S rRNA gene distribution 
using qPCR for only one replicate of cattle (two pens, 44 cattle) before and after treatment 
on Days 0, 4, 12, and 24 [37].  This study reported similar findings to the previous study.  
However, within this study, fecal samples from both replicates were explored (total of 4 
pens with 44 cattle).  Their results showed that ceftiofur statistically and significantly (P < 
0.05) increased the 16S standardized and non-standardized ceftiofur resistance genes 
(blaCMY-2, and blaCTX-M) copy numbers per gram feces on day 4 compared to Day 0; 
however, this trend was not significant after day 4 until Day 26.  Interestingly, the total 
number of 16S genes were not affected by the treatment during this study.  
Weinroth et al. (2018) further investigated these fecal samples collected from the 
study of Ohta et al. (2017), focusing on the effects of ceftiofur treatment on the resistomes 
of feces collected from only Day 0 and Day 26, and further focusing on the β-lactam genes  
using shotgun metagenomics [47].  They sequenced a total of 32 pooled metagenomic 
DNA samples.  The β-lactam genes were found to be higher on Day 26 when compared to 
Day 0.  However, this difference was not statistically significant (P < 0.05) and was not 
associated with ceftiofur treatment.  Their results did not indicate any significant effects of 
treatment groups on the number of β-lactam genes after the treatment on Day 26.  
Lowrance et al. (2007) investigated three different doses/regimens (single-dose of 
6.6 mg/kg on Day 0, single-dose of 4.4 mg/kg on Day 0, and three doses of 6.6 mg/kg on 
Days 0, 6, and 13), of subcutaneously injected ceftiofur on fecal E. coli populations 
recovered from 30 cattle (each group had 10 cattle housed in two pens) [39].  Another 31 





these cattle were collected before treatment (on Day 0) and following the treatment on 
Days 0, 2, 6, 9, 13, 16, 20, and 28. The findings of this study clearly demonstrated that the 
ceftiofur treatment, regardless of dose and regimen, significantly increased the ceftiofur 
resistant and ceftriaxone resistant E.coli and reduced the susceptible E. coli population 
starting from Day 0 until Day 28; further, these levels were recovered back to Day 0 
baseline values by Day 28.  However, the exception was of the lowest dose (4.4 mg/kg; 
extra-label and illegal to use since 2012) regimen, which recovered back to baseline values 
after Day 26, and was not significantly different than the control group on that day.  
Following the multiple-dose administration (also illegal since 2012) of 6.6 mg/kg ceftiofur 
after Day 9, ceftiofur resistance was significantly higher than the remaining ceftiofur 
treatment groups on Days 13, 16, and 20.  However, this group was not significantly 
different than the 6.6 mg/kg single-dose administered cattle group on Day 26.  Their 
overall result shows that ceftiofur had a selective effect on the E. coli population, and 
repeated use of ceftiofur resulted in the persistence of resistance in cattle fecal E. coli 
population.  
Alali et al. (2009) further investigated the study of Lowrance et al. (2007), to 
measure the effect of these regimens on the quantity the blaCMY-2 gene recovered from the 
feces on days 0, 3, 7, 10, 14, 18, 21, and 28 using qPCR [41].  This study showed that the 
administration of ceftiofur for all treatment groups increased the absolute and normalized 
(with 16SrRNA gene) number of blaCMY-2 genes detected in fecal samples compared to the 
control group throughout the 28-day period [41].  This study showed that administration of 





of both standardized and non-standardized blaCMY-2 genes detected in fecal samples.  This 
finding was similar to the findings of Kanwar et al. (2014). 
Overall findings of the studies presented above show that ceftiofur poses transient 
but significant selective pressures on both ceftiofur and ceftriaxone resistance profiles of 
Salmonella and E. coli recovered from the feces.  Usually, after a single-dose of 
subcutaneous 6.6 mg/kg ceftiofur treatment on Day 0, the temporary selection pressure on 
these bacteria species or resistome subsides and the microbiome recovers close to baseline 
values by Days 26 or 28.  However, the dynamics remain unknown until the slaughter age.  
In addition, none of these studies  evaluated the populations observed in cattle lymph 
nodes or on the cattle hides, which are potent sources of carcass contamination by cattle 
origin Salmonella at slaughterhouses. 
2.9.2.   Macrolides 
The macrolide class antibiotics that are used in cattle are erythromycin, 
gamithromycin, tildipirosin, tilmicosin, tulathromycin, tylosin, and tylvalosin (Table 2).  
To address the potential for these macrolides used in cattle to select for azithromycin 
resistance, it is important to understand the classification of macrolides and their 
chemical/molecular structures. 
  There are three major subclasses of macrolide antibiotics that are divided based on 
the number of carbons in their macrolactonic rings (C); these are listed as macrolides, 
azalides, and ketolides.  These subclasses also are further divided into two groups as 
natural or semisynthetic.  Azalides are 15-C semisynthetic antibiotics, which include the 





class, there is no natural group that exists [235].  The remaining antibiotics that are used 
for cattle are in the macrolide subclass, such as erythromycin (natural-14C), tylosin 
(natural-15C), and tildipirosin, tilmicosin, and tylvalosin (semisynthetic-16C) [235].  In 
cattle, gamithromycin and tulathromycin are the only azalide class macrolides used for 
BRD treatment and control [34].  Both antibiotics have the potential to select for 
azithromycin resistance in Salmonella.  Among these two antibiotics, tulathromycin is the 
most commonly used macrolide for BRD metaphylaxis in cattle.  Tulathromycin and 
azithromycin have very similar chemical structures [233] (Figure 8). Therefore, evaluating 
the potential effects of tulathromycin on Salmonella is important. 
 
Figure 8.  Chemical structure of tulathromycin and azithromycin 
Source: Open chemistry database (PubChem) at the NIH [233].  
The effects of tulathromycin metaphylaxis (single-dose 2.5 mg/kg) in relation to 
selection for azithromycin resistance has not been studied either for Salmonella or for E. 
coli, or for any other enteric bacterial species in cattle.  There are only two recently 
published (Doster et al. [2018] and Holman et al. [2019]) randomized controlled cattle 
  
    
  






field studies focused on the effects of tulathromycin and only on enteric microbiota and the 
resistome [46, 51].   
Doster et al. (2018) provided a comparison of the fecal resistome and microbiome 
among tulathromycin-treated and non-treated beef cattle before treatment (day 1) and after 
treatment (day 11) early in the feeding period (35).  Their study suggested that there was 
no significant difference (P < 0.05) in the cattle resistome and microbiome among 
tulathromycin treated and control groups; however, their results may be related to their 
small sample size (n = 15 per treatment group by day).  The authors did, however, report a 
significant increase in the 16S rRNA normalized ARG abundance and the average relative 
abundance of microbial taxa between Days 1 and 11.  Similar to the study of Weintroth et 
al. (2018) [47], Doster et al. (2018) ignored the likely peak day (close to Day 7) of 
antibiotic effect on enteric populations; importantly, their study did not measure the long-
term effects of tulathromycin treatment out to slaughter eligibility.  
Holman et al. (2019), evaluated the single-dose effects of metaphylaxis on the fecal 
microbiota of 24 beef cattle (12 each for tulathromycin treated and non-treated cattle 
groups) [51].  Cattle fecal swabs were collected three days before transportation (Day -5), 
before the tulathromycin treatment after two days of acclimation period (on Day 0), and 
following the treatment on Days 2, 5, 12, 19, and 34.  The ARGs conferring macrolide 
resistance via ermA and ermX were quantified using qPCR and results were normalized 
using the 16SrRNA gene copy number.  In their study, they only found ermX gene 
conferring macrolide resistance in the fecal microbiota of cattle, which did not differ 
among the treated and non-treated cattle when the results were normalized with the 16S 





the treatment on Day 0.  However, they reported a fecal microbial community shift 
observed before and after the transport, which was similar for all cattle prior to the cattle 
placement to the experimental feedlot.  This observation was more likely related to the 
cattle group that was selected from a closed herd, and which was already commonly 
exposed to a similar environmental bacterial flora and other environmental factors that can 
affect microbial diversity.  Specifically, the operational taxonomic unit (OTU) richness 
was reported to have decreased after the transportation, when cattle were housed in the 
same feedlot.  These findings suggest that the feedlot environment may reduce the 
microbial diversity in cattle feces, following transport to the feedlot. 
2.10.   Summary 
To summarize, the group-level administration of antibiotics to beef cattle represents 
a routine application by farmers to control BRD upon arrival to the feedlot.  Because 
feedlots are the last production stage prior to slaughter, it is important to assess the 
contribution of the use of BRD control antibiotics – early, during the feeding period, and 
most importantly at slaughter – in affecting AR Salmonella populations in human.  
Macrolides and 3rd generation cephalosporins play a critical role in the treatment of human 
Salmonella infections.  Ceftiofur and tulathromycin, which are the analogs of ceftriaxone 
and azithromycin are widely used in feedlot cattle for cohort-level control of BRD. 
The study previously published by Ohta et al. (2017) showed an expansion of MDR 
Salmonella related to a single-dose of ceftiofur metaphylaxis on Day 4, which remained 
prevalent until the end of the study (Day 26) [36].  In their study, the MDR phenotype was 





controlled field study that has measured the direct effects of ceftiofur on Salmonella 
populations for 26 days following antibiotic administration. However, in that study, the 
dynamics and persistence of MDR Salmonella between Day 26 and slaughter (typically, 
90+ days) remains unknown.  In parallel, studies conducted to measure ceftiofur treatment 
effects on the fecal E. coli populations [38, 39] and microbiome found significant or 
transient selective pressures on ceftiofur/ceftriaxone resistance [37, 41].  
There is a lack of research measuring the effects of tulathromycin metaphylaxis on 
Salmonella and any other enteric bacterial species in cattle.  Only Doster et al. (2018) and 
Holman et al. (2019) have conducted studies measuring the effects of tulathromycin on the 
cattle fecal microbiome and resistome, and only in limited ways.  Both of these studies 
compared the enteric microbiome and resistome, between tulathromycin-treated and non-
treated beef cattle population, before treatment and after treatment early (up to day 11 and 
34, respectively) in the feeding period and showed no statistically significant (P < 0.05) 
effect [46].   
None of the studies mentioned above was conducted until slaughter age and they 
also did not explore other contamination sources of beef products besides the feces.  
Clearly, there is a strong need for a longitudinal controlled study measuring longer-term 
effects of ceftiofur and tulathromycin on prevalence, quantity and antibiotic resistance 
patterns of Salmonella populations found not only in feces but also on hides and in lymph 
nodes of cattle, each of which represents potential contamination sources of Salmonella at 
slaughter.  
Given the importance of the increasing ceftriaxone- and azithromycin-resistant 





analogs in cattle feedlots, that beef is one of the important sources of Salmonella human 
outbreaks, and the lack of research on this subject, an immediate need for a randomized 
and controlled longitudinal study measuring effects of ceftiofur and tulathromycin on 
Salmonella populations is apparent.  A study is especially needed to determine the 
antibiotic resistance profiles and the population dynamics of Salmonella monitored for a 
longer duration than might be affected by the antibiotic treatments.  The focus of such a 
study should not only be on the fecal matter, but also the lymph nodes and the hide 
surfaces of cattle, which are known to be potential carcass and beef product contamination 






3.   MATERIALS AND METHODS* 
A randomized and controlled cattle field trial was conducted with one hundred 
thirty-four crossbred yearling cattle (beef steers) to measure long term effects of single-
dose ceftiofur and tulathromycin treatment on Salmonella populations in the West Texas 
A&M University Research Feedlot in Canyon, Texas, USA. 
3.1.   Study population 
The animal field trial was approved by the West Texas A&M University/ 
Cooperative Research, Educational and Extension Team Institutional Animal Care and Use 
Committee (Protocol no. 05-09-15).   
Previously backgrounded healthy cattle were purchased from two different sources; 
99 cattle were purchased from Abilene, Texas (430 km southeast of the experimental 
feedlot) and 35 cattle were purchased from Hereford, Texas (48 km southwest of Canyon) 
(Figure 9).  The prior antibiotic administration history of these cattle was unknown.   
Cattle were transported to the experimental feedlot in Canyon, TX with an initial 
body weight of 310-370 kg.  Upon arrival to the feedlot, individual steers were identified 
with a colored ear tag and an electronic ear tag in both ears.  After a three-day acclimation 
period, these cattle were source- and weight-blocked and then randomly assigned to 
treatment groups to control for possible origin- and host-related confounders.  The staff in 
the feedlot, slaughter plant, and in the microbiological laboratories were also blinded as to 
                                                 
*Part of this chapter is reprinted with permission from “Population Dynamics of Salmonella enterica within Beef Cattle 
Cohorts Followed from Single-Dose Metaphylactic Antibiotic Treatment until Slaughter” Levent G, Schlochtermeier A, 
Ives SE, Norman KN, Lawhon SD, Loneragan GH, Anderson RC, Vinasco J, Scott HM. 2019 Appl Environ Microbiol 





treatment to avoid possible biases.  This was possible since no differences existing in pen 
rations or other treatments after initial metaphylaxis was administered. 
During the feeding period, the same ration was provided for all cattle, regardless of 
source, block, or treatment.  Cattle were provided starter, grower, and finishing diets 
consisting of varying concentrations of wet corn gluten feed, chopped-corn stalks, steam-
flaked corn, and mineral supplements (without antibiotics) progressively throughout the 







Figure 9.  Map of Texas representing the sources of cattle and the experimental feedlot 
The experimental feedlot in Canyon, TX (blue), Source 1: Hereford, TX (orange), and Source 2: Abilene, TX (green).  
Adapted from Wikimedia Commons, https://commons.wikimedia.org.  The map has been made or improved in the 
German Kartenwerkstatt. 
3.2.   Experimental design  
Beef cattle (n = 134) were allocated into four blocks (Blocks 1-4) by source and 
initial body weights.  Steers in each block (33-35 cattle) were further randomly allocated 
into three pens.  Each pen (11-12 cattle) in a given block received either ceftiofur, 
tulathromycin, or else remained as a control group.  One or two cattle in the treatment pens 
remained as also a control (untreated) steer to measure the pen-level effects of the 





ceftiofur or tulathromycin) in each antibiotic treatment pen (Table 3).  Overall, 40 cattle 
received ceftiofur, 40 cattle received tulathromycin and 44 cattle remained as controls.   
Table 3.  Descriptive field trial data for cattle source, block, pen, treatment, and slaughter 
days 
 







1 1 7 12 Tulathromycin 134 
1 1 8 11 Control 134 
1 1 9 12 Ceftiofur 134 
2 2 51 11 Tulathromycin 141 
2 2 52 11 Control 141 
2 2 53 11 Ceftiofur 141 
2 3 54 11 Control 120 
2 3 55 11 Ceftiofur 120 
2 3 56 11 Tulathromycin 120 
2 4 57 11 Ceftiofur 99 
2 4 58 11 Tulathromycin 99 
2 4 59 11 Control 99 
Reprinted with permission from Levent et al. (2019) [236]. 
After the pen allocations at the sorting pens, cattle were placed into their study pens 
(Figure 10).  To eliminate possible source bias, cattle from Hereford (Pen 7-9) were placed 
at the far western end of the feeding area.  The cattle from Abilene were allocated into the 
remaining nine pens (Pen 51-59).  
After the placement, the trial began (Day 0) on March 14th, 2016.  Before the 
antibiotic treatments were administered, fecal contents were collected per rectum from the 
individual cattle by feedlot staff eligible to perform these tasks under the AUP.  These 





in the treatment groups that were assigned to have individual treatments received a single 
subcutaneous injection of either tulathromycin or ceftiofur.  
 
Figure 10.  Satellite view of pens located in the experimental feedlot 
34°58'02.2"N 101°48'04.8"W, retrieved on October 2, 2019.  Source: https://goo.gl/maps/pzWU9f2LeG2EsMXCA. 
Tulathromycin (Draxxin®, Zoetis, Kalamazoo, MI) was injected subcutaneously in 
the neck at a therapeutic dose of 2.5 mg/kg.  Ceftiofur crystalline-free acid (Excede®, 
Zoetis Inc., Kalamazoo, MI) was injected subcutaneously in the posterior aspect of the ear 





3.3.   Sampling frame  
Fecal samples were the only type of sample that was collected before the treatment 
and after the treatment during the feeding period in order to evaluate pre- and post-
treatment effects of antibiotics on Salmonella from Day 0 until Day 99.  In addition to the 
feeding period, fecal samples, lymph nodes and hide swabs were collected at slaughter age 
starting after Day 98 (on Days 99, 120, 134, and 141), in order to measure the dynamics of 
the Salmonella population in ready-to slaughter cattle (Figure 11).  This trial was 
completed on August 2nd, 2016.  
Each block of cattle was sent to slaughter on a single day after at least 98 days of 
feeding.  The decision as to timing of slaughter was made based on cattle approaching their 
desired body weights (varying from 450-635 kg) for slaughter.  Each block of cattle was 
sent to slaughter on different days:  Block 4 (Day 99), Block 3 (Day 120), Block 1(Day 
134), and Block 2 (Day 141) (Table 4).   
 
Figure 11.  Timeline of the study 
Antibiotic injection (blue) and fecal (red), and lymph node and hide collection (green) days.  Fecal and hide samples were 






Table 4.  Planned sampling day, date, and sample type collection scheme  
 
Sampling day Sampling date Sample type Number of cattle Pen 
0 14-Mar-2016 Feces 134 All 
7 21-Mar-2016 Feces 134 All 
14 28-Mar-2016 Feces 134 All 
28 11-Apr-2016 Feces 134 All 
56 09-May-2016 Feces 134 All 
99 21-Jun-2016 Feces, LN, Hide 33 (Block 4) 57-58-59 
120 12-Jul-2016 Feces, LN, Hide 33 (Block 3) 54-55-56 
134 26-Jul-2016 Feces, LN, Hide 35 (Block 1) 7-8-9 
141 02-Aug-2016 Feces, LN, Hide 33 (Block 2) 51-52-53 
LN (lymph node). 
Feces were collected before treatment (Day 0) and then one week after the 
treatment (Day 7) to measure the short-term effects of antibiotics.  Individual cattle were 
also sampled two weeks (Day 14), four weeks (Day 28) and eight weeks (Day 56) later in 
order to determine longer-term feeding period effects.  Effects at slaughter of the early 
period antibiotics on Salmonella were measured in feces collected the day before slaughter 
(after day 98 for all cattle in all blocks).  
On each fecal sampling day, individual cattle were restrained in a squeeze chute 
and weighed in the animal handling facility at 5 a.m. in the morning.  Sterile full-length 
obstetric sleeves were used to collect approximately 25 g of feces from each cattle per 
rectum.  After collection, each glove was inverted, knotted, and labeled with four-digit 
individual animal identifiers. 
Two bilateral sub-iliac lymph nodes from the flank region also were collected 
during the slaughter process from each carcass that had passed both ante- and post-mortem 





nodes from the flank region of individual steer carcasses were excised before the 
fabrication of the carcass and placed into 2.5-gallon Zip-lock plastic bags.  Each bag was 
marked with a unique four-digit animal identifier. 
Protocols from previously published studies were adapted to determine Salmonella 
carriage on cattle hides at slaughter [69, 117, 237].  Briefly, a one m2 area of the brisket 
(cranial ventral) hide area of individual steers was rubbed with a sterile sponge (Whirl-
Pak™ Speci-Sponge Environmental Sampling Bag, Nasco), which was pre-moistened with 
25 ml Butterfield’s phosphate buffer solution (REMEL®, Lenexa, KS) using sterile gloves.  
Hide swab collection was performed one day prior to slaughter in order the measure the 
likely Salmonella carriage on hide surfaces when cattle entered the plant.  These samples 
were collected at the same time as the terminal day fecal samples.   
Feces, lymph node and hide samples were immediately placed into the cooler with 
ice packs to maintain the cold chain at 4°C and shipped to the laboratory at the College of 
Veterinary Medicine and Biomedical Sciences at Texas A&M University after each 
sampling day. 
3.4.   Sample processing  
Microbiological methods, including those performed on animal tissues, were 
performed under a Texas A&M University Institutional Biosafety Committee permit 
(IBC2017-049).  Sample processing and microbiological methods were performed in 
biosafety level-2 biological safety cabinets. 
Upon the arrival to the laboratory, fecal samples were placed into sterile glycerol 





homogenized via vortexing, and then preserved at −80 °C until the time of microbiological 
and molecular processing.  In contrast, the lymph nodes and hide swabs were first pre-
enriched with TSB (Bacto, Becton Dickinson, Sparks, MD) and then placed into glycerol 
and non-glycerol tubes, homogenized and stored at −80 °C.  Prior to starting the 
microbiological processing of feces, samples were taken out of the freezer and thawed on 
ice at room temperature for about 30 min.  A 0.5 g aliquot of each fecal sample was 
weighed and placed into 10 ml sterile plastic tubes with 5 ml of TSB.  The suspension was 
homogenized via vortex for 1 min.   
Two large chunks of fat tissue were received from each individual animal.  The 
embedded lymph nodes were found by dissection and carefully cleaned from the excess fat 
and fascial tissue without causing rupture to the lymph node capsule by using a sterile 
knife, scalpel, and scissors (Figure 12).   
 
Figure 12.  Photo of a lymph node embedded in fat tissue 





Afterward, each lymph node was placed onto a sterile petri dish and weighed.  The 
trimmed and cleaned lymph nodes were exposed to boiling water, depending on size, for 3 
to 6 seconds to achieve surface sterilization via parboiling.  Right after the sterilization, 
each lymph node was placed inside the filter bag of a sterile plastic stomacher filter bag 
(Seward, Norfolk, UK) and then pulverized with a rubber mallet.  After the pulverization 
step, 80 ml of TSB was added into the bag.  Later, the suspension was homogenized using 
a stomacher (Seward Circulator 400, Norfolk, UK) at 230 revolutions per min (rpm) for 2 
min. 
The pre-moisturized hide swab sponges in the plastic Whirl-pack bags were 
suspended with 75 ml of TSB.  These bags were placed into the stomacher and 
homogenized at 230 rpm for 2 min. 
3.5.   Quantification of Salmonella  
After homogenization, each of the three sample type TSB suspensions was 
subjected to a short incubation at 42°C for 3 h.  After the 3 h incubation, a 50 µl aliquot of 
the suspension was spiral-plated onto BGA (Difco, Becton Dickinson, Sparks, MD) 
containing 25 g/L of novobiocin sodium salt (Sigma Aldrich, N1628-5G) – in order to 
reduce the false-positive counts [70] – using the Eddy Jet 2 Spiral Plater (Neutec Group 
Inc, Farmingdale, NY).  The BGA plus novobiocin plates were incubated at 37 °C for 18 h.  
After incubation, colonies typical (pink and rounded) of Salmonella were counted to obtain 
CFU numbers using the Flash & Go Automatic Colony Counter (IUL Instruments S. A.).  
The CFUs were later back-calculated – either per gram (feces and lymph node) or per m2 





3.6.   Isolation of Salmonella  
After the initial 3 h incubation of the three sample types, 1 ml of TSB suspension 
was transferred into 9 ml tetrathionate broth (Difco, Becton Dickinson, Sparks, MD) 
containing 180 µl iodine solution (REMEL®, Lenexa, KS) and further incubated at 37 ºC 
for 24 h.  After incubation, 100 µl of the bacterial suspension of tetrathionate broth was 
transferred into 10 ml RV (Difco, Becton Dickinson, Sparks, MD) and further incubated at 
42 ºC for 18 h.  Upon completion of RV incubation, a 50-µL aliquot was spiral-plated onto 
the plain BGA plate.  The plates were further incubated at 37 °C for 18 h.  After the 
specific enrichment broth steps, up to two pink round colonies emerging on BGA plate 
were streaked onto blood agar (tryptic soy agar with 5% sheep blood, Remel, Lenexa, KS) 
and incubated at 37 °C for 18 h.  A  loop full of culture from each isolate was placed into 
CryoCare beads (Scientific Device Laboratory, Des Plaines, IL), mixed well and stored at 
−80 °C for further characterization at a later date. 
3.7.   Confirmatory tests 
Salmonella colonies were subjected to a serum agglutination testing by using 
Salmonella O Antiserum Poly A-I & Vi (factors 1-16, 19, 22-25, 34, Vi) (Difco, Becton 
Dickinson, Sparks, MD) for initial screening.  Approximately 100 µl of antisera was 
placed on a sterile petri dish and mixed with pure colonies.  The reaction was observed for 
30 seconds for signs of agglutination.  The agglutination positive isolates were accepted as 
presumptive Salmonella isolates.  After the preliminary confirmation with antisera, the 
MALDI-TOF MS method was used for secondary confirmation.  Isolates grown on blood 





(Bruker Daltonics, Bremen, Germany) as a thin layer.  Next, one µl of Bruker HCCA (α-
Cyano-4-hydroxycinnamic acid) matrix solution was applied to each well containing 
bacteria and the plate was air-dried.  A quality control (bacterial test standard, Bruker 
Daltonics) and negative control (matrix only) were included in each plate.  The Microflex 
LT instrument (Bruker Daltonics GmbH, Leipzig, Germany) was used to measure the 
protein-mass.  Spectra were analyzed using FlexControl® v.3.4 and MBT Compass 
software (Bruker Daltonics GmbH, Leipzig, Germany).  Genus and species were identified 
using the main spectra (Bruker Daltonics [BDAL] main spectrum profile [MSP]) library.  
Salmonella isolates scoring ≥ 2.0 were confirmed as Salmonella.  The isolates confirmed 
by both confirmation methods were considered as Salmonella and were carried to the next 
step of analysis. 
3.8.   Phenotypic antibiotic susceptibility 
Phenotypic antibiotic susceptibilities of each Salmonella isolate were determined 
by the broth microdilution method on the Sensititre® system (TREK, Thermo Scientific 
Microbiology, Oakwood Village, OH) using the National Antimicrobial Resistance 
Monitoring System (NARMS) gram-negative (CMV3AGNF, Thermo Fisher Scientific, 
Waltham, MA) panel.  The NARMS gram-negative panel contains various concentrations 
of 14 antibiotics (9 classes of antibiotics) including cefoxitin, azithromycin, 
chloramphenicol, tetracycline, ceftriaxone, amoxicillin-clavulanic acid, ciprofloxacin, 
gentamicin, nalidixic acid, ceftiofur, sulfisoxazole, trimethoprim-sulfamethoxazole, 
ampicillin, and streptomycin (Figure 13).  The MICs for each antibiotic were determined 





The isolates were inoculated onto blood agar and incubated at 37 °C for 18 h. 
Approximately one colony was picked and suspended in 5 ml sterile deionized water to 
adjust to a 0.5 McFarland equivalence turbidity standard (Remel®, Lenexa, KS) using the 
Sensititre® Nephelometer (TREK, Thermo Scientific Microbiology, Oakwood Village, 
OH).  Next, 50 µl of the suspension was transferred to 11 ml Mueller-Hinton (MH) broth 
(Thermo Scientific Microbiology, Oakwood Village, OH), and 50 µl of MH broth was 
delivered to each well of the Sensititre plate using the TREK Sensititre® Automated 
Inoculation Delivery System (TREK, Thermo Scientific Microbiology, Oakwood Village, 
OH).  
 
Figure 13.  Gram-negative NARMS plate (CMV3AGNF) format 
Cefoxitin (FOX), azithromycin (AZI), chloramphenicol (CHL), tetracycline (TET), ceftriaxone (AXO), 
amoxicillin/clavulanic acid 2:1 ratio (AUG2), ciprofloxacin (CIP), gentamicin (GEN), nalidixic acid (NAL), ceftiofur 
(XNL), sulfisoxazole (FIS), trimethoprim/sulfamethoxazole (SXT), ampicillin (AMP), and streptomycin (STR).  MICs 







Each new lot number of CMV3AGNF plates was tested against quality control 
strains of E. coli ATCC 25922, E. coli ATCC 35218, Pseudomonas aeroginosa ATCC 
27853, Staphylococcus aureus ATCC 29213, and Enterococcus faecalis ATCC 29212 
(American Type Culture Collection, Manassas, VA) as recommended by the CLSI [90]  
Plates were sealed and incubated at 37 °C for 18 h and then read using the 
Sensititre OptiRead™ Automated Fluorometric Plate Reading System (TREK, Thermo 
Scientific Microbiology).  The results were initially interpreted as resistant, intermediate or 
susceptible based on CLSI methods and referent NARMS MIC breakpoint values where 
applicable [90].  The CLSI breakpoints for streptomycin in Salmonella are not established.  
NARMS used the breakpoint of ≥ 64 µg/ml for resistance between 1996 and 2013.  After 
examining phenotypic and genotypic resistance mismatches of streptomycin in Salmonella, 
NARMS lowered the resistance breakpoint to ≥ 32 µg/ml and applied this standard to 
isolates tested since 2014.  Azithromycin was included into the NARMS CMV3AGNF 
panel in 2011.  The interpretation criteria for azithromycin are available for only S. Typhi, 
and this criterion was included by CLSI in 2014.  Based on the CLSI interpretation, 
azithromycin susceptibility for S. Typhi is ≤ 16 µg/ml and the resistance value is ≥ 32 
µg/ml.  NARMS uses these breakpoints for non-typhoidal Salmonella strains in order to 
monitor resistance in Salmonella; however, these criteria were not considered as valid to 
predict the clinical efficacy of azithromycin on non-typhoidal Salmonella [32]. 
  Since the MIC interpretative criteria for azithromycin and streptomycin are not 
established for non-typhoidal  Salmonella by CLSI, the NARMS interpretative criteria 
(https://www.cdc.gov/narms/antibiotics-tested.html) were used for azithromycin (≥ 32 





Table 5.  Interpretative MIC criteria of antibiotics used in this study 
 
CLSI Class Antimicrobial Agent MIC (μg/ml) Sus Int Res Plate 
β- Lactam/ β-lactamase 
inhibitor combinations 
Amoxicillin-clavulanic 
acid ≤8/4 16/8 ≥32/16 ≥32 
Penicillins Ampicillin ≤8 16 ≥32 ≥32 
Macrolides Azithromycin ≤16 NA ≥32 >16 
Cephems 
Cefoxitin ≤8 16 ≥32 ≥32 
Ceftiofur ≤2 4 ≥8 ≥8 
Ceftriaxone ≤1 2 ≥4 ≥4 
Phenicols Chloramphenicol ≤8 16 ≥32 ≥32 
Quinolones Ciprofloxacin ≤0.06 0.12-0.5 ≥1 ≥1 
Aminoglycosides Gentamicin ≤4 8 ≥16 ≥16 
Quinolones Nalidixic acid ≤16 NA ≥32 ≥32 
Aminoglycosides Streptomycin ≤16 NA ≥32 ≥64 
Folate pathway 
inhibitors Sulfisoxazole ≤256 NA ≥512 >256 




sulfamethoxazole ≤2/38 NA ≥4/76 ≥4 
Sus (Susceptible), Int (Intermediate), Res (Resistant), Plate (Sensititre panel upper detection limit).  Adapted from 
https://www.cdc.gov/narms/antibiotics-tested.html in September 2019. 
3.9.   DNA extraction and WGS 
The QIAcube® HT (Qiagen, Valencia, CA) platform and QIAamp 96 DNA 
QIAcube® HT Kit (Qiagen, Valencia, CA) were used to extract the bacterial DNA from a 
single-colony, according to the manufacturer’s instructions.  A single-colony was 
suspended into 5 ml of TSB and incubated at 37 °C for 18-24 h.  After incubation, 1 ml of 
suspension was transferred into a micro-collection tube (1.2 ml) and centrifuged at 4,000 
rpm for 15 min at room temperature.  After the incubation period, the supernatant was 
discarded and the remaining pellet was re-suspended in 180 ml of ATL-DX buffer 
(Qiagen, Valencia, CA) that was previously prepared with 15 ml ATL and 100 µl DX.  





suspension and the suspension was disrupted with the Qiagen TissueLyser system (Qiagen, 
Valencia, CA) for 5 min at 25 Hz.  The tubes were briefly centrifuged to remove foam.  
Next, 40 μl of Proteinase K was added to each tube.  The tubes were incubated for 1 h at 
900 rpm and 56 °C followed by a heat shock for 10 min at 95 °C using a ThermoMixer 
(Eppendorf, Hauppauge, NY).  The suspension was placed into the fridge at 4 °C for 5 min 
to cool down.  Later, 4 μl of RNAse was added into the suspension and incubated for an 
additional 5 min at room temperature.  After the bench step, samples were set in the 
QIAcube HT instrument for the DNA wash and elution steps using a modified protocol for 
gram-negative bacterial DNA extraction.  
The DNA purity was assessed at 260 nm/280 nm ratio of absorbance on the 
FLUOstar® Omega multi-mode microplate reader (BMG LABTECH, Cary, NC).  The 
DNA quantity was confirmed by fluorometric methods using Quant-IT PicoGreen dsDNA 
Assay kit (Thermo Fisher Scientific, Waltham, MA) on the FLUOstar® Omega multi-mode 
microplate reader and Qubit 1X dsDNA HS Assay Kit in the Qubit 4 Fluorometer (Life 
Technologies, Carlsbad, CA) following the manufacturers’ instructions.   
The Illumina® Nextera XT (or, the Flex) library preparation kit (Illumina, San 
Diego, USA) was used to generate sequencing libraries following the manufacturer's 
instructions -.  The two kits (XT and Flex) were slightly different in terms of the reagents 
and the protocols used.  However, the main principal steps of each kit were similar and  
include steps for tagmentation of DNA, amplification of libraries using specific index 
primers, pooling the libraries, and denaturation of the libraries.  For tagmentation, the 
DNA was tagmented with specific buffers such as: TD®, ATM®, and NT® using the XT 





step, a clean-up process was utilized in the Flex Kit protocol using the TSB® and TWB® 
reagents.  The library amplification step was performed via PCR using the index primers 
(index 1-2 or index oligos) and PCR reagents (NPM® or EPM®).  The libraries were cleaned 
up with ethanol and the reagents of RSB®, AMPure® beads and/or SPB®.  To arrange the 
library sizes, the AMPure beads were applied when the XT Kit was used; whereas in the 
Flex Kit, this reaction took place in the tagmentation step using the BLT® (a bead-linked 
transposome reagent). 
The fragment sizes of libraries were evaluated using the Standard Sensitivity NGS 
Fragment Analysis Kit® (Agilent, Santa Clara, CA) and Fragment Analyzer Automated CE 
System® (Advanced Analytical, Des Moines, IA).  The library quantities were validated 
using the fluorometric methods performed by the FLUOstar® Omega multi-mode 
microplate reader and Qubit 4 Fluorometer.  The fragment smear analysis and the 
concentration of the individual libraries were assessed based on the manufacturer’s 
instructions.  Good quality libraries, with fragments ranging from 250-1,500 bp (base-pair) 
and an average 500-600 bp length, were carried to the pooling and library denaturation 
steps.  After cleaning the libraries, an additional normalization and denaturation step took 
place for the XT Kit using the LNA1®, LNB1®, LNW®, LNS®, and the sodium hydroxide 
reagents.  On the other hand, the Flex Kit followed a straight denaturation process with 
sodium hydroxide, without the normalization step.  After the libraries were pooled and 
denatured, they were loaded on sequencing cartridges with either MiSeq® Reagent v.2  or 
MiSeq® Reagent v.3 chemistry.  The sequencing runs were performed on the Illumina® 





(Illumina, San Diego, CA, USA) v.2 chemistry with paired-end 2 × 250-bp reads or else 
v.3 chemistry with paired-end 2 × 300-bp reads[96]. 
3.10.   Descriptive statistics   
The data types obtained from our study were: 1) quantification of log10 CFU 
Salmonella (continuous, normalized), 2) number of samples with Salmonella following the 
enrichment (prevalence, binary), 3) phenotypic antibiotic resistance (binary: CLSI or 
NARMS ordered interpretive data reclassified as resistant or susceptible (includes the 
intermediate class)), 4) serotype and STs (multinomial categorical),  5) antimicrobial 
resistance genes (ARGs) (multinomial categorical), and 6) plasmids (multinomial 
categorical).   
For descriptive statistics, data were initially cross-tabulated across sampling days 
and treatments by sample type.  Overall frequency distributions of the data were 
determined graphically.   
Phenotypic antibiotic resistance data, plus point estimates and confidence intervals 
(CIs), were examined individually (14 antibiotics) using the Clopper-Pearson exact method 
that calculates the "binomial exact CIs" based on the beta distribution rather than 
calculating the approximate CIs, which are based on the normal distribution [238].  
Graphical visualizations and tables were generated using Microsoft Excel 2016 
(Microsoft Corporation, Redmond, Washington, USA).  For statistical analyses, the 
slaughter days were collapsed to a single-period (Day 112, also called terminal day) for all 





Univariate analysis was performed using the likelihood-ratio chi-square test to 
address shared pen effects on serotype presence in hide samples.  The interrater agreement 
test (kappa, - kap- in Stata) was applied to measure agreement between for quantifiable 
CFUs and enrichment results.  Pairwise comparisons of the total genome assembly length 
means were conducted by serotype with equal variances hypothesis using Tukey’s test.  
3.11.   Multi-variable regression analyses  
Stata version 15.1 (StataCorp LLC, College Station, TX) was used for multi-
variable analyses of the enrichment results and CFU counts.  The regression analyses were 
performed separately for each of feces, lymph node and hide samples.  For all sample 
types, the treatment was forced as a fixed effect.  Day and treatment by day interactions 
were only forced as fixed effects in the regression model utilized for the fecal samples.   
Clustering effects of pen and animal identifier were included in each model to 
avoid underestimating variance factors.  Categorical pen identifiers were included in all 
models either as a random effect variable or else robust variance component, regardless of 
sample type.  The individual animal identifiers were forced into each model where there 
was a repeated measurement (i.e., feces and lymph nodes), either as a random effect or else 
a robust variance component, except for the hide samples where there were no repeated 
measurements within animal.   
The observations obtained from the control group were considered as baseline 
observations to measure the effect of either ceftiofur or tulathromycin on a variety of 
outcomes.  In addition, Day 0 observations were considered as the baseline to measure the 





3.11.1.   Two-part and interval-linear regression models 
Dilution factors were used to back-calculate either the CFUs in one gram of lymph 
node or fecal sample (recorded as CFU/g); or, on one meter-square of hide surface area 
(recorded as CFU/m2).  Results obtained from overall CFUs were log10 transformed to 
normalize data more suited to the assumptions of linear regression. 
In our study, two types of regression models (two-part regression models or 
imputation models followed by interval-linear regression) were found to be well suited for 
different sample types and data features.  The decision of selecting the appropriate model 
for CFUs was made based on two criteria: 1) presence of excess zero counts, and 2) 
likelihood of CFU zero counts were being either structural (true zero) or else sampled as 
zero (i.e., not zero, but under the LLQ of the assay).   
Two-part models: 1) zero-inflated Poisson (ZIP), 2) zero-inflated negative binomial 
(ZINB), and 3) Cragg’s hurdle (CHURDLE or hurdle) were explored for feces and lymph 
node observations.  The log10 transformed CFUs were rounded for ZIP and ZINB 
regression models to obtain integers, as required for the models.  The CHURDLE models 
directly utilized continuous log10 CFUs.  Both the binary inflation (part 1) and the selection 
models (part-2) were built using the fixed effects of individual treatments (and interaction), 
sampling day (feces only) and pen; meanwhile, clustered robust variances were generated 
by the individual animal identifier for fecal and lymph node related regression analyses, 
due to limitations of two-part models to apply multi-level regression analysis (Table 6).   
The best-fit model was selected according to the lowest Akaike's information 





the post-estimation marginal means and 95% CIs from the selected model were evaluated 
and visualized using - marginsplot - either in linear connected plot format (for feces) 
showing the day and treatment effects, or else in bar plots (for lymph nodes) showing the 
treatment effects.  The average marginal effects were also computed using the multiple-
pairwise comparisons and these comparisons were adjusted using Bonferroni’s method 
[239] for each contrast of the fixed effects and their interactions. 
Table 6.  Parameters forced into the two-part regression models 
Models Sample types Fixed effects Robust  
variance 
ZIP Feces Day, treatment, day#treatment*,Pen Animal  Lymph nodes Treatment, Pen Animal  
ZINB Feces Day, treatment, day#treatment*, Pen Animal  Lymph nodes Treatment, Pen Animal  
CHURDLE Feces Day, treatment, day#treatment*, Pen Animal  Lymph nodes Treatment, Pen Animal 
*Interaction terms; the random effects forced as categorical observations. 
 A multiple imputation technique using an interval linear regression model was 
adapted to impute the only the zero CFUs as they were accepted as missing values (n=27) 
and the actual missing values (n=2) according to the distribution between zero and the 
LLQ for observations that were likely the sampling sampled as zero.  Briefly, first the 
multiple imputation datum style was set to wide format, individual treatment and pen 
variables were added as the regular registered variables, and a new variable was assigned 
as the imputation variable.  The imputation was performed using interval regression (- mi 
impute intreg -) including the new imputation variable as the dependent, and treatment and 





limit was set to zero, whereas the upper censoring limit was set to the LLQ value.  Twenty 
imputations and a random seed number of 1234 were selected to begin the process of 
imputation according to the standards (29, 50).  The estimations using the multiple 
imputation data were performed with multi-level mixed-effects linear regression model 
using - mi estimate: mixed - command with fixed effect of treatment and the random effect 
of pen.  The marginal predictive counts of treatments were analyzed using the -mimargns- 
and graphically visualized using the - marginsplot - commands (51). 
3.11.2.   Logistic regression models 
Multi-level mixed-effect logistic regression (-melogit-) was used for the binary 
coded observations obtained from the confirmed Salmonella isolated  from the enrichment 
process separately for feces, lymph nodes, and hides.  The default full-factorial model (or 
main fixed effects) of individual treatments and sampling days were added where 
appropriate to fecal, lymph node, and hide results (Table 7).  The interaction terms for 
treatment by day were forced into the fecal model.   
The variance correlation structures and matrices (- estat vce, correlation -) were 
explored before the final regression analyses.  The pen-level and animal-level 
dependencies were determined to be exchangeable for all sample types; in contrast, 
individual animal dependencies were set as unstructured for feces (n = 6 per animal) and 
lymph nodes (n = 2 per animal).  The predicted marginal means and the 95% CIs of day 
(feces only) and treatment were examined.  
For the fecal regression analysis, graphical visualizations of the predicted margins 





node and hide model results were presented as bar graphs showing only the treatment 
effects. 
Table 7.  Parameters forced into the logistic regression models 
Sample types Fixed effects Random effects 
Feces Day, treatment, day#treatment* Pen, animal 
Lymph nodes Treatment Pen, animal 
Hides Treatment Pen 
*The interaction terms. 
In addition, each fixed effect or interaction-term was explored using the stepwise 
comparisons from the full model to the intercept-only model.  To obtain the direct effect of 
day and treatment on the predictive marginal means and the 95% CIs, each parameter was 
examined from the full model comparing to the intercept-only model by the -2(Log-
likelihood), degrees of freedom (df), and P-values.  The average marginal effects were also 
computed using multiple-pairwise comparisons and these comparisons were adjusted with 
Bonferroni’s method for each contrast of fixed effect and interaction term.  In addition, the 
residual intra-class correlation coefficients (ICCs) that were reported from the regression 
analyses were examined to explore the magnitude of the variance that was attributable to 
the clusters such as pen or/and individual animal. 
3.12.   Bioinformatic analyses 
Web-based and command-line tools on the Texas A&M University High-





3.12.1.   Quality assessments of the sequencing data 
Bad quality FASTQ (raw sequence reads) reads (i.e., reads with a PHRED score 
less than 33 [240]) and less than 36 bp length (- MINLEN:36 -) were removed using 
Trimmomatic v.0.36 [241] on the command-line.  In addition, we removed at the end of 
each read the low-quality or N bases that were below-quality 3 using the - LEADING:3 – 
and the - TRAILING:3 - options.  The - SLIDINGWINDOW: 4:15 - option was also 
included to scan the reads with a 4-base wide sliding window, removing the reads when 
the average quality per base dropped below a threshold of 15.  To clean the Illumina® 
Nextera kit specific primer adapters listed in the Nextera-PE-PE.fasta file with maximum 
allowable mismatches of 2, palindrome clip (between two 'adapter ligated' reads) threshold 
of 30 and the simple clip (between any adapter) threshold of 10 settings were adapted 
using the - ILLUMINACLIP: NexteraPE-PE.fa:2:30:10 - option.  FastQC software 
v.0.11.7 [242] was used to assess raw-read quality, and reports were aggregated using 
MultiQC v.1.5 on command-line [243].  Statistics such as per base sequence quality, per 
tile sequence quality, per sequence quality, per base sequence content, per base N content, 
sequence length distribution, sequence duplication-level, over-represented sequences, 
adapter content, and the K-mer content were examined.  In addition, the average read 
lengths were obtained per FASTQ pairs, to calculate the coverage in depth.  Sequences 
passing these quality matrices were carried to the next step: assembly process.   
Pair-end trimmed FASTQ files were assembled using SPAdes v.3.11.1 on the 
command-line with default parameters except - careful – option that reduced the number of 
mismatches and short indels compared to the default settings [244].  The default 





read error corrections of pairs and, the k-mer assembly sizes set to 21, 33, 55, 77, 99, and 
127, since the expected read length was equal to or greater than 250 bp.  The assembly 
qualities of the FASTA (assembled sequence file) files were assessed using the Quality 
Assessment Tool for Genome Assemblies (QUAST) [245]. The number of the total contigs 
larger than 5,000 bp, the total read lengths, the N50 values, and the GC (%) contents were 
obtained.  The depth of coverage was calculated for each isolate based on the average 
sequence length, the number of reads and the genome size using the formula for the depth 
coverage = ([average sequence length × number of reads] / genome size).  The assemblies 
more than 200 contigs and less than 28X depth of coverage were considered bad quality 
and re-sequenced. 
3.12.2.   Serotype and sequence typing  
SeqSero v.1.0 software was used for Salmonella serotyping from raw sequencing 
reads (FASTQ files) [85].  The serotyping results obtained from the SeqSero database, 
which is curated from somatic O-antigen and flagellar H1 (fliC), and H2 antigen (fljB) 
encoding genes, is known to corresponds with current antigenic profiles recognized in the 
Kauffmann-White-LeMinor scheme [82].  STs were determined using SRST2 (Short Read 
Sequence Typing for Bacterial Pathogens) v.0.2.0 and the Salmonella MLST database, 
curated from Public Databases for Molecular Typing and Microbial Genome Diversity 
Platform (www.pubmlst.org) and accessed in July 2018.  The STs were determined based 
on sequence matches with the MLST database consisting of the seven housekeeping genes, 





3.12.3.   Antibiotic resistance gene and plasmid detection 
Mass screening of contigs harboring ARGs and plasmids was conducted using the 
pipeline ABRicate v.0.8.5 (https://github.com/tseemann/abricate) and determined using a 
resistance gene database ResFinder and a plasmid database PlasmidFinder (both updated as 
of 28 July 2018) [98, 110].  A coverage threshold of 60% and, identity match threshold of 
90% were utilized for alignment parameters for each gene detected.  In addition, the 
database accession number (GeneBank accession no.), and the name of the gene matched 
was reported for each positive inquiry.  The ARG that was identified was further explored 
for a contig-related inquiry to validate the location (chromosomal vs plasmidal) of the 
ARG using the RAStk annotation tool [247], and the basic local alignment search tool 
(BLAST) [248].  Later, if the ARG was found to be in a plasmid, this contig was 
graphically visualized with SnapGene software v.4.1.3.  (GSL Biotech; available at 
www.snapgene.com).  
3.12.4.   Phylogenetic analyses 
SNP analyses were conducted across all serotypes, and for each serotype 
individually.  While a cladogram was adapted mainly showing the clustering and genetic 
relatedness among all serotypes by ignoring the branch lengths, additional phylograms 
were generated to calculate the SNP variations represented within the branch lengths 
observed for each serotype. 
Reference genomes were selected using the Similar Genome Finder service on the web-
based PATRIC (the Pathosystems Resource Integration Center) platform (available at 





by keeping the threshold values at default (i.e., maximum hit value of 50, P-value of 1, and 
Mash/MinHash distance [estimating the distance based on rate of sequence mutation] value 
of 0.05) [249, 250].  Using the Similar Genome Finder, the closest genomic distance 
complete genome reference was selected for each serotype.  A reference strain from one of 
the most prevalent serotypes was selected for the phylogenetic analysis conducted across 
all serotypes.  A complete genome of each reference was obtained from the NCBI 
(National Center for Biotechnology Information) database in FASTA format.  
These selected reference genomes were further uploaded to a web-tool called 
PHASTER (Phage Search Tool Enhanced Release, available at http://phaster.ca/) to detect 
the existing prophage regions [251].  The sequences belonging to the phage regions were 
further masked with the letter of “N” utilizing BEDTools v.2.18 [252]. These masked 
references were carried to the next step; that is, the alignment process for the phylogenetic 
analyses.  
All Salmonella genomes in this study were aligned to the reference strain using the 
core genome SNP analysis via ParSNP v.1.2 [253] using the assembled (FASTA) 
sequencing files.  The extended multi-fasta files (XMFA) obtained from the core-genome 
SNP alignment were converted to the multi-fasta file format using HarvestTools v.1.2 
[253].  To select the best nucleotide substitution model to include in the maximum-
likelihood tree, a model testing tool called Model-test NG v.0.1.5 was adopted [254].  
Further, the phylogenetic tree was inferred using the selected best model with IQ-tree 






Later, the phylogenetic tree was visualized as a cladogram and the graphics were 
generated using a web-based Interactive Tree of Life (iTOL, available at 
https://itol.embl.de) tool [256].  The genotypic relatedness (clade-level) was explored by 
pen, block, and cattle origin/source among the serotypes and graphically represented by 
colors.  
The phylogenetic comparisons for individual serotypes were determined by the 
McOutbryk SNP calling pipeline (available under the MIT license at 
https://github.com/hcdenbakker/McOutbryk ) using raw (FASTQ) sequencing reads.  This 
genome graph-based pipeline uses the McCortex tool [257] to build graphs of a reference 
sequence and the data of the genomes to be queried for SNPs.  The SNP calling stage 
consists of two phases: (Phase 1) an initial phase, which consists of a comparison of the 
reference graph and each query genome to construct a list of putative variable sites within 
the population, and (Phase 2) a final SNP calling phase, which calls the allele for each 
putative SNP site found in the Phase 1.  While the SNP calling is done de novo at the 
initial step, the pipeline uses BWA (Burrow-Wheeler aligner)-mem [258] at the final step 
to place the SNP sites in relation to the reference sequence.  In addition to BWA, the 
pipeline relies on VCFtools [259], and vcflib (available under the MIT license at 
https://github.com/vcflib/vcflib) for VCF (Variant Call format) file manipulation.  The 
SNPs from prophage regions were excluded by using a referent strain with masked 
prophage regions.  This pipeline was written in Python3, distributed by the Python 






The variant SNP sites were later carried to a final filtration using IQ-tree and the 
variant site output was further evaluated for the best nucleotide substitution model using 
IQ-tree v.1.6.10 -m MPF+ASC- option to construct a maximum-likelihood phylogeny.  
This option finds the best fit substitution model among the total 22 nucleotide substitution 
models listed in Table 8 based on the BIC criteria, including the ascertainment bias 
correction (ASC), where the SNPs data no longer include any constant regions, but 
includes the variant regions (detailed information can be found in the IQ-tree manual 
provided at http://www.iqtree.org/doc/iqtree-doc.pdf ).  The output file containing only 
variant sites was carried to the next-step: analyses for model testing using best-fit 
maximum-likelihood approaches. 
The phylogenetic tree was inferred using the selected model with IQ-tree, including 
bootstraps values with 1,000 iterations using the option of - m(selected model) +ASC –alrt 
1000 - [255].  Later, the phylogenetic tree was visualized with the branch lengths reflecting 
individual SNP differences observed within each serotype using iTOL.  The tree topology 
observed in each serotype was visualized and the pen (Pen 7 to 59), source (Source 1 or 2), 
day (Days 0, 7, 99, 120, 134, or 141), and sample type (fecal, lymph node, or hide) 
characteristics were shown in the cells with either colors, or else binary formatted, in 
which were all presented as square.  
The sample types were presented as a circle (fecal), star (lymph node), or as a left-
pointing triangle (hide).  Again, the branches that had the bootstrap support value of 800-
1,000 were presented with a grey circle located the middle of the corresponding branch and 






Table 8.  Nucleotide substitution models 
Year Name Model  Base-rates 
1969 Jukes-Cantor[260] JC or JC69 (e) AC = AG = AT = CG = CT = GT 1981 Felsenstein[261] F81 (u) 
1993 Tamura, Nei[262] TN or TN93 (u) AC=AT=CG=GT, AG, CT TN (e) 




TPM1, K80 or K2P (e) 
TPM1, K81 or K3P (e) AC=GT, AG=CT, AT=CG TPM1, K81u 
  
TPM2 (e)* AC=AT, CG=GT, AG=CT TPM2 (u)* 
TPM3 (e)* AC=CG, AT=GT, AG=CT TPM3 (u)* 
1990 Transition[266] 
TIM1 (u) AC=GT, AT=CG, AG, CT TIM1 (e) 
TIM2 (u) AC=AT, CG=GT, AG, CT TIM2 (e) 
TIM3 (u) AC=CG, AT=GT, AG, CT TIM3 (e) 
2003 Transversion[266] TVM (u) AC, AT, CG, GT, AG=CT TVM (e) 
1986 General time reversible[267] GTR (e) AC, AG, AT, CG, CT, GT 
1994 Symmetric[268] SYM (u) 
(e) equal base frequencies, (u) unequal base frequencies.  *Year and model information not available.  The list of models 





4.   RESULTS* 
4.1.   Descriptive statistics  
A total of 1,155 samples was received.  Of these, 799 were fecal samples, 224 were 
lymph nodes (one or two per animal), and 132 were hide samples.  Two animals left the 
study due to illness after Day 28 and thus were lost to follow-up.  Therefore, feces, lymph 
nodes, and hide samples were not obtained from those two cattle subsequent to their loss.  
One steer that left the study was from a tulathromycin-treated pen (Pen 51) and the other 
steer was from a ceftiofur-treated pen (Pen 55); these losses were due to foot injury and 
BRD, respectively.  As a result, a total of 132 cattle completed the study. 
On Day 0, there was one fecal sample missed due to a steer escaping the chute.  In 
addition, a total of 36 lymph nodes from cattle in Pens 57, 58, and 59 were missing due to 
a lack of training in sample collection by personnel at the commercial slaughter plant on 
the first day of slaughter (Day 99).  Later, a single-staff member was retrained and we 
successfully collected the subiliac lymph nodes during the subsequent three slaughter 
periods without any missed samples.  Among the 224 lymph nodes obtained, the mean 
weight was 22 g per node with a minimum of 4.6 g and a maximum of 70.4 g (Figure 14).  
                                                 
* Part of this chapter is reprinted with permission from “Population Dynamics of Salmonella enterica within Beef Cattle 
Cohorts Followed from Single-Dose Metaphylactic Antibiotic Treatment until Slaughter” Levent G, Schlochtermeier A, 
Ives SE, Norman KN, Lawhon SD, Loneragan GH, Anderson RC, Vinasco J, Scott HM. 2019 Appl Environ Microbiol 






Figure 14.  Histogram representing the weight distribution of the lymph nodes 
 
4.1.1.   Quantitative results 
Salmonella colony counts obtained from the spiral plater were back-calculated 
using the corresponding dilution factors and converted to CFUs per gram (for feces and 
lymph nodes) and per meter-squared for hide swabs.  The CFUs thus obtained were highly 
right-skewed.  In order to approach to normal distribution, the CFUs were log10 
transformed.  After the log10 transformation, histograms of CFU frequencies for each 






Out of a total of 799 fecal samples, 531 observations were recorded as zero counts 
and the remaining 268 observations were quantifiable.  Among these 268 observations, the 
minimum fecal log10 CFU was 2.64 and the maximum was 7.04.  Out of a total of 224 
lymph node samples, 81 observations were recorded as zero and the remaining 143 
observations were quantifiable.  Among these, the minimum lymph node log10 CFU 
observed was 1.84 and the maximum was 6.34. Out of a total of 132 hide observations, 25 
observations were recorded as zero and the remaining 107 observations were quantifiable.  
Among these, the minimum hide log10 CFU was 3.3 and the maximum was 7.2.  The 
minimum value of the LLQ was observed among the lymph nodes (1.84 log10), followed 
by the feces (2.64 log10), and the hides exhibited the highest LLQ (3.3 log10).   
On Days 0, 7, and 14 the distribution of the log10 CFUs was highly right-skewed 
with a 75th percentile of zero and means of 0.79, 0.43 and 0.73 log10 CFU per gram feces, 
respectively.  On Day 28, at the 50th percentile the log10 CFUs was zero versus 4.54 at the 
75th percentile and with a mean of 1.79 log10 CFU per gram of feces.  On Day 56 and at the 
terminal day (aggregated into Day 112) log10 CFUs at the 50th percentiles were 3.2 and 
5.53 with means of 2.71 and 4.08 log10 CFU per gram feces, respectively.  The lymph node 
CFUs at the 50th percentile was 3.48 with a mean of 2.95 log10 CFU per gram of lymph 








Figure 15.  Histograms representing the log10 CFU frequencies for feces, lymph nodes, and 
hides 







Table 9.  Log10 CFU mean, percentiles and standard deviation distribution across days and 
sample types 
Samples Obsa Percentiles Mean Std. Dev. 25th 50th 75th 
Day 0 feces 133 0 0 0 0.79 1.8 
Day 7 feces 134 0 0 0 0.43 1.47 
Day 14 feces 134 0 0 0 0.73 1.81 
Day 28 feces 134 0 0 4.54 1.79 2.6 
Day 56 feces 132 0 3.2 5.2 2.71 2.67 
Terminal (feces) 132 0 5.53 6.31 4.08 2.75 
Lymph node 224b 0 3.48 5.32 2.95 2.44 
Hide 132 3.78 4.96 6.61 4.47 2.4 
a Total number of observations, b Two lymph nodes per animal, Std. Dev. (Standard deviation). 
4.1.2.   Enrichment results 
Salmonella prevalences in fecal samples were estimated at: 43.6% (58/133) on Day 
0, 20.1% (27/134) on Day 7, 20.1% (27/134) on Day 14, 41.0% (55/134) on Day 28, 
57.5% (76/132) on Day 56, and 80.3% (106/132) on the terminal day.  Lymph node 
Salmonella prevalence at the carcass-level was 84.2% (96/114 – 20 cattle lymph nodes 
were missing); whereas, overall lymph node prevalence was 75.4% (169/224).  Hide 
prevalence was 84.8% (112/132) across all cattle and pens.   
Among control-, tulathromycin- and ceftiofur-treated animals, terminal fecal 
prevalences were distributed as 66.6%, 92.3%, and 87.1%, lymph node prevalences were 
distributed as 77.0%, 88.2%, and 90.6%, and hide prevalences were distributed as 77.7%, 






Table 10.  Overall and treatment-level Salmonella prevalence distribution by day (feces 
only) and sample type 
 Fecal samples by day Lymph 
node* Hide  0 7 14 28 56 Terminal 
Cef 32.5 15 17.5 35 66.6 87.1 90.6 92.3 (13/40) (6/40) (7/40) (14/40) (26/39) (34/39) (29/32) (36/39) 
Con 54.7 16.6 22.2 42.5 42.5 66.6 77.0 77.7 (29/53) (9/54) (12/54) (23/54) (23/54) (36/54) (37/48) (42/54) 
Tul 40 30 20 45 69.2 92.3 88.2 87.1 (16/40) (12/40) (8/40) (18/40) (27/39) (36/39) (30/34) (34/39) 
Tot 43.6 20.1 20.1 41 57.5 80.3 84.2 84.8 (58/133) (27/134) (27/134) (55/134) (76/132) (106/132) (96/114) (112/132) 
*Animal-level frequencies are presented for the lymph node data.  Overall lymph node prevalence was 75.4% (169/224).  
Ceftiofur (ceftiofur), Con (control), Tul (tulathromycin), Tot (total).Top values are prevalence represented as percentage.  
No. of positive/total No. values presented below each percentage.  Reprinted with permission from Levent et al. (2019) 
[236]. 
4.1.3.   Kappa agreement 
Overall, among the 1,156 observations, 504 samples resulted in zero CFU counts 
and were also enrichment negative.  In contrast, 491 observations that resulted in 
quantifiable CFUs were also enrichment positive.  The disagreement between the two 
outcomes was illustrated in 134 observations that were Salmonella positive after 
enrichment but the CFUs of these observations were zero; in contrast, 27 observations 
were negative after enrichment, but their CFUs were greater than zero (Table 11).  
The agreement observed comparing the two methods was classified as good (i.e., 
for kappa values larger than 70.0%) with 85.7%.  The lowest kappa agreement during fecal 
sampling was observed on Day 0 with 72.1% kappa value, and ranged from 84.3 to 91.7% 
on the following days.  The kappa agreement of the overall fecal observations was 85.8%.  
The lymph node samples yielded 83.9% kappa value whereas hides represented the lowest 
kappa value (79.5%) of all sample types.  In summary, CFU quantification and enrichment 





Table 11.  Agreement between the observations obtained from CFU and enrichment results 
by day and sample types 
 E (p), C(p) E (n), C(n) E(p), C(n) E(n), C (p) Total  
Day 0 22 74 36 1 133 
Day 7 9 104 18 3 134 
Day 14 18 105 9 2 134 
Day 28 43 77 12 2 134 
Day 56 68 53 8 3 132 
Terminal 90 23 16 3 132 
Total (feces) 250 436 99 14 799 
Lymph node 138 50 31 5 224 
Hide 96 9 16 11 132 
Grand total 491 504 134 27 1156 
E (enrichment), C (CFU positive [a value larger than zero]), p(positive), n(negative). 
4.2.   Two-part and interval-linear regression analyses 
The LLQs were determined as 2.64 log10 for feces, 1.84 log10 for lymph nodes and 
3.3 log10 for hide samples.  Two-part models were explored to find the best fit model for 
excess zero counts in the fecal and lymph node log10 CFU observations.  For the hide data, 
the zero and the missing observations were imputed with the fixed and random effects 
parameters using interval linear regression between zero and the LLQ (3.3 log10); 
thereafter, estimates were obtained from the imputed data using multi-level mixed linear 
regression with the same model parameters. 
4.2.1.   Two-part regression models 
For the fecal and lymph node observations, ZIP, ZINB, and CHURDLE regression 
models were explored separately.  The ZIP and ZINB models provided identical 
coefficients and similar AIC and BIC values (1,871 versus 1,873 for feces and 796 versus 





The CHURDLE model was selected as the best fit model for the feces and lymph 
node observations, since the AIC and the BIC values were significantly lower (1,241 and 
437) for both feces and lymph nodes than the ZIP and the ZINB models provided.  
Therefore, the effects of treatment and day (feces only) are presented based on the 
CHURDLE model. 




No. of  
observations ll (null) ll (model) df AIC BIC 
 ZIP 799 -888.39 -877.94 58 1871.88 2143.5 
Feces ZINB 799 -888.39 -877.94 59 1873.88 2150.2 
 CHURDLE 799 -715.80 -553.17 58 1222.35 1452.1 
Lymph nodes 
ZIP 224 -382.00 -370.22 28 796.44 891.9 
ZINB 224 -382.00 -370.22 29 798.44 897.3 
CHURDLE 224 -271.44 -201.80 28 459.60 555.1 
ll (log-likelihood).  
CHURDLE model considering interaction terms revealed no treatment effects 
across days (with the P value ranged from 0.068 to 0.919) on Salmonella log10 CFUs in 
feces.  However, each of Day 56 and the Day 122 (terminal day)_ had a statistically and 
significantly higher effect (P = 0.000) on CFUs when compared to earlier days (Figure 16).  
Even though the antibiotic treatments did not significantly affect the Salmonella CFUs 
observed in cattle feces, day had a significant effect (P value ranging from 0.001 to 0.045).  
In the control group, this effect was observed increasing by day as shown as between Day 
0 and Day 122 (P = 0.001), between Day 7 and Day 122 (P < 0.001), and between Day 14 
and Day 122 (P = 0.001).  We did not observe any period effects among other day-to-day 





observe any significant difference among days in the tulathromycin treatment group; the 
minimum detected P value was 0.295 and the maximum was 1.000 among the pairwise 
comparisons of days within that group.  In the ceftiofur group, similar to the control group, 
we found a significant increase by the end of the study.  In this group, the CFUs on Day 56 
were significantly higher than on Day 7 (P = 0.011), Day 112 was also significantly higher 
than each of Days 0, 7, 14, and 59 (P = 0.002, P < 0.001, P = 0.002, P = 0.045, 
respectively).  All pairwise CFU period contrasts and the corresponding P-values are 
provided for each treatment in  Table 13. 
 







Table 13.  Bonferroni-adjusted pairwise fecal log10 CFU contrasts between day pairs for 
each treatment group using the CHURDLE model 
Trt   Day  Contrast Std.Err. Bonferroni adjusted comparisons Z P-value 95% CIs 
Con 
7 0 -0.02289 0.133167 -0.17 1 -0.50137 0.455585 
14 0 -0.03997 0.097162 -0.41 1 -0.38908 0.309138 
28 0 0.374496 0.177297 2.11 1 -0.26255 1.011537 
56 0 0.396341 0.162805 2.43 1 -0.18863 0.98131 
112 0 1.190647 0.266388 4.47 0.001 0.233494 2.147799 
14 7 -0.01708 0.146016 -0.12 1 -0.54172 0.50757 
28 7 0.397389 0.189166 2.1 1 -0.2823 1.077076 
56 7 0.419235 0.163547 2.56 1 -0.1684 1.006873 
112 7 1.21354 0.257619 4.71 0 0.287894 2.139186 
28 14 0.414466 0.174826 2.37 1 -0.2137 1.042629 
56 14 0.436312 0.172207 2.53 1 -0.18244 1.055065 
112 14 1.230617 0.276115 4.46 0.001 0.238514 2.222719 
56 28 0.021845 0.202247 0.11 1 -0.70484 0.748534 
112 28 0.816151 0.276643 2.95 0.486 -0.17785 1.810148 
112 56 0.794305 0.253442 3.13 0.264 -0.11633 1.704941 
Tul 
7 0 -0.02021 0.082613 -0.24 1 -0.31704 0.276626 
14 0 -0.01125 0.079263 -0.14 1 -0.29605 0.273547 
28 0 0.29758 0.158675 1.88 1 -0.27255 0.86771 
56 0 0.733504 0.236523 3.1 0.295 -0.11634 1.583348 
112 0 1.192832 0.39892 2.99 0.427 -0.24052 2.626182 
14 7 0.008958 0.080889 0.11 1 -0.28168 0.299596 
28 7 0.317787 0.165574 1.92 1 -0.27713 0.912708 
56 7 0.753712 0.249378 3.02 0.384 -0.14232 1.649744 
112 7 1.21304 0.42236 2.87 0.624 -0.30453 2.730612 
28 14 0.30883 0.16201 1.91 1 -0.27328 0.890943 
56 14 0.744754 0.244501 3.05 0.355 -0.13376 1.623266 
112 14 1.204083 0.415443 2.9 0.574 -0.28863 2.6968 
56 28 0.435925 0.236221 1.85 1 -0.41284 1.284686 
112 28 0.895253 0.378249 2.37 1 -0.46382 2.25433 
112 56 0.459328 0.347107 1.32 1 -0.78785 1.706511 
Cef 
7 0 -0.22615 0.136014 -1.66 1 -0.71486 0.262554 
14 0 -0.01497 0.138258 -0.11 1 -0.51174 0.481805 
28 0 0.313079 0.207606 1.51 1 -0.43287 1.059024 
56 0 0.353088 0.15745 2.24 1 -0.21264 0.918819 
112 0 1.416695 0.326541 4.34 0.002 0.24341 2.589979 
56 7 0.427233 0.19438 2.2 1 -0.27119 1.125654 
14 7 0.211187 0.113819 1.86 1 -0.19777 0.620148 
28 7 0.539232 0.215582 2.5 1 -0.23537 1.313835 
56 7 0.57924 0.145752 3.97 0.011 0.055542 1.102939 
112 7 1.642847 0.351315 4.68 0 0.380548 2.905147 
28 14 0.328044 0.198541 1.65 1 -0.38533 1.041417 
56 14 0.368053 0.145998 2.52 1 -0.15653 0.892636 
112 14 1.43166 0.328287 4.36 0.002 0.252102 2.611218 
56 28 0.207783 0.264197 0.79 1 -0.7415 1.157061 
112 28 1.27139 0.43238 2.94 0.501 -0.28218 2.824964 
56 28 0.040009 0.191293 0.21 1 -0.64732 0.727337 
112 28 1.103616 0.322548 3.42 0.095 -0.05532 2.262556 
112 56 1.063607 0.293552 3.62 0.045 0.008853 2.118361 
Trt (Treatment), Con (Control), Tul (Tulathromycin), Cef (Ceftiofur).  P-values that are less then <0.05 and their 






Similarly, no statistically significant effect was observed among log10 CFUs in the 
lymph nodes among the ceftiofur and control groups (P = 0.754), ceftiofur and 
tulathromycin groups (P = 1.000), and tulathromycin and control groups (P = 0.797). 
Bonferroni adjusted contrasts of each two-way treatment comparison are provided 
in Table 14.  In addition, the predicted mean CFUs were graphically presented in Figure 
17. 
 







Table 14.  Bonferroni-adjusted pairwise lymph node CFU contrasts between treatments 
using the CHURDLE model 
Treatments Delta method Bonferroni adjusted Contrast Std. Err. Z-value P-value 95% CIs 
Tul Cont 0.908712 0.816614 1.11 0.797 -1.04625 2.863669 
Cef Cont 0.815487 0.710859 1.15 0.754 -0.88629 2.517268 
Cef Tul -0.09322 1.039197 -0.09 1.000 -2.58104 2.394592 
Trt (Treatment), Con (Control), Tul (Tulathromycin), Cef (Ceftiofur). 
4.2.2.   Multiple imputation-based interval-linear regression estimated by linear 
regression 
An imputation method using interval-based linear regression provided log10 CFUs 
for negative hide samples due to the low-percentage (18.9%) of zero counts in hide 
samples.  In a shared pen environment, hide prevalence by pens varied from 54.5% to 
100% with an overall mean of 84.8%.  Therefore, the Salmonella enrichment negative (n = 
25) and the missing (n = 2) observations were accepted as LLQ and imputed across the 0 to 
3.3 log10 CFU range to better meet normality and heteroscedasticity assumptions of linear 
regression.  A total of 15 observation from the control group, and six observations from 
each of ceftiofur and tulathromycin treated groups were imputed using the fixed effect of 
treatment and the cluster effect of pen.  Before and after the imputation, slight mean 






Table 15.  Log10 CFU mean and standard deviation differences among treatment groups 
before and after imputation method  
Trt Number of  imputed obs. 





Mean Std. dev. Min. Max. 
Con 15 0 39 5.3 1.3 3.3 7.1 20 54 4.5 1.7 1.4 7.1 
Tul 6 0 34 5.7 1.0 3.7 7.0 20 40 5.3 1.5 2.3 7.0 
Cef 6 0 34 5.6 1.1 3.6 7.2 20 40 5.1 1.4 2.5 7.2 
*Observations before and after 20 imputations.  Trt (Treatment), Con (Control), Tul (Tulathromycin), Cef (Ceftiofur). 
The estimates were obtained using the multi-level mixed effects linear regression 
model, which did not show any statistically significant effect observed in log10 CFUs 
among hide samples of cattle treated with or without ceftiofur or tulathromycin (Figure 
18).  The marginal predicted means, standard errors and the 95% CIs are presented in 
Table 16. 
Table 16.  Marginal predicted hide log10 CFU means, standard errors and 95% CIs of 
imputed interval-regression model  
 Margins Std. Err. 95% CIs 
Control 4.904 0.403 4.114 5.694 
Tulathromycin 4.826 0.466 3.911 5.741 








Figure 18.  Predictive log10 CFU margins by treatment for hides modeled with interval-






4.3.   Logistic regression analyses 
4.3.1.   Feces 
The likelihood-ratio based test showed that treatment group did not result in 
statistically significant differences (P = 0.825) among the treatment and control groups for 
fecal prevalence of Salmonella (Figure 19).  However, there was a significant (P < 0.0001) 
day effect observed across all treatment groups in fecal prevalence of Salmonella (Table 
17). 
 
Figure 19.  Adjusted fecal marginal prevalence mean predictions and 95% CIs by treatment 
and day 





According to pairwise adjusted comparisons of marginal results, Salmonella 
prevalence in antibiotic-treated groups showed similarity across all treatment groups for 
any given day (Table 18).   
Table 17.  Stepwise multi-level logistic regression analyses of the fixed effects with 
corresponding df, -2(log-likelihood) and P-values 
Sample  
Type Model df -2(Log-likelihood) P-value** 
Feces Full model*  17 879.40032 0.000 
  Day and Treatment 7 907.13836 0.000 
  Treatment 2 1074.79028 0.825 
  Day  5 907.52280 0.000 
  Intercept only 0 1075.10612 . 
Lymph nodes Full model (Treatment)  2 223.14966 0.297 
  Intercept only 0 225.74820 . 
Hide Full model (Treatment) 2 102.63036 0.218 
  Intercept only 0 105.92971 . 
Each mixed model included within-pen and within-animal (feces and lymph nodes only) random effects to account for 
clustering.  * Day, treatment, and interaction term.  **Comparisons via likelihood-ratio chi-square tests are versus 
intercept-only model.  Additional comparisons among nested forms of each sample-type model can be determined as the 
difference between both -2(log-likelihood) and df of the two models compared against the chi-square distribution.  
Reprinted with permission from Levent et al. (2019) [236]. 
However, Period (Day)- had a significant effect on the prevalence of Salmonella 
within each treatment group as follows: a significant (P = 0.001 and P = 0.018, 
respectively) prevalence decrease was observed from Day 0 to Days 7 and 14 in the control 
group.  Later, for this same group a recovery to baseline value was observed by Days 28 
and 56.  By Day 112, the prevalence was significantly increased when compared to Day 7 
and Day 14 (P < 0.0001 for both).  The Salmonella prevalence in tulathromycin- and 






A significant increase was observed at Day 56 when compared to Day 7 (P = 0.006 
and P < 0.0001, for tulathromycin and ceftiofur, respectively) and Day 14 (P < 0.0001 for 
both antibiotics). 
Table 18.  Bonferroni-adjusted pairwise comparisons of prevalence contrasts for feces, 





comparisons Contrast Std.Err. 
Bonferroni adjusted 




Tul Con -0.19439 0.11567 -1.68 1.000 -0.61002 0.22124 
Cef Con -0.22092 0.11274 -1.96 1.000 -0.62601 0.18418 
Cef Tul -0.02653 0.12635 -0.21 1.000 -0.48053 0.42747 
7 
Tul Con 0.08723 0.09715 0.90 1.000 -0.26185 0.43631 
Cef Con -0.01891 0.08514 -0.22 1.000 -0.32484 0.28702 
Cef Tul -0.10614 0.10433 -1.02 1.000 -0.48103 0.26874 
14 
Tul Con -0.06459 0.09042 -0.71 1.000 -0.3895 0.26032 
Cef Con -0.05065 0.09273 -0.55 1.000 -0.38385 0.28255 
Cef Tul 0.01394 0.09630 0.14 1.000 -0.3321 0.35998 
28 
Tul Con -0.02696 0.11817 -0.23 1.000 -0.45158 0.39766 
Cef Con -0.07899 0.11372 -0.69 1.000 -0.48760 0.32961 
Cef Tul -0.05204 0.12971 -0.40 1.000 -0.51813 0.41405 
56 
Tul Con 0.22424 0.11694 1.92 1.000 -0.19595 0.64443 
Cef Con 0.23825 0.11130 2.14 1.000 -0.16168 0.63819 
Cef Tul 0.01401 0.12475 0.11 1.000 -0.43425 0.46227 
Ter 
Tul Con 0.23805 0.08615 2.76 0.876 -0.07151 0.54761 
Cef Con 0.19878 0.08903 2.23 1.000 -0.12111 0.51868 
Cef Tul -0.03927 0.07521 -0.52 1.000 -0.30951 0.23097 
LNs Ter 
Tul Con 0.15891 0.10072 1.58 0.344 -0.08223 0.40005 
Cef Con 0.10003 0.10445 0.96 1.000 -0.15002 0.35009 
Cef Tul -0.05887 0.10873 -0.54 1.000 -0.31918 0.20143 
Hides Ter 
Tul Con 0.09080 0.10217 0.89 1.000 -0.15380 0.33541 
Cef Con 0.15815 0.08749 1.81 0.212 -0.05130 0.36761 
Cef Tul 0.06734 0.09153 0.74 1.000 -0.15177 0.28646 
LNs (lymph nodes), Con (Control), Cef (Ceftiofur), Tul (Tulathromycin), Std.Err.  (Standard errors).  Reprinted with 






This increase continued through Days 56 and 122 (P < 0.0001 for both), and by the 
end of study Salmonella prevalence in both the ceftiofur and tulathromycin treated groups 
was significantly higher (P < 0.05) than the earlier days (Table 19).  
Table 19.  Bonferroni-adjusted pairwise fecal prevalence contrasts between days for each 
treatment group 
Trt   Day  comparisons Contrast Std.Err. 
Bonferroni adjusted 
Z P-value 95% CIs 
Con 
7 0 -0.38012 0.08208 -4.63 0.001 -0.67505 -0.08520 
14 0 -0.32257 0.08378 -3.85 0.018 -0.62362 -0.02153 
28 0 -0.11688 0.08746 -1.34 1.000 -0.43115 0.19739 
56 0 -0.11688 0.08746 -1.34 1.000 -0.43115 0.19739 
112 0 0.11918 0.08490 1.40 1.000 -0.18587 0.42423 
14 7 0.05755 0.07424 0.78 1.000 -0.20921 0.32431 
28 7 0.26324 0.08164 3.22 0.193 -0.03012 0.55661 
56 7 0.26324 0.08164 3.22 0.193 -0.03012 0.55661 
112 7 0.49930 0.07845 6.36 0.000 0.21741 0.78119 
28 14 0.20569 0.08334 2.47 1.000 -0.09378 0.50517 
56 14 0.20569 0.08334 2.47 1.000 -0.09378 0.50517 
112 14 0.44175 0.08064 5.48 0.000 0.152007 0.73150 
56 28 -0.00000 0.08722 -0.00 1.000 -0.31340 0.31339 
112 28 0.23605 0.08499 2.78 0.838 -0.06932 0.54143 
112 56 0.23605 0.08499 2.78 0.838 -0.06932 0.54143 
Tul 
7 0 -0.09850 0.09500 -1.04 1.000 -0.43987 0.24286 
14 0 -0.19278 0.09076 -2.12 1.000 -0.51891 0.13335 
28 0 0.05055 0.10051 0.50 1.000 -0.31060 0.41170 
56 0 0.30175 0.10119 2.98 0.438 -0.06184 0.66534 
112 0 0.55162 0.09121 6.05 0.000 0.22389 0.87934 
14 7 -0.09427 0.08417 -1.12 1.000 -0.39671 0.20816 
28 7 0.14905 0.09686 1.54 1.000 -0.19899 0.49709 
56 7 0.40025 0.09750 4.10 0.006 0.04991 0.75059 
112 7 0.65012 0.08368 7.77 0.000 0.34945 0.95079 
28 14 0.24332 0.09307 2.61 1.000 -0.09111 0.57775 
56 14 0.49452 0.09328 5.30 0.000 0.15935 0.82970 
112 14 0.74439 0.07303 10.19 0.000 0.48197 1.00681 
56 28 0.25120 0.10248 2.45 1.000 -0.11702 0.61942 
112 28 0.50107 0.09360 5.35 0.000 0.16473 0.83740 





Table 19.  Continued 
Trt Day comparisons Contrast Std.Err. 
Bonferroni adjusted 
Z P-value 95% CIs 
Cef 
7 0 -0.15921 0.10195 -1.56 1.000 -0.52554 0.20711 
7 0 -0.17812 0.09079 -1.96 1.000 -0.50437 0.14812 
14 0 -0.15231 0.09185 -1.66 1.000 -0.48235 0.17773 
28 0 0.02504 0.09815 0.26 1.000 -0.32764 0.37773 
56 0 0.34229 0.09736 3.52 0.067 -0.00755 0.69213 
112 0 0.53888 0.08990 5.99 0.000 0.21586 0.86190 
14 7 0.02581 0.08072 0.32 1.000 -0.26425 0.31587 
28 7 0.20316 0.09187 2.21 1.000 -0.12696 0.53327 
56 7 0.520412 0.09049 5.75 0.000 0.195273 0.84555 
112 7 0.717002 0.07608 9.42 0.000 0.443634 0.99037 
28 14 0.177348 0.09285 1.91 1.000 -0.15628 0.51098 
56 14 0.494599 0.09166 5.40 0.000 0.165241 0.82395 
112 14 0.691189 0.07873 8.78 0.000 0.408273 0.97410 
56 28 0.317251 0.09796 3.24 0.184 -0.03475 0.66924 
112 28 0.513841 0.09098 5.65 0.000 0.186937 0.84074 
112 56 0.196590 0.08718 2.25 1.000 -0.11668 0.50985 
Trt (Treatment), Con (Control), Tul (Tulathromycin), Cef (Ceftiofur).  P-values that are less then <0.05 and their 






4.3.2.   Lymph nodes 
A total of 224 observations were included in the model.  The marginal predicted 
means of Salmonella prevalence in lymph nodes for the control group were estimated as 
0.66 (0.51-0.81 95% CI), the tulathromycin group was 0.82 (0.68-0.96 95% CI), and the 
ceftiofur group was 0.76 (0.60-0.92 95% CI) (Figure 20). 
 








4.3.3.   Hides 
For the hide observations (n = 132), only the fixed effect of treatment was included 
in the regression analysis, since hide swab samples were also only collected at slaughter 
age.  Pens were included as the single-random effect and animal identifiers were excluded 
from the random effects because a single-observation obtained from each animal.  The 
predicted means were 0.77 (0.61-0.93 95% CI) for control-, 0.86 (0.71-1.00 95% CI) for 
tulathromycin-, and 0.93 (0.83-1 95% CI) for ceftiofur-treatment groups (Figure 21). 
 







Overall, likelihood-ratio based tests did not reveal any statistically significant 
differences in Salmonella prevalence among the treatment groups for lymph node and hide 
samples (P = 0.297 and P = 0.218, respectively) (Table 17).  Salmonella prevalence in the 
control group was not significantly different than the tulathromycin and ceftiofur group 
among the lymph nodes (P = 0.344 and P = 1.000, respectively) (Table 18).  Similarly, 
Salmonella prevalence in the control cattle was not significantly different from 
tulathromycin and ceftiofur groups among the hide samples (P = 1.000 and P = 0.212, 
respectively).  A detailed summary of pairwise contrasts of predicted margin comparisons 
are provided in Table 18. 
Pen-level ICCs for Salmonella prevalence were reported as 0.21 (0.12-0.35 95% 
CI) for feces, 0.13 (0.02-0.44 95% CI) for lymph nodes and 0.30 (0.06 -0.73 95% CI) for 
hide samples.  The animal-level ICCs for Salmonella prevalence were 0.21 (0.12- 0.35 
95% CI) for temporally dependent fecal samples within animals, and 0.64 (0.37- 0.84 95% 
CI) for contemporaneously sampled bilateral sub-iliac lymph nodes within animals. 
4.4.   Quality metrics of the sequencing data 
The WGS was performed on all fecal isolates (n=191) recovered from Days 0, 7 
and the terminal day, one lymph node isolate from each animal (n=96), and all hide 
isolates (n=112) in order to explore the population dynamics of Salmonella before 
treatment, immediately after treatment and at slaughter age.  Run parameters were 
evaluated after genome assembly of the 399 isolates.  The average number of contigs was 
43 (range 17-95), the N50 value was 423,770 bp (range 101,429 - 966,986 bp), and the 





Salmonella isolates was 4,775,057 bp (range 4,541,106 - 5,072,387 bp) (Figure 22).  The 
average GC content was 52.1% (range 51.8- 52.3).  Sequencing data from this project can 
be found under NCBI BioProject accession number PRJNA521731. 
 
Figure 22.  Histograms of descriptive assembly data 
 
4.5.   Serotypes and STs 
A total of seven different serotypes was identified during the study.  Serotypes 
found in this study were S. Anatum (n = 113), S. Cerro (n = 64), S. Kentucky (n = 11), S. 





Among these seven serotypes, S. Cerro and S. Montevideo had only one flagellar 
antigen (H1); therefore, these serotypes are also called mono-phasic, while the remaining 
serotypes had both H1 and H2 flagellar antigens.  S. Lubbock, S. Montevideo, and S. 
Norwich were in the O:7 while S. Kentucky and S. Newport were in the O:8 antigen group.  
S. Anatum and S. Cerro were in the O:3 and O:18 antigen groups, respectively.  The 
antigenic formulas of these serotypes are presented in Table 20.  
Table 20.  O, H1, and H2 antigenic profiles of serotypes found in this study 
 Oa O H1 H2 Antigenic formula 
Anatum E1 3 e, h 1, 6 3,10:e,h:1,6 
Cerro K 18 z4 - 18:z4,z23:- 
Lubbock C1 7 g, m, s e, n, z15 7:g,m,s:e,n,z15 
Montevideo C1 7 g, m - 7:g,m,s:- 
Kentucky C2 8 i z6 8:i:z6 
Newport C2 8 e, h 1, 2 8:e,h:1,2 
Norwich C1 7 e, h 1, 6 7:e,h:1,6 
a Historical O group designation by letters [82]. 
Serotype-level genome length was compared via one-way analysis of variance 
(ANOVA) after dropping the single-isolate observation of S. Norwich.  A significant (P < 
0.005) length difference was observed among isolates at the serotype-level.  However, no 
significant difference was observed regarding the genome length of the isolates within the 
same serotype.  Pairwise comparisons of the marginal linear predictions by serotypes and 
WGS assembly lengths showed that S. Cerro, S. Lubbock, and S. Montevideo WGS 
assembly lengths were statistically significantly different from each other and the 
remainder of the serotypes.  S. Anatum was statistically different from all serotypes except 





Table 21.  Pairwise comparisons of mean assembly lengths of each serotype 
No. of observation Serotype Mean Std.Err 95% CI Tukey group 
113 Anatum 4764826 3895.418 4757168 4772484 B 
64 Cerro 4551648 2738.685 4546264 4557032  
136 Lubbock 4974442 4051.287 4966477 4982407  
68 Montevideo 4614955 4788.598 4605541 4624369  
11 Kentucky 4746997 407.2556 4746197 4747798 AB 
6 Newport 4689851 5607.97 4678826 4700875 A 
1 Norwich 4819889 0 - - - 
Means sharing a letter in the Tukey group label are not significantly different at the 5% level. 
Based on pairwise comparisons of the total length of sequence assemblies per 
serotype, S. Cerro, S. Lubbock, and S. Montevideo were significantly (P < 0.05) different 
from the rest of the serotypes.  S. Anatum was significantly different (P < 0.05) from S. 
Newport; however, both serotypes were not significantly different from S. Kentucky.  
All Salmonella serotypes that were screened for seven legacy MLST genes (aroC, 
dnaN, hemD, hisD, purE, sucA, thrA) belonged to a single-ST classification per serotype.  
The STs were identified as follows: 1) ST 64 (S. Anatum), 2) ST 367 (S. Cerro), 3) ST 413 
(S. Lubbock), 4) ST 138 (S. Montevideo), 5) ST 118 (S. Newport), 6) ST 2119 (S. 
Norwich), and 7) ST 152 (S. Kentucky) (Table 22). 
Table 22.  Serotype and legacy MLST allele gene distributions of the serotypes 
 ST aroC dnaN hemD hisD purE sucA thrA 
Anatum 64 10 14 15 31 25 20 33 
Cerro 367 14 112 43 123 118 115 120 
Lubbock 413 15 70 93 78 113 6 68 
Montevideo 138 11 41 55 42 34 58 4 
Newport 118 16 2 45 43 36 39 42 
Norwich 2119 2 31 10 62 14 19 34 
Kentucky 152 62 53 54 60 5 53 54 





4.6.   Population structure of Salmonella 
When the distribution of Salmonella serotypes was examined across sampling days 
and sample types, distinct distributions of serotypes were identified.  Specifically, the 
unique patterns were made clear when the distribution of serotypes was examined 
considering cattle source, block designation of pens, and their corresponding slaughter 
days: Block 1 (Pen 7-9) on Day 134, Block 2 (Pen 51-53) on Day 141, Block 3 (Pen 54-
56) on Day 120, Block 4 (Pen 57-59) on Day 99.  Block 1 was assigned to the cattle from 
Source 1, the remaining blocks were from Source 2.  
4.6.1.   By sample type and day 
All seven serotypes (S. Anatum, S. Cerro, S. Kentucky, S. Lubbock, S. Montevideo, 
S. Newport, and S. Norwich) were isolated from fecal samples.  Five different serotypes (S. 
Anatum, S. Cerro, S. Lubbock, S. Montevideo, and S. Newport) were isolated from lymph 
nodes, and six different serotypes (S. Anatum, S. Cerro, S. Lubbock, S. Montevideo, S. 
Newport, and S. Norwich) were isolated from hide samples [236].  S. Anatum, S. Lubbock, 
and S. Montevideo were recovered across all sample types and sampling days (i.e., 0, 7, 
terminal).  The Salmonella serotype distribution observed among the sampling day and 







Figure 23.  Serotype distribution of Salmonella across days and sample types 
Reprinted with permission from Levent et al. (2019) [236]. 
In contingency table analysis, unadjusted likelihood-ratio chi-square tests showed 
significant associations among the 12 pens when comparing detected serotypes isolated 
from hide samples.  The unadjusted crude likelihood ratio chi-square statistic was 168.9 
with 33 df (P <0.0001) for the effect of pen.  The unadjusted crude likelihood-ratio chi-
square was 32.2 with 6 df (P <0.0001) for pen-level treatments (Figure 24).  Note however, 







Figure 24.  Hide-level unadjusted frequencies and prevalence proportions of Salmonella 
serotypes by pen 
Frequencies of serotypes are indicated with  grey color scale.  Reprinted with permission from Levent et al. (2019) [236]. 
S. Anatum was prevalent across all days that were sequenced, but mainly found on 
Days 0, 7 and 120, and not the other slaughter days (Table 23).  Interestingly, at slaughter 
age, all isolates recovered from feces, lymph nodes, and hides were in complete serotype 
agreement and all were identified as S. Anatum in cattle from Pen 54. 
In contrast, the S. Cerro serotype was only observed on terminal slaughter days 
across multiple types of samples and the majority of the pens, except this serotype was not 
isolated from Pen 53, Pen 54, or Pen 57.  Interestingly, all hide isolates recovered from 
cattle in Pens 7 and 56 were identified as S. Cerro.  This serotype was observed across all 
slaughter days, but was found mainly on Days 120 and 134 (Table 23). 
Half (34/68) of the S. Montevideo isolates recovered in this study were found in 
Day 0 fecal samples.  However, this serotype was also prevalent (32/68) on Day 134 and 





in Blocks 2, 3, or 4 but was found in the lymph nodes of cattle in Block 1, which went to 
the slaughter on Day 134 (Table 23).  Besides Block 1, this serotype was also only 
identified on the hides from two cattle in Pen 52, which was in Block 2 and slaughtered on 
Day 141.  This serotype was observed in all types of treatment pens. 
S. Lubbock was the most prevalent serotype across the study.  On Day 0, this 
serotype was only isolated from fecal samples collected from Pens 9, 52, 55, 58 and 59 and 
on Day 7, this serotype was only identified in Pen 9.  At slaughter age, this serotype was 
recovered from all sample types, especially on Days 99 and 141 (Table 23).  Interestingly, 
all isolates from the hide samples collected from Pen 53 and 57 were of the S. Lubbock 
serotype.  
S. Kentucky serotype was observed only on Day 0 (n = 7) and 7 (n = 4) fecal 
samples, and only in pens where cattle originated from a single-source (Source 1) and thus 
were in Block1.  This serotype was not identified at slaughter age from any of the fecal, 






Table 23.  Serotype distribution by day and sample type 
Day Anatum Cerro Kentucky Lubbock Montevideo Newport Norwich 
0 12 0 7 9 30 0 0 
7 17 0 4 2 4 0 0 
99 
7 3 0 19 0 0 0 
1 2 0 30 0 0 0 
6 1 0 6 0 0 0 
120 
10 11 0 2 0 0 0 
9 20 0 0 0 0 0 
25 2 0 0 0 0 0 
134 
7 4 0 4 11 0 0 
1 12 0 5 4 0 0 
3 7 0 7 17 0 0 
141 
7 1 0 18 0 1 1 
3 1 0 22 2 0 0 
5 0 0 12 0 5 0 
Total 113 64 11 136 68 6 1 
Observations from feces are indicated by the white, hide are indicated by the darker gray, and the lymph nodes are 
indicated by the lighter gray.  Terminal isolates that were collected at the slaughter age were Days 99, 120, 134, and 141.  
Values larger than zero are bolded in the cells. 
Six S. Newport isolates were found in cattle placed in one pen (Pen 53); of those, 
five were in lymph nodes and one was in the final fecal sample collected from one of the 
steers.  This serotype was only observed at slaughter age on Day 141 (Table 23).  The 
single pen that harbored S. Newport isolates was in the ceftiofur-treated group.  A single S. 
Norwich isolate was isolated once from a terminal day fecal sample of a steer located in 
Pen 52 and that was slaughtered on Day 141 (Table 23).   






Figure 25.  Salmonella serotype distribution observed in individual animals by pen, day, sample type and treatment 
ID; unique animal identifier, 0; Day 0, 7; Day 7, TER; Terminal fecal isolates, LYM: lymph node isolates, HD: hide isolates.  Each block of pens, (three pens on each corner) was 
harvested on the same day: Block 1 (Pen 7-9) on Day 134, Block 2 (Pen 51-53) on Day 141, Block 3 (Pen 54-56) on Day 120, Block 4 (Pen 57-59) on Day 99. Block 1 is from 
Source 1; the remaining blocks are from Source 2.  The numbers in the upper left corner are pen IDs.  Pen treatments are located at the top of each pen.  Geographic locations of 





4.6.2.   By pen, block, source, and treatments 
The serotype distribution by pen is presented in Table 24, and by source and blocks 
is presented in Table 25, while the treatment distributions are presented in Table 26. 
Table 24.  Serotype distribution by pen 
 Pen 7 8 9 51 52 53 54 55 56 57 58 59 
Anatum 13 1 2 2 14 9 26 15 18 14 12 8 
Cerro 15 6 3 3 1 0 0 19 14 0 1 6 
Lubbock 3 11 6 24 17 15 0 1 2 14 26 17 
Montevideo 14 9 25 3 2 4 7 3 2 1 0 2 
Kentucky 3 6 2 0 0 0 0 0 0 0 0 0 
Newport 0 0 0 0 0 6 0 0 0 0 0 0 
Norwich 0 0 0 0 1 0 0 0 0 0 0 0 
Values larger than zero are bolded in the cells. 
Table 25.  Serotype distribution by source and block 
 Source 1 Source 2 
 Block 1 Block 2 Block 3 Block 4 
Anatum 16 25 59 34 
Cerro 24 4 33 7 
Lubbock 20 56 3 57 
Montevideo 48 9 12 3 
Kentucky 11 0 0 0 
Newport 0 6 0 0 
Norwich 0 1 0 0 






Table 26.  Serotype distribution by pen-level treatment 
 Pen-level Treatment 
 9-53-55-57 8-52-54-59 7-51-56-58 
 Ceftiofur Control Tulathromycin 
Anatum 40 49 45 
Cerro 22 13 33 
Lubbock 36 45 55 
Montevideo 33 20 19 
Kentucky 2 6 3 
Newport 6 0 0 
Norwich 0 1 0 
Assigned pen IDs are placed above the treatment names.  Values larger than zero are bolded in the cells. 
S. Anatum was the only serotype observed across all blocks, sources, and pens.  S. 
Cerro was observed in all sources, blocks and pens except Pen 53, 54, and 57; this serotype 
was less prevalent (< 8) in Block 2 and 4 compared to Block 1 and 3 (> 23).  S. 
Montevideo was observed in all sources, blocks and pens except Pen 58; however, it was 
mainly prevalent in Source 1 (n=48) as compared to Source 2 (n=24).  S. Kentucky was 
only observed in Source 1 and Block 1 in Pens 7, 8 and 9.  S. Lubbock was observed in all 
sources, blocks and pens except Pen 54.  S. Newport was observed in only Source 2, Block 
2 and Pen 53.  The single S. Norwich serotype was observed in Source 2, Block 2 and Pen 
52.  
When the serotype distributions were examined across pen-level treatments, all 
serotypes were observed across treatments, except S. Newport that was only observed in a 
single ceftiofur treated pen, and the single S. Norwich which was recovered from a control 






4.7.   Phenotypic antibiotic resistance  
Among 630 Salmonella isolates, the majority were pan-susceptible (79.0%).  The 
remaining isolates presented with either single (20.4%) or double (0.4%) phenotypical 
antibiotic resistance.  Most of the isolates resistant to a single-antibiotic (n=108) exhibited 
resistance to tetracycline, while 21 other isolates were resistant to streptomycin.  Three 
isolates were resistant to both tetracycline and streptomycin.  Isolates tested in this study 
did not show any phenotypic resistance to the remaining 12 antibiotics tested including, 
but not limited to: azithromycin, ceftiofur, ceftriaxone, and ceftiofur. 
In this panel, amoxicillin/clavulanic acid (a β-lactam combination antibiotic) was 
tested at concentrations of 1, 2, 4, 8, 16, and 32 µg/ml.  These values were listed based on 
the first antibiotic (amoxicillin) concentration in the combination that was at a 2:1 ratio.  
The cut-off value for amoxicillin/clavulanic acid resistance was ≥ 32 µg/ml.  Among the 
isolates tested, the observed MIC range was 1 to 4 µg/ml; therefore, all isolates were 
classified as susceptible to amoxicillin/clavulanic acid.  The majority of the Salmonella 
isolates (92.8%) in this study showed an MIC at ≤ 1 µg/ml.  Only 6.9% of the isolates 
showed an MIC at 2 µg/ml, and 0.1% of the isolates had an MIC at 4 µg/ml.  No isolates 
were found with MIC at the levels of 8, 16, and 32 µg/ml.   
Similarly, ampicillin (a penicillin class antibiotic) was tested at concentrations of 1, 
2, 4, 8, 16, and 32 µg/ml.  The cut-off value for ampicillin resistance was ≥ 32 µg/ml.  
Among the isolates tested, the observed MICs were between 1-16 µg/ml, and all isolates 
were susceptible to ampicillin.  The majority of the isolates (92.8%) showed an MIC at ≤ 1 
µg/ml.  Only 6.8% of the isolates had an MIC at 2 µg/ml, and 0.1% of the isolates had an 





Azithromycin (a macrolide class antibiotic) was tested at concentrations of 0.12, 
0.25, 0.5, 1, 2, 4, 8, and 16 µg/ml.  The cut-off value for azithromycin resistance was >16 
µg/ml.  The majority of the isolates (80.3%) showed an MIC of 4 µg/ml.  The MICs of 2 
and 8 µg/ml were observed in 8.7% and 8.8% of the isolates, respectively.  In addition, 
MICs at 1, 0.5, and 0.12 µg/ml were observed in 1.1%, 0.3%, and 0.4% of the isolates, 
respectively.  The remaining 0.1% of isolates had an MIC equal to 16 µg/ml.  There was 
no isolate resistant to azithromycin with an MIC >16 µg/ml (Table 27). 
Table 27.  Azithromycin MIC distribution by individual-treatment 
MICs (µg/ml) 0.12 0.25 0.5 1 2 4 8 16 
Ceftiofur 2 0 0 3 11 157 14 0 
Control 1 0 0 3 29 184 21 0 
Tulathromycin 0 0 2 1 15 165 21 1 
Total 3 0 2 7 55 506 56 1 
Total number of isolates tested = 630.  Values larger than zero are bolded in the cells. 
Cefoxitin (a cephem class antibiotic) was tested at concentrations of 0.5, 1, 2, 4, 8, 
16, and 32 µg/ml.  The cut-off value for cefoxitin resistance was ≥ 32 µg/ml.  The MICs at 
levels of 2, 4, and 8 µg/ml were observed in 25.2%, 68.5%, and 5.4% of the isolates, 
respectively.  The remaining isolates had MICs of 0.5 µg/ml (0.3%), 1 µg/ml (0.3%), and 
16 µg/ml (0.1%).  No MIC was observed at ≥ 32 µg/ml.  
Ceftiofur (a third-generation cephalosporin – another cephem class antibiotic) was 
tested at the MIC concentrations of 0.12, 0.25, 0.5, 1, 2, 4, and 8 µg/ml.  The NARMS cut-
off value for ceftiofur resistance was ≥ 8 µg/ml.  The majority of the isolates (92.5%) 





2 µg/ml, respectively.  The MICs of 0.12 and 0.25 µg/ml were observed only in 0.3% and 
0.4% of isolates, respectively.  The MICs at 4 and 8 µg/ml were not observed in any 
isolates (Table 28).  Therefore, in our study all isolates were determined to be susceptible 
to ceftiofur. 
Table 28.  Ceftiofur MIC distribution by individual-treatment 
MICs (µg/ml) 0.12 0.25 0.5 1 2 4 8 
Ceftiofur 1 1 8 174 3 0 0 
Control 1 1 15 216 5 0 0 
Tulathromycin 0 1 9 193 2 0 0 
Total 2 3 32 583 10 0 0 
Total number of isolates tested = 630.  Values larger than zero are bolded in the cells. 
Ceftriaxone (a third-generation cephalosporin – another cephem class antibiotic) 
was tested at concentrations of 0.25, 0.5, 1, 2, 4, 8, 16, 32 and 64 µg/ml.  The cut-off value 
for ceftriaxone resistance was ≥ 4 µg/ml.  All isolates (100.0%) exhibited MIC at ≤ 0.25 
µg/ml, which meant they were phenotypically susceptible to ceftriaxone.  
Chloramphenicol (a phenicol class antibiotic) was tested at concentrations of 2, 4, 
8, 16 and 32 µg/ml.  The cut-off value for ceftriaxone resistance was ≥ 32 µg/ml.  The 
MICs were observed at 2, 4, 8, and 16 µg/ml among 3.9%, 30.0%, 65.7%, and 0.3% of the 
isolates, respectively.  No MIC was observed above 16 µg/ml.  Therefore, all isolates were 
phenotypically susceptible to chloramphenicol.   
Ciprofloxacin (a fluoroquinolone class antibiotic) was tested at concentrations of 
0.015, 0.03, 0.06, 0.12, 0.25, 0.5, 0.1, 2, and 4 µg/ml.  The cut-off value for ciprofloxacin 





µg/ml.  The remaining 4.2% and 0.1% of isolates showed MICs at 0.03 and 0.06 µg/ml, 
respectively.  No MIC was detected above the concentration of 0.06 µg/ml.  Therefore, all 
isolates were phenotypically susceptible to ciprofloxacin.  We also did not identify any 
isolates with reduced susceptibility (MICs of 0.12– 1 μg/ml) to ciprofloxacin (Table 29).  
Table 29.  Ciprofloxacin MIC distribution by individual-treatment 
MICs (µg/ml) 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 
Ceftiofur 175 12 0 0 0 0 0 0 0 
Control 231 7 0 0 0 0 0 0 0 
Tulathromycin 196 8 1 0 0 0 0 0 0 
Total 602 27 1 0 0 0 0 0 0 
Total number of isolates tested = 630.  Values larger than zero are bolded in the cells. 
Nalidixic acid (a quinolone class antibiotic) was tested at concentrations of 0.5, 0.1, 
2, 4, 16, and 32 µg/ml.  The cut-off value for nalidixic acid resistance was ≥ 32 µg/ml.  
The majority of the susceptible isolates (50.1% and 49.6%, respectively) had MICs at 2 
and 4 µg/ml.  Only 0.1% of the isolates exhibited 0.5 µg/ml MIC for nalidixic acid.  No 
MIC was observed at concentrations higher than 4 µg/ml.  Therefore, all isolates were 
susceptible to nalidixic acid. 
Gentamicin (an aminoglycoside class antibiotic) was tested at concentrations of 
0.25, 0.5, 1, 2, 4, 16, and 32 µg/ml.  The cut-off value for gentamicin resistance was ≥16 
µg/ml.  The MICs of 0.25, 0.5, 1, and 2 µg/ml were observed in 22.3%, 57.7%, 19.2% and 
0.5% of the isolates.  No MIC was observed above 2 µg/ml; therefore, all isolates were 





Streptomycin (another aminoglycoside class antibiotic) was tested at concentrations 
of 2, 4, 16, 32, and 64 µg/ml.  The cut-off value for streptomycin resistance was ≥ 16 
µg/ml.  Among the Salmonella isolates tested, 46.0% and 41.7% of the isolates exhibited  
MICs at 8 and 16 µg/ml, respectively.  The remaining 0.6% of the isolates showed an MIC 
at 2 µg/ml and 7.7% of the isolates showed the MIC at 4 µg/ml.  Streptomycin-resistant 
isolates were observed in 3.1% (20/630) and 0.6% (4/630) of the total isolates, which 
represented MICs at 16 and 64 µg/ml, respectively. 
Sulfisoxazole (a folate pathway antagonist class antibiotic) was tested at 
concentrations of 16, 32, 64, 128, and 256 µg/ml.  The cut-off value for sulfisoxazole 
resistance was > 256 µg/ml.  The majority (40.4%) of the isolates showed the MIC at ≤ 16 
µg/ml, followed by 32 µg/ml (20.4%), 64 µg/ml (25.0%), 128 µg/ml (13.1%) and = 256 
µg/ml (0.7%) of the isolates.  All isolates were susceptible to sulfisoxazole in this study.  
Trimethoprim/sulfamethoxazole (another potentiated folate pathway antagonist 
class antibiotic) was tested at concentrations of 0.12, 0.25, 0.5, 0.1, 2 and 4 µg/ml 
(trimethoprim only).  The cut-off value for trimethoprim/sulfamethoxazole resistance was 
≥ 4 µg/ml.  The majority (99.8%) of the isolates showed the MIC at ≤ 0.12 µg/ml.  The 
remaining (0.1%) isolates exhibited the MIC at 0.25 µg/ml.  No MICs were observed at 
0.5, 1, 2, and 4 µg/ml.  All isolates were susceptible to the trimethoprim/sulfamethoxazole 
combination.  
Tetracycline (a tetracycline class antibiotic) was tested at concentrations of 4, 16, 
and 32 µg/ml.  The cut-off value for tetracycline resistance was ≥ 16 µg/ml.  The majority 





were phenotypically resistant to tetracycline either at 32 µg/ml (0.2% [1/630]) or above 32 
µg/ml (17.4% [110/630]) such that they were right-censored on this plate.  
Overall results suggest that among the 630 Salmonella isolates tested for 14 
antibiotics, 79.0% of these isolates were pan-susceptible.  The remaining isolates 
represented single (20.4%) or double (0.4%) phenotypical antibiotic resistance against 
either tetracycline, or streptomycin.  The majority of these isolates (n = 108) exhibited 
single-resistance to tetracycline (17.6%, 4.7- 20.8 [95% CI]), while 21 isolates were 
resistant only to streptomycin (3.8%, 2.4 - 5.6 [95% CI]).  Three isolates were resistant to 
both tetracycline and streptomycin.  No resistance was observed against amoxicillin/ 
clavulanic acid, ampicillin, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, 






Table 30.  Overall MICs distribution and antibiotic resistance classification of Salmonella isolates 
 
aMIC to the first antibiotic in each combination is listed.  bNARMS breakpoints used for classification.  *One-sided 97.5% CI was used when the prevalence estimate was zero.  R: 
Resistance.  Grey areas indicate out-of-dilution range of the Sensititre® plate.  Breakpoints for resistance classification are indicated using vertical lines.  Numbers in grey areas are 





Cross-tabulations of serotype by individual phenotypic antibiotic resistance data 
showed strong associations.  Among S. Montevideo isolates, 95.5% (63/68) exhibited 
tetracycline resistance.  In contrast, the remaining six serotypes (S. Anatum, S. Kentucky, 
S. Lubbock, S. Newport, and S. Norwich) exhibited either complete susceptibility to 
tetracycline or had a limited number of tetracycline resistant isolates (i.e., one S. Cerro and 
two S. Lubbock isolates).  Phenotypic streptomycin resistance was found in seven S. 
Anatum, six S. Lubbock, one S. Montevideo, and one S. Kentucky isolates (Table 31).  
Table 31.  Antimicrobial resistance phenotype distributions by serotype 
 Stra Tetb Tet-Str Pan-susc Total 
Anatum 7 0 0 106 113 
Cerro 0 1 0 63 64 
Lubbock 6 2 0 128 136 
Montevideo 1 63 2 2 68 
Kentucky 1 0 0 10 11 
Newport 0 0 0 6 6 
Norwich 0 0 0 1 1 
a Streptomycin, b tetracycline, c pan-susceptible.  Values representing phenotypic antibiotic resistance larger than zero are 
bolded in the cells.  Reprinted with permission from Levent et al. (2019) [236]. 
Only the MICs of 4 and 32 µg/ml were observed against tetracycline in the isolates.  
All S. Anatum, S. Newport, and S. Cerro isolates showed an MIC at 4 µg/ml.  The majority 
of S. Lubbock isolates (134/136) and S. Cerro (63/64) showed an MIC at 4 µg/ml. 
4.8.   Antibiotic resistance genes and plasmids  
A total of 399 isolates were screened with 95% identity match and 60% of 
coverage threshold for ARG identification using the ResFinder database in ABRicate.  





harbored a single-aminoglycoside resistance gene aac(6')-Iaa, A total of 67 isolates 
harbored the tetracycline resistance gene tet(A) and also the fosfomycin resistance gene 
fosA7 (Table 32).  All these isolates were also screened with 95% identity match and 60% 
of coverage threshold for plasmid identification using the PlasmidFinder database in 
ABRicate.  Among these, 67 isolates had the IncN plasmid and 64 isolates had the IncI1 
plasmid (Table 33). 
Table 32.  Antibiotic resistance genes identified in the study 
Gene name Gene product  Coverage (%) ID (%) GeneBank No. 
fosA fosA7_1 65.9 96.06 LAPJ01000014 
aac(6')-Iaa aac(6')-Iaa_1 100 97.0-99.0 NC_003197 
tet(A) tet(A)_6 97.8 100 AF534183 
ID: Identity match, Coverage: Coverage of the actual sequence length.  GeneBank No: Accession numbers in GenBank 
database. 
Table 33.  Plasmids identified in the study 
Plasmid Gene name Gene product Coverage ID GeneBank No. 
IncI1 IncI1 IncI1_1_Alpha 100 99.3 AP005147 
IncN IncN IncN_1 100 100 AY046276 
ID: Identity match, Coverage: Coverage of the actual sequence length.  GeneBank No: Accession numbers in GenBank 
database. 
All of the Salmonella isolates had the aac(6')-Iaa aminoglycoside gene regardless 
of the serotype.  The specific ARG profiles that were found in all Salmonella isolates were 
fosfomycin resistance gene fosA and tetracycline resistance gene tet(A) that was in S. 
Montevideo serotype (Table 34).  A detailed information about the ARGs found in this 






Table 34.  Resistance genes and plasmidal distributions by serotype 
 Resistance genes Plasmids aac(6')-Iaa tet(A) fosA IncN IncI1 
Anatum 113 0 0 0 16 
Cerro 64 0 0 0 3 
Kentucky 11 0 0 0 0 
Lubbock 136 0 0 0 43 
Montevideo 68 67 68 67 2 
Newport 6 0 0 0 0 
Norwich 1 0 0 0 0 
Values larger than zero were bolded in the cells. 
In terms of comparing the genotypic and phenotypic antibiotic resistance observed 
in isolates, S. Montevideo isolates that were phenotypically resistant to tetracycline all 
harbored tet(A) gene (65/65).  Among the remaining three S. Montevideo isolates, one did 
not harbor the tet(A) gene and IncN plasmid, and did not show any phenotypic tetracycline 
resistance whereas another one carried both tet(A) gene and IncN plasmid but was 
phenotypically susceptible to tetracycline; interestingly, this isolate had phenotypic 
streptomycin resistance.  The remining one did not harbor the tet(A) gene and IncN 
plasmid but also did not have phenotypic tetracycline resistance.  
In this study, we did not test for fosfomycin resistance; therefore, we could not 
observe the expression of fosA gene with a phenotype; moreover, this gene was detected at 
the relatively low (65.7%) coverage that was close to the threshold value (60.0%).  The 
isolates that harbored aac(6')-Iaa gene were susceptible to the aminoglycoside class 
antibiotics tested in this study.  
Among the 399 sequenced isolates, a total of 129 of isolates had a minimum of one 





IncN plasmids (Table 33).  A total of 64 isolates harbored the IncI plasmid, whereas 68 
isolates harbored the IncN plasmid.  Three isolates had both the IncN and the IncI1 
plasmids.  The distribution of these plasmids was highly serotype specific.   
IncN plasmid was found in 67 of the 68 S. Montevideo isolates.  Later, with the 
BLAST and RAStk analyses, the tet(A) gene along with its repressor tet(R) gene) was 
identified in a contig annotated to an IncN plasmid, which proved this gene was in the 
IncN plasmid (Figure 26).  
The IncI1 plasmid was commonly found in the S. Lubbock (43/136) serotype, 
followed by S. Anatum (16/113) and S. Cerro (3/64) serotypes, but did not harbor any 
ARGs.  Among those, only two S. Montevideo isolates that harbored the IncI1 plasmid 
also carried the second IncN plasmid.  S. Newport and S. Norwich were the only serotypes 
that did not harbor any identified plasmids.  Detailed information about the plasmids found 







Figure 26.  Circular representation of the IncN plasmidal contig harboring the tet(A) gene 






4.9.   Cladogenetic relationships 
The serotype S. Anatum was one of the most prevalent serotypes found in our 
study.  Therefore, a complete genome of an S. Anatum (GenBank: CP007483.2) was 
selected as the reference to perform the genome alignments of all Salmonella serotypes and 
strains observed in this study.  This reference was initially isolated from a ground beef 
product from Beef Industry Food Safety Council (BIFSCo) Region-3, which was located in 
the southern USA (unpublished data), and this isolate was submitted by USDA-Meat 
Animal Research Center in 2014.  This strain was the closet genome to the S. Anatum 
isolates recovered from our study, with a k-mer count coverage of 959/1,000, a 
Mash/MinHash distance of 1.00 e-3, and a P-value of 0.00. A total of 5 prophage regions 
were detected and masked in this reference genome, regardless of their score.  Of those, 
three were intact regions and the remaining two regions were either questionable or 
incomplete (Table 35).  
A Generalized Time Reversible (GTR)+G4 (gamma parameter 4) model was 
selected from Model-test NG based on the best AIC value.  This model only counts for 
SNP regions and generates the phylogeny using those sites.  The tree was further inferred 
using IQ-tree with 1,000 bootstrap iterations.  Later, the tree was rooted on the reference 
strain described above for graphical visualizations.  The cladogram branch that was found 
in the same phylogenetic structure of the tree for 800-1,000 sampling times (iterations) was 
accepted as highly confident for its position.  Those branches are graphically shown with 





Table 35.  Prophage regions masked in the S. Anatum reference genome  
Phage Name RefSeq No. Score Size (kb) Position (bp) 
Salmon_Fels_2 NCC_010463 Intact 44.5 1,145,366-1,189,915 
Salmon_Fels_1 NCC_01039 Intact 16.2 2,040,464-2,056,760 
Salmon_118970_sal3 NCC_031940 Intact 45.3 2,691,803-2,737,129 
Entero_P4 NCC_001609 Questionable 11.8 4,099,187-4,111,081 
Burkho_BcepMu NCC_005882 Incomplete 18.1 4,390,249-4,408,403 
RefSeq No: Reference sequence number in NCBI. 
The cladogram was accompanied with the graphical input as the unique colors 
representing each serotype with a closely related scale of colors to distinguish each 
block/cattle origin related metadata easily.  Pens (n = 12) were colored individually while 
blocks (1-4) were colored by shades of blue, pink/purple, red/orange and green, 
respectively.  The sources were indicated by shades of blue (for Source 1) versus the 






Figure 27.  Cladogram representing the pen-level overall population structure of Salmonella serotypes 
The maximum-likelihood cladogram was generated using GTR+G4 Model.  Serotype colors are represented in the cladogram branches and outer circle. Colors in the inner circle 
represent pen distribution. Block 1 (pens with shades of blue), Block 2 (pens with shades of pink/purple), Block 3 (pens with shades of red/orange), Block 4 (pens with shades of 





4.10.   Phylogenetic relationships 
Serotype-level SNP analyses were conducted only for the serotypes of S. Lubbock, 
S. Anatum, S. Montevideo, and S. Cerro.  The S. Kentucky, S. Newport, and S. Norwich 
serotypes were excluded from these analyses due to small numbers of observations (< 12 
isolates) within each of these serotypes. 
4.10.1.   S. Lubbock 
A complete genome of an S. Lubbock (GenBank: CP032814.1) isolate, which was 
obtained from the sub-iliac lymph node of a cow located in Texas, United States was found 
to be the closet genome to the S. Lubbock isolates recovered from our study; that is, with 
k-mer count coverage of 999/1,000, Mash/MinHash distance of 2.38e-5 and a P value of 0 
[15, 270].  A total of 11 prophage regions were detected and masked in this reference 
genome, regardless of their score.  Of those, nine were intact regions and the remaining 
two regions were incomplete prophage regions (Table 36). 
Table 36.  Prophage regions masked in the S. Lubbock reference genome 
Phage Name RefSeq No. Score Size (kb) Position (bp) 
Haemop_HP1 NC_001697 Intact 54.5 1,103,664-1,158,175 
Salmon_Fels_2  NC_010463 Intact 34.3 1,148,048-1,182,440 
Entero_PsP3 NC_005340 Intact 34.2 1,212,067-1,246,302 
Salmon_g341c NC_013059 Intact 40.6 1,505,665-1,546,354 
Edward_GF_2 NC_026611 Intact 41.6 2,084,146-2,125,762 
Riemer_RAP44 NC_019490 Intact 35.8 2,111,701-2,147,564 
Entero_mEp235 NC_019708 Intact 55.5 2,674,744-2,730,306   
Salmon_SEN34 NC_028699 Intact 47.9 2,963,014-3,010,960 
Salmon_ST160 NC_014900 Incomplete 42.4 3,240,527-3,283,000 
Burkho_BcepMu NC_005882 Incomplete 20.9 4,569416-4,590,395 
Escher_pro483 NC_028943 Intact 40.3 4,710353-4,750,711   





SNP analysis of 136 S. Lubbock isolates was performed in the McOutbryk SNP 
calling pipeline.  One of the 136 isolates could not be genotyped using the McCortex 
genotyping algorithm, and was excluded from the analysis.  Therefore, 135 isolates were 
carried forward for SNP analysis.  After filtration of variant sites by IQ-tree, a total of 84 
variant (SNP) sites with 76 distinct patterns was detected (Figure 28).  Among the 84 SNP 
sites, 36 were parsimony-informative, and the remaining 48 were singleton sites. 
The phylogenetic tree was inferred using the K2P+ASC model, which was the best 
nucleotide substitution model according to the BIC value.  The log-likelihood of the tree 
was -509.6744.  The total tree length (sum of branch lengths) was 0.0027 with a total of 84 
SNP sites.  Therefore, a single-SNP was equivalent to a 0.000032 branch length.  The tree 
scale (0.000099) was equivalent to approximately three nucleotide substitutions per site 
(Figure 29). 
The phylogenetic tree was divided into two distinct clades (Clades I and II) 
showing distinct patterns.  While Pens 57, 58, and 59 were commonly observed in Clade I 
with significant branching, Pens 7, 8, and 9 (Source 1) were only observed in Clade II, 
along with the majority of cattle in Pens 51-53.  When the day distribution was assessed, 
Days 0 and 7 S. Lubbock isolates were only observed in Clade II; that is, there were no 
early day isolates observed in Clade I.  The phylogeny of S. Lubbock had the highest 
number of SNPs (n = 84) and distinct day, source, and pen patterns.  There were no 






Figure 28.  SNP variations and distributions observed among S. Lubbock isolates 
Colors refer to the bases as follows: A (green), G (Black), C (blue), and T (red). The referent isolate that was chosen for 






Figure 29.  Phylogram representing S. Lubbock isolates  
The maximum-likelihood phylogram was generated using the K2P+ASC nucleotide substitution model.  Pen (first 
column) and source (second column) are presented in the legends; Days are represented in the following 6 columns.  The 
sample types are indicated in circles (fecal), stars (lymph node) or left-sided triangles (hides) in the last 3 columns. The 






4.10.2.   S. Anatum  
The SNP analysis of 113 S. Anatum isolates was performed in the McOutbryk 
pipeline.  One isolate could not be genotyped using the McCortex genotyping algorithm 
and was excluded from the analysis.  Therefore, 112 isolates were carried forward to SNP 
analysis.  The reference genome of S. Anatum was also used as the reference in this 
phylogenetic analysis.  The masked prophage regions of this reference were previously 
presented in Table 35.  After filtration of the variant sites, a total of 65 SNP sites with 61 
distinct patterns was detected (Figure 30).  Among the 65 SNP sites, 35 were parsimony-
informative and the remaining 30 were singleton sites.  The best-fit nucleotide substitution 
model was selected as K3P+ASC according to the lowest BIC value.  The log-likelihood of 
the tree was -373.633.  The total tree length (sum of branch lengths) of 0.0028 was 
equivalent to 65 SNP sites.  Therefore, one SNP in this tree was calculated as equal to 
0.000043 branch length.  The tree scale (0.000099) shows approximately 2.3 nucleotide 
substitution/per site (Figure 31). 
The phylogenetic tree was divided by two significant clades (Clade I and II) 
showing distinct patterns.  While Pens 7, 8, and 9 (Source 1 and Day 134)  was only 
observed in Clade I with significant branching, Pen 56 was only observed in  Clade II. 
When the day distribution was explored, there was no Day 7 isolate observed in Clade I; 
meanwhile, the S. Anatum isolates from the remaining days in this clade remained intact 
with significant branch support values.  There were no sample-type-related dynamics 







Figure 30.  SNP variations and distributions observed among S. Anatum isolates 
Colors refer to the bases as follows: A (green), G (Black), C (blue), and T (red).  The referent isolate that was chosen for 






Figure 31.  Phylogram representing S. Anatum isolates 
The maximum-likelihood phylogram was generated using a K3P+ASC nucleotide substitution model.  Pen (first column) 
and source (second column) are represented in the legends.  Days are represented in the following 6 columns.  Sample 
types are indicated in circles (fecal), stars (lymph nodes) or left-sided triangles (hides) in the last 3 columns.  Bootstrap 
support values in the range of min. 80.1 and max. 100 are represented with grey circles in the middle of each 






4.10.3.   S. Montevideo  
A complete genome of S. Montevideo (GenBank: CP032816.1) was obtained from 
the same study [15, 270] that we used for the S. Lubbock reference genome.  This genome 
was the closet genome to the S. Montevideo isolates recovered from our study with k-mer 
count coverage of 957/1,000, Mash/MinHash distance of 1.00 e-3 and a P value of 0.00.  A 
total of 4 prophage regions were detected and masked in this reference genome.  Of those, 
two were intact regions and the remaining two regions were incomplete (Table 37). 
Table 37.  Prophage regions masked in the S. Montevideo reference genome 
Phage Name RefSeq No. Score Size (kb) Position (bp) 
Salmon_Fels_2 NC_010463 Intact 42.4 1,108,750-1,151,168 
Cronob_vB_CsaM_GAP32 NC_019401 Incomplete 19.8 1,948,518-1,968,382 
Entero_cdtI NC_009514 Incomplete 6.1 2,595,886-2,602,054 
Entero_P2 NC_001895 Intact 31.3 4,332,529-4,363,916 
RefSeq No: Reference sequence number in NCBI. 
SNP analysis of 68 S. Montevideo isolates conducted by McOutbryk SNP pipeline, 
showed a total of 12 SNP sites (Figure 32) that all had distinct patterns.  Among the 12 
SNP sites, only one was parsimony-informative and the remaining 11 were singleton sites.  
The best-fit nucleotide substitution model was selected as K2P+ASC according to the 
lowest BIC value.  The log-likelihood of the tree was -53.849.  The total tree length (sum 
of branch lengths) was 0.003 with a total of 12 SNPs site.  Therefore, one SNP in this tree 
was equal to 0.00025 branch length.  The tree scale of 0.0001 is equivalent to approx. 0.4 





The phylogenetic tree was divided by two clades (Clade I and II) for S. Montevideo 
isolates.  Clade I consisted of a single distinct isolate from Pen 52 that was from Day 141.  
In Clade II, there was a significant sub-branch (Clade II/a).  The majority of Source 1 was 
located in this clade.  In Clade II/a, there were only slaughter age isolates isolated from 
only Pens 7, 8, 9 and 52.  Isolates from the remaining days (Day 0 and 7) were all located 
in the other sub-clades, along with the additional pens (except Pen 52 and Pen 9).  The 
phylogeny of S. Montevideo had the lowest number of SNPs (n = 12) and distinct day and 
pen patterns were observed among these isolates.  There was no sample-type-related 







Figure 32.  SNP variations and distributions observed among S. Montevideo isolates 
Colors refer to the bases as follows: A (green), G (Black), C (blue), and T (red).  The referent isolate chosen for SNP 






Figure 33.  Phylogram representing S. Montevideo isolates  
The maximum-likelihood phylogram was generated using a K2P+ASC nucleotide substitution model.  Pen (first column) 
and source (second column) are represented in the legends.  Days are represented in the following 6 columns.  Sample 
types are indicated in circles (fecal), stars (lymph nodes) or left-sided triangles (hides) in the last 3 columns.  A single 





4.10.4.   S. Cerro 
The complete genome of an S. Cerro strain (wild-type serovar 87, GenBank: 
CP008925.1) that was isolated in China was selected as the reference genome for the 
phylogenetic analysis.  This genome found to be the closest available genome to the S. 
Cerro isolates recovered from our study, with a k-mer count coverage of 997/1000, 
Mash/MinHash distance of 7.16 e-5 and a P value of 0.00.  A total of 5 prophage regions 
was detected and masked in this reference genome.  Of those, one was intact, three were 
questionable and the remaining one had incomplete prophage regions (Table 38) 
Table 38.  Prophage regions masked in the S. Cerro reference genome 
Phage Name RefSeq no. Scoring Size (kb) Position (bp) 
Salmon_vB_SosS_Oslo NC_018279 Intact 50.2 130,352-180,614 
Gifsy_2 NC_010393 Questionable 11.3 234,157-245,537 
Salmon_SEN34 NC_028699 Questionable 11.5 910,517-922,099 
Salmon_RE_2010 NC_019488 Incomplete 7.0 1,730,341-1,737,418 
Entero_UAB_Phi20 NC_031019 Questionable 44.8 4,167,324-4,212,148 
RefSeq No: Reference sequence number in NCBI. 
Phylogenetic analysis of 64 S. Cerro isolates resulted in 17 SNP sites with 16 
distinct patterns (Figure 34).  Among the 17 SNP sites, nine were parsimony-informative 
and the remaining eight were singleton sites.  When the SNP alignment was tested for the 
best-fit nucleotide substitution model, the best-fit model was TIMe+ASC according to the 
lowest BIC value.  The log-likelihood of the tree was -78.5521.  The total tree length (sum 
of branch lengths) was 0.0038 with a total of 17 SNP sites.  One SNP in this tree was equal 
to 0.00022 branch length.  The tree scale (0.0001) shows approximately 0.4 nucleotide 





The phylogenetic tree was divided into two significant clades (Clade I and II) for S. 
Cerro isolates.  Since this serotype was limited to slaughter days, there were no earlier 
observations.  Clade I had unique day, source, and pen patterns.  For example, all slaughter 
day isolates except from Day 120 were located in this clade.  Also, Source 1 (Pens 7,8 and 
9) isolates were only found in this clade, along with isolates from Pens 51,58, and 59.  In 
Clade II, only isolates from Source 2 and Pens 56 and 57 were found.  One additional 
isolate from Pen 52 also was located in this clade and that unique isolate was the only 
isolate from Day 141.  All remaining isolates from this clade were from Day 120 and its 
associated block.  The phylogeny of S. Cerro revealed distinct day, source, and pen 
patterns.  There were no sample-type-related dynamics observed among the S. Cerro 
isolates (Figure 35). 
When the overall patterns were explored for the phylogenetic trees using the SNP 
analysis, the largest variations were observed among the S. Lubbock isolates (84 SNPs/135 
isolates); this tree was inferred with the K2P model, which assumes equal base frequencies 
and unequal transition/transversion rates.  The second largest variations were observed 
among S. Anatum isolates (65 SNPs/112 isolates). That tree was inferred using the K3P 
model, which also results from equal base frequencies; however, equal substitution rates 
occur across all bases.  S. Cerro had the third largest variations (17 SNPs/ 68 isolates); this 
tree was inferred with the TIM1 model, which assumes equal base frequencies and equal 
transition rates.  The smallest variations were observed in S. Montevideo isolates (12 






Figure 34.  SNP variations and distributions observed among S. Cerro isolates 
Colors refer to the bases as follows: A (green), G (Black), C (blue), and T (red).  The referent isolate chosen for SNP 






Figure 35.  Phylogram representing S. Cerro isolates 
Maximum-likelihood phylogram was generated using the TIMe+ASC model. Pen (first column) and source (second 
column) are represented in the legends.  Days are represented in the following 6 columns.  Sample types are indicated in 
circles (fecal), stars (lymph nodes) or left-sided-triangles (hides) in the last 3 columns. Bootstrap support values in the 





5.   DISCUSSION* 
The judicious use of antibiotics in veterinary medicine has been widely discussed 
due to the potential risks of cross-resistance to antibiotics used in human medicine.  Public 
health authorities and agencies have been applying restrictions to control and decrease the 
use of medically important antibiotics and their analogs in feedlot cattle since 1969 [205, 
217, 219].  A subset of these antibiotics is still frequently administered to cattle arriving to 
the feedlots; thus, may pose a selection pressure on cattle origin AR bacterial pathogens 
that may enter to the food-chain or else spread in the environment up until the slaughter 
date at 90+ days.  This situation can further cause a public health problem by resulting in 
the treatment failure of antibiotics in humans that are infected by a cattle origin AR 
pathogen.  Therefore, the longer-term effects of antibiotic administrations early in the 
feeding period needed to be better evaluated to gauge the public health risks associated 
with antibiotic use in cattle feedlots and their effects on foodborne pathogens in cattle at 
slaughter.  
Our study was the first randomized, controlled, and longitudinal field trial that 
monitored cattle origin Salmonella from the time of the antibiotic treatment (Day 0) up 
until the slaughter (Day 99+).  We achieved this by focusing on fecal, lymph node, and 
hide samples; each sample type represented a potential source of Salmonella contamination 
in beef products.  We employed standard microbiological and advanced molecular methods 
for initial isolation and confirmation of Salmonella.  The phenotypic antibiotic 
                                                 
* Part of this chapter is reprinted with permission from “Population Dynamics of Salmonella enterica within Beef Cattle 
Cohorts Followed from Single-Dose Metaphylactic Antibiotic Treatment until Slaughter” Levent G, Schlochtermeier A, 
Ives SE, Norman KN, Lawhon SD, Loneragan GH, Anderson RC, Vinasco J, Scott HM. 2019 Appl Environ Microbiol 





susceptibility profiles of Salmonella isolates were determined using the broth 
microdilution method.  In addition, we also determined the serotype, ST, resistance genes, 
and plasmidal profiles of these isolates using WGS-based analyses and with commonly 
accepted in silico tools.  We also aimed to understand the cattle, environment, and time 
related population dynamics of Salmonella, which represent a public health problem 
regardless of antibiotic resistance profiles.  Therefore, we explored the genetic population 
dynamics of fecal, lymph node and hide origin Salmonella isolated from cattle coming 
from different sources, pens, and treatment groups using WGS data and SNP analyses.  
5.1.   Model selection for quantitative data 
Using a linear regression model for a quantitative linear dataset is appropriate when 
the observations are normally distributed (also, without the excess zero counts and those 
below the LLQ), the variance is constant, and the measured outcomes of observations are 
assumed independent of one another [271].  Often, in microbiology the CFU observations 
are log10 transformed in order to better fit to the normal distribution prior to linear 
regression model application.  However, when the quantitative observations have the 
excess zero counts or/and zero values due to the limits of quantification of the method 
used, the transformation often does not help the data to entirely meet the assumptions of 
the linear regression.  These excess zero counts are usually the products of the LLQ of the 
microbiological method chosen for the quantification, but also may reflect underlying 
variability and relatively low counts in the targeted ecological niche.  The excess zero 





observations that can be either structural or else artefactual sampling zero (i.e., not zero but 
under the LLQ) counts. 
Handling the excess zero counts that are part of an overdispersed and correlated 
quantitative data is considered one of the more difficult decisions to make by researchers 
[272].  Each dataset has it is own unique nature and biology, each of which plays a key 
role for the selection of the appropriate method to handle excess zero counts in such data.  
For example, if the excess zero counts are obtained from a count observation of a 
commensal bacterial species, that is almost always found in a sample, it is reasonable to 
assume that these observations are likely sampling zeros.  However, when the zero counts 
arise from a bacterial species that may or may not regularly be found in a sample, the 
sampling zero assumption can be problematic.  This uncertainty needs to be evaluated 
carefully based on biological reasoning, along with the other observations obtained from 
the data.  Otherwise, a biased assumption could be made on the nature of the zero counts, 
which can result in Type-I or Type-II errors for the tested hypothesis.   
Decreasing the LLQ and conducting accurate estimates for exposure is highly 
important for risk analyses [273]. There are various solutions to avoid this kind of biases.  
A few solutions focus on decreasing the LLQ, either before the analyses at the sample 
collection stage or in the laboratory, using highly sensitive but also specific methods [272, 
273].  Several solutions can be also applied at the statistical analysis stage using methods 
appropriate to handle the excess zeros [272-276]. 
One way to avoid excessive zero counts at the sample collection stage is to 
determine the proper sampling area, time, and transport method that can increase the 





based methods by using lower-dilution factors (e.g., using a spiral plater), retesting the 
sample, increasing the number of replicates, or utilizing a pre-enrichment or amplification 
method that provides a relative abundance (usually combined with molecular 
quantification methods).  Another way of handling the zero-count uncertainty is using the 
statistical methods at the data analysis stage using different statistical approaches based on 
observations in the data and biological reasoning [273]. 
The statistical solutions that are used to handle the excess zero counts at the 
analysis stage can be listed as: 1) omitting the zero counts and applying a parametric model 
[272, 274], 2) substituting the zero counts with a value related to the LLQ (e.g., the LLQ, 
1/2 the LLQ, or LLQ√2) and applying a parametric model [274, 275], 3) assuming the all 
zero counts are structural, the data are zero-truncated and then applying a zero-truncated 
regression model [277], 4) assuming tall the zero counts are sampling zeros (left-censored) 
and applying a non-parametric survival analyses [278], 5) assuming zero counts are either 
missing or left-censored observations; therefore, assigning unique values to the zero counts 
based on the probability of the parental distribution using a multiple imputation based 
regression model [276], 7) assuming zero counts can be either structural or sampling and 
using zero-inflated models (two-part models) [279], and 8)  assuming the zero counts are 
structural using hurdle (also, a two-part) models [280].  
The two-part models are less biased compared to other methods when the true 
nature of data is unknown; however, usually the selection of the model is made by testing 
several two-part models with the same parameters and choosing the lowest AIC and BIC 
values when selecting the best model.  However, when the zero counts are more likely to 





distribution using an imputation regression model is the most accurate and least biased 
[281]. 
Two-part regression models are adopted when the zero counts that are not likely 
sampling errors and are of unknown structure; meanwhile, the observations often are 
overdispersed and highly correlated to potential clusters [281].  The zero counts for these 
kinds of data are usually handed with: 1) ZIP models when the variance is equal to the 
mean, 2) ZINB models when the variance is not equal to the mean, and 3) CHURDLE 
models using appropriate models based on the distribution of the observations [279-281].  
These regression models consist of two model parts: 1) a binary probability model using 
either logit or probit distribution for the zero counts, and 2) inflation models or selection 
models that account for i) continuously coded observations (linear) or ii) integer 
observations using either Poisson or negative-binomial probability distributions. 
Two-part Poisson and negative-binomial models are usually preferred when zero 
counts are assumed to be either structural zero or else sampling zero counts (these also are 
called zero-inflated models).  Therefore, these types of models include the zero count 
observations in both first and second part of the model.  On the other hand, Cragg’s hurdle 
model assumes that all zero counts are structural (true) zeros and these counts are not 
included in the second part of the model; that is, they are included only in the first part of 
the model [282].  The statistical hurdle model was first proposed in 1971 as an alternative 
model for handling excess zero counts when there is the probability that these zero counts 
are not sampling zero [283].  Soon after, the hurdle models became widely used to handle 





begun to be preferred to handle excess zero counts of data in microbiological fields [279, 
284].   
To be able to improve the LLQ in our study, we collected feces that is a sample 
type more likely to harbor intestinal origin Salmonella.  We also sampled the sub-iliac 
lymph nodes that have previously been reported to harbor higher numbers of Salmonella 
compared to the other lymph nodes of cattle.  We swabbed a large surface of brisket area 
(1,000 cm2) of the ventral cattle hide that was more likely to reflect the environmental 
Salmonella in high numbers [15, 121, 285-287].  This study also was purposely started in 
March and ended in early August to increase the likelihood of quantifying Salmonella at 
slaughter due to previously conducted studies reported increasing count and prevalence of 
Salmonella in summer periods [69, 132].  To avoid the possible reduction of numbers of 
viable and quantifiable bacteria during transportation, all samples were delivered to our 
laboratory via overnight shipment in coolers maintained at +4 °C.  
In our study, we utilized the same quantitative methods across all samples and days 
to better be able to compare our findings.  We also utilized a spiral-plating method, which 
significantly decreases the LLQ for CFU data [119].  However, we also utilized a non-
selective (TSB) media incubation for 3 h as a pre-enrichment step in order increase the 
likelihood of obtaining a CFU value from the samples that were Salmonella positive. 
Even though we aimed to apply the best possible practices to decrease the LLQ of 
our quantification method,  our fecal and lymph node CFU data had excess zero counts in 
all types of samples.  After the log10 transformation, only the quantifiable hide 
observations approached normality; however, the fecal and lymph node observations were 





node CFU data with zero-inflated and hurdle models.  The marginal trends and coefficients 
were similar for all models, and especially were nearly identical for ZIP and ZINB models, 
suggesting the mean was equal to the variance.  These results suggest that all three models 
provided a good-fit for data yielding excess zero counts.  However, CHURDLE 
significantly improved the model fit (based on the AIC and BIC values), which is most 
likely due to using non-rounded observations or perhaps the higher probability of zeros 
being structural when compared to hides.  The structural zero hypothesis was also 
supported by the kappa agreement, showing that only a minor proportion of these zero 
counts were positive after a much more extensive Salmonella enrichment process (Table 
11).   
Since enrichment results were obtained with Salmonella specific enrichment media 
and this step eliminates the non-Salmonella colonies during the incubation stage, and all 
these isolates were confirmed with serum O-antigen and MALDI-TOF MS methods, they 
were more likely to reflect the closest value to the true prevalence when Salmonella 
prevalence is low or else the background microbiota are complex.  Therefore, an animal-
level assessment has also been conducted assuming if an observation that had CFU was 
zero but the prevalence was positive, it was more likely the CFU was under the limit of 
detection for CFU.  Similarly, if an enrichment result was negative but the CFU number 
was a positive value, it was accepted to be more likely those colonies may not be true 
Salmonella colonies but another species with similar morphological characteristics as 
Salmonella on selective agar plate.  When we examined the kappa agreements between the 
CFU data of either negative (below-LLQ) or positive (above the LLQ), and the binary 





This also supports the idea that zero counts observed in the study were likely structural 
zero counts (assuming the enrichment method was accurate); therefore, the hurdle model 
was the best-fit model for our data. 
Beside handling the uncertainty of zero counts observed in fecal and lymph node 
results, we assumed the zero counts obtained from hide samples were the result of an LLQ 
error, since it was highly unlikely to obtain structural zero Salmonella counts in any given 
pen where up to 80% of animals tested as positive on hide and fecal samples.  Therefore, 
imputing CFUs between the zero and the LLQ was assumed reasonable.  This model first 
imputes the missing or zero observations between the zero and LLQ values for a given 
number of iterations under the parenteral distribution of an interval-based regression with 
the selected model parameters; later, these iterations were included in the selected 
regression model analyses with the same parameters.  This method is widely used to deal 
with missing observations in a given dataset [288, 289].  We applied multiple imputation 
along with the interval-linear regression followed by a multi-level linear regression to 
estimate log10 CFUs of the “zero counts”, which were assumed to not truly be zero but 
instead remained under the LLQ for hide samples.  Following the imputations, the 
distribution of hide log10 CFUs better met the assumptions of linear regression, including 
normalized residuals and a more constant variance.  Even though imputation is usually 
suggested for data containing up to 80% missing or zero counts, in our study we had only 
32% (43/132) of the data points that were imputed; moreover, the equal distribution of 
these data among the treatments (14-15 observations in each treatment group), provided 






5.2.   Quantitative Salmonella results 
Previous studies investigating the effects of seasonal and cattle age-related factors 
on fecal Salmonella shedding have shown that shedding often is higher in summer and in 
older feeder cattle when compared to other seasons and in calves [290, 291].  In our study, 
we also observed increasing CFUs during sampling periods approaching summer (Figure 
17).  In particular, there was a significant increase of fecal Salmonella CFUs in ceftiofur 
and control groups observed after Days 56 and 112, respectively, when compared to earlier 
sampling days.  Interestingly, this significant increase was not observed in feces from the 
tulathromycin-treated cattle.  When the overall CFU distribution comparing the 
tulathromycin and the other treatment groups was examined on Day 0, the tulathromycin 
group CFUs were relatively lower than the other groups and, after treatment, remained 
almost the same on Day 7 while the other groups were decreasing; therefore, this 
difference among groups by day may be related to the gradual increase observed in the 
tulathromycin over the entire study length.  Overall, our study did not show any significant 
effects of ceftiofur and tulathromycin metaphylactic treatments on Salmonella CFUs 
estimated from feedlot cattle feces, lymph nodes and hide samples. 
The smallest value for the LLQ was observed in lymph nodes, followed by feces 
and hides (Figure 15).  One possible explanation for these differences could be the 
competition by the background microbiota during the 3 h pre-enrichment process, since 
possibly a less complex microbiota is expected to be found in lymph nodes compared to 
feces, and with feces compared to hide samples.  Within this discussion, we mainly 
focused on the LLQ as other authors have done; however, when samples are overloaded 





we did not observe a high limit of detection in feces and the lymph nodes.  However, we 
observed several right-censoring observations on the hides at the possible upper limit of 
quantification of 7.2 log10 (Figure 14), which could potentially affect the underlying 
distribution, and consequently our interpretation of the results.  However, considering no 
treatment effects were observed in the other sample types, and hide origin Salmonella were 
less likely to have been affected by the antibiotics injected subcutaneously to the cattle, 
this would probably not change our final conclusion regarding the effects of ceftiofur and 
tulathromycin on cattle hide origin Salmonella quantities at slaughter age. 
A 3 h pre-enrichment incubation applied to our samples prior to quantification 
provided the ability to increase the proportion of zero counts that were structural zeros; 
meanwhile, applying the same method across sampling days and all sample types also 
provided an internal validity to compare the treatment and period effects on Salmonella 
CFUs obtained from the study.  However, utilizing a pre-enrichment step results in reduced 
external validity; that is, the ability to be able compare our results with those from other 
laboratories.  A laboratory-based method is therefore also needed to better estimate the 
initial CFUs in these samples prior to enrichment, perhaps by simulating this experiment 
with a known Salmonella concentration spiked into a subset of samples constructing a 







5.3.   Prevalence of Salmonella  
Our findings suggest that neither ceftiofur nor tulathromycin used for control of 
BRD early in the feeding period affects Salmonella prevalence at slaughter, whether 
observed in cattle feces, lymph nodes or hides.  However, the sampling day had a 
significant (P <0.05) effect on the fecal prevalence of Salmonella that was reflected as an 
increasing prevalence associated with the shift from spring through to the summer months.  
Similar to the CFUs, this increase could be related to the seasonal effect on Salmonella 
persistence in animals and in the environment due to the increase of the ambient 
temperature from March 2016 to August 2016.  However, this change also can be linked to  
cattle related factors associated with time such as age, immune status, or other 
environmentally related factors besides temperature.  This finding is similar to those in 
other studies reporting significant effects of the summer season on fecal shedding of 
Salmonella when compared to the winter or spring seasons; this includes a survey 
conducted by USDA-APHIS in 1999 [138]. Similar findings also were observed in cattle 
feces by Vikram et al. (2017), who observed a significant increase (P < 0.01) of the 
prevalence of Salmonella recovered from 719 beef cattle in summer when compared to 
fall, winter, and spring [136].  
In our study, the mean fecal prevalence observed in March was 43.6%, which 
increased to 80.3% by the beginning of August.  However, the peak prevalence that was 
observed in summer time in the USDA-APHIS study (1999) was 11.4% and in winter time 
was 4.0%; however, the APHIS results were obtained from fecal samples collected from 
the pen floors whereas in our study we collected fecal samples per rectum.  In addition, the 





in more northern latitudes, whereas we were more limited with a single-feedlot in the 
panhandle of Texas. 
On the other hand, Vikram et al. (2017) [136] reported the Salmonella prevalence 
obtained from the fecal samples directly collected by the incision from the colon of the 
cattle at harvest was around 2.5% in March, and increased to 22-47% by July-August.  
These samples were collected from a single-beef processing plant in the United States; 
however, the location (i.e., state) of this plant was not provided.  It has been previously 
shown that Salmonella prevalence in cattle is higher in the southern regions compared to 
other U.S. regions; therefore, the obvious prevalence difference that was observed in our 
study can most likely be attributed to the locational (latitude) or feedlot dynamics of 
Salmonella.  
Gragg et al. (2013) [15] showed a significant regional effect on the sub-iliac lymph 
node Salmonella prevalence obtained from slaughterhouses located in the southern United 
States, including Texas.  In their study they longitudinally sampled sub-iliac lymph nodes 
at slaughter throughout the year; this way, they also showed a significant increase in the 
prevalence in summer months.  Webb et al. (2017) also observed similar effects of season 
and geographically regional Salmonella prevalence differences in cattle sub-iliac lymph 
nodes in their repeated cross-sectional study [132].  Their results were also similar to our 
study, showing significantly higher prevalence in the summer, and southern United States 
when compared to the winter and midwestern United States.  In contrast, the findings of 
Haneklaus et al. (2012) [16] showed that the Salmonella prevalence in cattle superficial 
cervical and iliofemoral lymph nodes varied significantly among the seven different 





unusual for that region.  However, this contradictory finding may be due to the Salmonella 
prevalence variations observed in different lymph node types of cattle [68] [285], other 
host immunity and age-related factors [286], or the route, amount and time of Salmonella 
exposure in the feedlots [133, 285].  Perhaps seasonal and regional effects reflect more on 
Salmonella prevalence in the sub-iliac lymph nodes than other peripheral lymph nodes.  In 
our study, lymph nodes were only collected during the summer months so no seasonal 
variability was observed outside of that seen in the fecal samples.  Overall, these 
comparative results support our finding of high Salmonella prevalence in the sub-iliac 
lymph nodes of cattle located in Texas in the summer.  However, in our study we only 
sampled lymph nodes from cattle within a 42-day period during the middle of summer.  If 
our study was conducted in the northern or western parts of United States, sampled other 
lymph node types, or cattle in winter, we would most likely observe major differences in t 
Salmonella prevalence in lymph nodes. 
In our study, at slaughter age the highest Salmonella prevalence was found in the 
hide (84.8%) samples followed by the lymph nodes (84.2%), and then fecal (80.3%) 
samples.  However, it is important to note that in our study hide swab and lymph node 
samples were processed fresh, while the fecal samples were initially frozen and later 
thawed and processed.  Such dramatic temperature differences can impact numbers of 
viable bacteria in fecal samples that can lower the rate of isolation from feces, even though 
samples were stored in a cryo-protectant (glycerol).  Both Kunze et al. (2008) [69], and 
Gragg et al. (2013) [68] also found higher Salmonella prevalence on hide swabs when 
compared to feces and sub-iliac lymph nodes.  The higher Salmonella prevalence on hide 





the farm environment (e.g., soil and manure) and replenished frequently through the feces 
of the cattle to the environment [166].  Even though Salmonella prevalence  is usually 
higher on hides when compared to other potential beef product contamination sources (i.e., 
feces and lymph nodes) of cattle, it has been shown that slaughter-plant carcass and hide 
interventions significantly reduce Salmonella carcass prevalence both pre- and post-chill 
[122, 143] (Table 1). 
ICC reveals the magnitude of the effect of clustering within the nested components 
of variance observed among observations.  The ICC has absolute values between zero and 
one.  While an ICC value of zero suggests no correlation among observations within 
clusters, positive values suggest a positive correlation among observations within clusters 
[271].  The ICC values can play an important role in understanding the ecological and 
animal aggregating factors (such as pen, or repeated observations within animal) related to 
the overall ecology and epidemiology of Salmonella in feedlot settings.  In our study, 30% 
of the variance relating to Salmonella presence on hides, 21% of the variance in feces and 
13% of the variance in lymph nodes were attributed to pen-level variability.  This result 
suggests a strong role played by environmental versus animal-related factors, since at the 
pen-level Salmonella presence/absence is more likely to be similar within a pen than for 
the lymph nodes obtained from each animal.  Animal-level dependencies were measurable 
only for fecal and lymph node samples.  The ICC for animal level clustering showed that 
64% of the variance in lymph nodes and 21% of the variance in feces observed for 
Salmonella prevalence were attributed to within-animal dependencies.  The lymph node 
prevalence was likely influenced by fact that the two nodes from individual animal 





dependencies arose longitudinally over multiple weeks, starting in the spring and ending in 
the summer.  In our study, overall results show that pen and animal level clustering had the 
greatest impact on Salmonella prevalence regardless of assigned treatment groups.  To the 
best of our knowledge, pen-level and animal-level ICC estimates for Salmonella 
prevalence have not been previously reported in randomized cohorts of beef cattle.  
However, Cull et al. (2017) [292], reported the ICC of enterohemorrhagic E. coli from 
different pens and feedlots.  Our estimates were similar to the recent cross-sectional study 
published by Cull et al. (2017), measuring feedlot and pen-level ICC of E. coli collecting 
fecal cattle samples across eight commercial feedlots in a region near the Texas Panhandle.  
In their study, E. coli ICCs ranged from 4% to 8% among the cattle feces and feedlots 
whereas at the pen-level ICC ranged from 26% to 31%. 
5.4.   Antibiotic resistance dynamics 
Our study did not reveal any selection effect of ceftiofur or tulathromycin on 
phenotypic or genotypic ceftriaxone or azithromycin resistance in cattle Salmonella 
populations immediately after the antibiotic administration, as well as at slaughter.  In our 
study, we tested a total of 630 Salmonella isolates recovered from feces, lymph nodes and 
hides on non-antibiotic-selective media.  Approximately 80% of the Salmonella isolates 
were pan-susceptible; the remaining 20% of the Salmonella isolates exhibited tetracycline 
(≥ 16 µg/ml) and/or streptomycin (≥ 32 µg/ml) resistance (Table 30).  In this study, all 
Salmonella isolates were susceptible to ceftiofur, ceftriaxone, and azithromycin.  The MIC 
distribution for ceftiofur (Table 28), ceftriaxone (all isolates had an MIC of 0.25 µg/ml), 





ceftiofur, tulathromycin or control cattle. The absence of resistance to beta-lactams and 
macrolides among these Salmonella means their selection was not possible. In a parallel 
study, a master’s thesis published in 2017 showed there were AmpC and ESBL beta-
lactamase-producing genes present and selected for among the E. coli in this same cattle 
population. Since these genes were not present in the Salmonella, they could not be 
selected. Our results should be interpreted in line with that important caveat. 
The most prevalent phenotypic resistance found in this study was tetracycline.   
Phenotypic tetracycline resistance is the one of the most commonly observed among 
Salmonella isolates originating from humans [32], cattle [68, 132, 137, 144], and beef 
products [13, 149]. Tetracycline is classified as highly important for human medicine by 
the WHO [54].  Based on the comparisons of phenotypic antibiotic resistance data and 
serotypes, we found that phenotypic tetracycline resistance was observed almost 
exclusively among S. Montevideo serotypes found in feces, lymph nodes and on hides 
throughout the study; that is, without any known direct selection pressure caused by using 
tetracycline.  Our findings also demonstrated that serotype and antibiotic resistance 
patterns were closely associated (Table 31) as previously suggested by numerous studies 
[15, 36, 69, 149, 192]. In our study, we observed the tet(A) gene conferring phenotypic 
tetracycline resistance at an MIC of ≥ 16 µg/ml.  This is not unusual, since the tet(A)  gene 
is commonly observed in Salmonella isolates resistant to tetracycline [192].  Our 
annotation results showed that the tet(A)  gene was on a contig that was part of the IncN 
plasmid; this result also confirms why almost all S. Montevideo isolates were resistant to 
tetracycline and at the same time harbored the IncN plasmid.  S. Montevideo was prevalent 





25).  When the distribution of this serotype was examined, cattle from Source 1 had the 
majority of the S. Montevideo isolates and these were the single group of cattle had S. 
Montevideo in their lymph nodes and on hides at slaughter age.  The IncN plasmid 
harboring a bla gene (specifically, the blaCTX-M-1 or bla CTX-M-32 genes) was previously 
reported in the Enterobacteriaceae family [293]. This plasmid harboring bla genes was also 
isolated from E. coli recovered from beef cattle [294].  In our study, we did not identify 
any bla gene on this plasmid; likely, this reflects the variation in the STs of the IncN 
plasmids recovered from different locations and times [295]. 
Tetracycline is the most commonly used medically important antibiotic in cattle 
[223, 224]; perhaps, the dissemination of S. Montevideo harboring IncN plasmid in our 
study could be attributable to the cattle source, which consequently could be related to the 
historical use of the tetracycline in that location [209].  However, the prior antibiotic 
exposure history of our study cattle was unknown; therefore, such conclusions should be 
avoided.  Another possible explanation for the persistence and dissemination of the tet(A)  
gene on an IncN plasmid could be a possible reduction of fitness cost that can provide 
survival selection for the S. Montevideo isolates, especially if the IncN plasmid is carrying 
functional genes (e.g., virulence genes) [108].  However, this was not explored in our 
study. 
Even though  tetracyclines are not typically preferred for the treatment of 
Salmonella infections in human, they are classified as medically important antibiotics for 
humans [54].  In our study, we identified S. Montevideo harboring a tetracycline resistance 
gene on a plasmid in 11 fecal, 17 lymph node and six hide samples from the cattle that 





interventions, the fecal and hide origin S. Montevideo population will be reduced before 
these beef products are offered for human consumption (Table 1).  However, the lymph 
nodes harboring S. Montevideo that are resistant to tetracycline still pose a risk of final 
transmission of this pathogen to humans through the consumption of undercooked and 
contaminated ground beef products. 
Another ARG that also was observed in all S. Montevideo isolates was a 
chromosomally located fosA7 gene.  Fosfomycin is a broad-spectrum antibiotic discovered 
in 1961 that inhibits the MurA enzyme, which plays a role in peptidoglycan synthesis of 
the bacterial cell wall [296].  Even though fosfomycin is commonly used for the treatment 
of urinary tract infections in humans, it is not used in food-producing animals in the United 
States [223].  There are three major classes of fosfomycin modifying enzymes (FosA, 
FosB, and FosX).  The first FosA enzyme expressing fosfomycin resistance gene (fosA) 
was described in 1988 [297].  Since then, numerous fosA genes have been described  
(fosA3, fosA4, fosA5, and fosC2 ) in the literature [298].  In 2016, the fosA6 gene was first 
identified in an ESBL-producing E. coli strain [299].  Recently, in 2017 a novel fosA7 
gene was also identified in a S. Heidelberg isolate recovered from chicken [300].  The 
sequence comparisons between the fosA7 gene found in our study versus the fosA7 gene 
isolated from S. Heidelberg isolates demonstrated that all S. Montevideo isolates harbored 
fosA7 gene that showed 96% similarity to the first reported fosA7 gene (data not shown).  
Moreover, when we also examined the S. Montevideo isolates from Ohta et al. (2017 – 
though in same experimental feedlot), with the updated ARG database, we identified this 
gene in the S. Montevideo isolated recovered from the cattle feces in 2009.  This suggests 





isolates.  Fosfomycin is not an antibiotic tested in the NARMS gram-negative Sensititre 
plate; therefore, the phenotypic conferred resistance to fosfomycin of S. Montevideo 
isolates remains unknown in our study.  For comparison, we tested a subset of (n = 10) S. 
Montevideo isolates against phenotypic fosfomycin resistance (the EUCAST MIC 
interpretation criterium for resistance zone-diameter is ≤ 12 mm) using the disk-diffusion 
method (data not shown here).  All tested isolates were found to be susceptible to 
fosfomycin.  Although we did not use any positive control strain in our approach, if we 
assume that the fosA7 gene in S. Montevideo isolates is not expressed, this could be likely 
that this gene has a different function in the genome or else is cryptic, or it is expressed 
when it is on a plasmid rather than on a chromosome as suggested by Rehman et al. (2017) 
[300]. 
In this study, we detected 21 isolates with phenotypic streptomycin resistance, 
which was not associated with any particular serotype.  However, WGS-based analyses of 
our study did not detect any streptomycin resistance genes such as str, aad, aph, or arm.  
This could be due to the uncertainty of the MIC breakpoint for streptomycin resistance.  In 
our study, we interpreted the phenotypic resistance using the most up-to-date NARMS 
MIC breakpoint for streptomycin (≥ 32 µg/ml), which was updated and changed from ≥ 64 
µg/ml in 2014.  This update was rendered due to the previously observed inconsistencies in 
the genotypic and phenotypic resistance profiles [301].  When we apply here the previous 
breakpoint of ≥ 64 µg/ml, we observed an approximately 7-fold decrease in the number of 
resistant isolates.  Therefore, utilizing the lowered break-point of ≥ 32 µg/ml might be 
biased, and potentially lead us to obtain false-positive results based on a lack of 





as-yet unidentified streptomycin resistance gene that is not in the ARG database.  This 
hypothesis is also supported by Tyson et al. (2016) who reported isolates’ lack of a known 
resistance gene exhibiting phenotypic streptomycin resistance at the MIC of 32 µg/ml 
[301].  Clearly, more studies are needed to understand both phenotypic and genotypic 
insights into streptomycin resistance.  Updating the breakpoints based on genetic resistance 
traits may not be suitable without ensuring such genetic traits are expressed at certain 
levels to encode and express a phenotypic resistance for the antibiotic of interest. 
We also observed an aminoglycoside resistance gene (aac(6')-Iaa) in all 
Salmonella isolates, regardless of the serotype profiles.  This gene is often found in 
Salmonella isolates; further, based on what is known to date the aac(6')-Iaa gene is not 
known to confer any aminoglycoside resistance in Salmonella [302-304].  Previously, 
similar to aac(6')-Iaa,  the cryptic aac(6’)-Iy aminoglycoside gene on Salmonella was 
activated for aminoglycoside resistance by a transcriptional fusion resulting from a 
chromosomal deletion [184].  A study contacted by Salipante et al. (2003)[303] also 
generated artificial mutations (with a possible 2,165 single-amino acid substitutions and 
1,699,110 possible double amino acid substitutions) in vitro in a S. Typhimurium LT2 
strain harboring aac(6')-Iaa gene on its chromosome, in order to understand if there was 
any evolutionary potential of this gene to express phenotypic aminoglycoside resistance 
such as to tobramycin, kanamycin, amikacin or gentamicin.  The artificial mutations 
resulted in one or two possible mutations that were likely to occur on aac(6')-Iaa gene 
located in the chromosome of the  S. Typhimurium  LT2 strain.  Their result showed with 
99.9% confidence that any mutation that could potentially occur on this gene would not 





the S. Montevideo chromosome that provides a positive selection for the isolates and that 
has not yet been identified. 
In our study, we also identified an IncI1 plasmid that was not associated with any 
particular serotype.  The IncI1 plasmid that was found in our study also did not carry any 
known ARGs, and the isolates carrying the IncI1 plasmid did not show any phenotypic 
resistance against the 14 antibiotics tested.  However, this plasmid was previously reported 
to harbor the blaCMY-2 gene in S. Typhimurium, S. Newport, S. Heidelberg, and S. Infantis 
serotypes that also expressed phenotypic ceftriaxone resistance.  Among these serotypes, 
only S. Typhimurium serotype harboring the IncI1 plasmid with blaCMY-2 resistance gene 
was recovered from a ground beef/cattle source [190].  The IncI1 plasmid is an 
incompatibility group plasmid more frequently isolated from Salmonella compared to the 
IncN plasmid [109].  This was not the case in our study, since we determined a higher 
number of IncN plasmids (n= 68) compared to the IncI1 plasmid (n = 64) (Table 34).  This 
difference was related to the vertical transfer of the IncN plasmids among S. Montevideo 
isolates throughout the study time (and their prolific numbers) versus the IncI1 plasmid 
that was widely shared and spontaneously found and horizontally transferred among many 
different serotypes found in feces, lymph nodes and on hides of the cattle housed in 
different pens [305]. Other than in our study with high prevalence of S. Montevideo, it is 
therefore more likely that the IncI1 plasmid would predominate. 
The IncI1 plasmid harboring ARGs has often been found in clinically important 
Salmonella serotypes, both in human and animals [306].  Based on a recent study 
conducted in 2019, the IncI1 plasmid was reported as not being fully associated with 





Cerro, S. Montevideo, and S. Heidelberg serotypes [302].  Clearly, the potential functions 
of the IncI1 plasmid, that is not responsible for any ARGs when located in cattle origin 
Salmonella strains, are not fully addressed yet; therefore, further in vitro studies are needed 
to determine its functions. 
5.5.   Findings related to the BRD metaphylaxis 
In our study, ceftriaxone, ceftiofur or azithromycin resistance genes and phenotypes 
were not selected in cattle origin Salmonella under the selection pressure of single-dose 
ceftiofur or azithromycin.  Our result was in direct contrast with the study conducted by 
Ohta et al. (2017), which reported a significant increase (P < 0.05) in phenotypic ceftiofur 
and ceftriaxone resistance among Salmonella on Day 4, following a single-dose of CCFA 
administered to cattle on Day 0.  However, in that study the 3rd generation cephalosporin 
resistance was found only in S. Reading isolates.  The MDR profile (ACSSuT+Cef) was 
only identified in the S. Reading serotype.  Interestingly this serotype was not identified on 
Day 0; perhaps, the S. Reading was present in the feces, but was not prevalent without the 
selection pressure of the antibiotic and therefore was not identified.  This finding was 
parallel with other studies that reported S. Reading was associated with certain MDR 
profiles including ACSSuT or MDR-AmpC profile in cattle [15, 69].  This could 
potentially explain the absence of ceftriaxone and ceftiofur resistant or MDR Salmonella in 
our study, since we failed to identify this serotype.  It is possible that the cattle group in the 
study of Ohta et al. (2017) had harbored S. Reading prior to placement in the experimental 
pens, since we identified certain serotypes from cattle from certain sources.  In our study, if 





0, the antibiotic treatments would more likely select for that resistant population; thus, our 
findings could be dramatically different with different starting serotypes.  Similarly, if 
Ohta’s study was conducted up until the date of slaughter, the earlier observed declining 
prevalence of S. Reading isolates, starting from Day 14 to Day 26, would likely continue 
and eventually disappear without the selection pressure of antibiotics.  We base this 
argument on the time-related dynamics of Salmonella that have been shown in our study 
[236] and also time-related reductions observed on the antibiotic selection of other AR 
bacterial populations after single-dose antibiotic administration [37-39].  
In Ohta et al. (2017), the Salmonella prevalence significantly (P < 0.05) decreased 
after the ceftiofur administration on Day 4, and this decrease was recovered back to Day 0 
values by Day 14.  In our study we did not observe any significant effect of ceftiofur 
treatment on Salmonella prevalence observed in cattle feces.  The differences can be 
related to the initial prevalence of Salmonella observed in feces that were most likely 
affected by the seasonal variations in the sample collection periods of the two studies.  
Ohta et al. (2017), conducted their study in early August with a starting Salmonella 
prevalence of approximately 80.0%; in our study, we observed a 32.5% Salmonella 
prevalence on Day 0 starting in March.  Later, both studies reported almost the half of the 
reduction in Salmonella prevalence (to 34.1% and 15%, respectively) on Day 4 and 7, 
respectively.  In addition, since Ohta et al. (2017), sampled their animals  4-day after the 
initial ceftiofur treatment, the 3-day difference in our study may also contribute to 
observed differences in effects on Salmonella prevalence.  
Previously, it has been documented that there can be certain dissimilarities 





that is, before transportation and after transportation up to 19 days [51]. In Ohta’s (2017) 
study the cattle came from a single-origin and were provided a one-month acclimatization 
period before the first sample collection. In our study, only 3 days of acclimatization was 
provided to cattle from two different origins; therefore, it is possible that the transport and 
environment related stress factors of cattle in our study carried forward and this potentially 
increased the dissimilarities in the fecal microbiome that manifested as highly variable 
Salmonella serotypes.  This could also possibly favor the fecal Salmonella population 
following the treatment, either by reducing the prevalence of ceftiofur susceptible 
microbiota or else with the help of certain Bacillus spp. and Bacteroides spp. that can 
degrade ceftiofur in cattle intestine [234].  
Alali et al. (2009) quantified the blaCMY-2 gene in feces (collected on Days 0, 3, 7, 
10, 14, 18, 21, and 28 after treatment) of beef cattle during a 28-day period, following the 
single (on Day 0) or multiple (on days 0, 6 and 13) administration of two different doses of 
ceftiofur (4.4 mg/kg and 6.6 mg/kg) [41].  They found that administration of ceftiofur 
increased the absolute and normalized number of blaCMY-2 genes detected in fecal samples 
compared to the control group throughout the 28-day period.  The observed increase in 
blaCMY-2 genes found by Alali et al. (2009) was most likely related to ceftiofur-resistant E. 
coli, which was phenotypically observed in the same cattle study in a study published by 
Lowrance et al. (2007) [39].  According to their findings, ceftiofur treatment increased 
resistant E. coli populations after treatment; however, they observed the population 
returning to pre-administration resistance levels after a two-week period.  Weinroth et al. 
(2017) also investigated the effects of ceftiofur use on the resistome of cattle feces, 





26 [47].  In contrast to Alali et al. (2009), but similar to our results, their results did not 
indicate any significant changes in genes encoding ceftriaxone resistance over a 26-day 
period, though they did not analyze the samples taken during peak antibiotic activity (i.e., 
Days 4- 12) and shotgun metagenomics are of notoriously poor sensitivity for all but the 
most prevalent and high abundance ARGs. 
Doster et al. (2018) found that there was no significant difference in the cattle 
resistome and microbiome among tulathromycin treated and control groups; however, their 
results may be related to their small sample size (n=15 per treatment group by day) [46].  
The authors, however, reported a significant increase in the 16S rRNA normalized ARG 
abundance and the average relative abundance of microbial taxa between Days 1 and 11 
[46].  Similar to the study of Weintroth et al. (2018) [47], Doster et al. (2018)  ignored the 
likely peak period of antibiotic effect on enteric populations; importantly, their study did 
not measure the long-term effects of tulathromycin treatment out to slaughter eligibility.  
The study of Doster et al. (2018)  was also supported by Holman et al. (2019) [51] showing 
no significant difference in the cattle resistome and microbiome among tulathromycin-
treated and control groups; however, similar to Doster et al. (2018), this may also be 
related to their small sample size (n = 15 per treatment).  However, unlike the Doster et al. 
(2018), Holman et al. (2019) reported a decrease in OTU after the before transport (day -5) 
after transport (Days 5, 12, and 19) and by the end of the study (Day 32).  In contrast to 
Weintroth et al. (2018), [47] and Doster et al. (2018), Holman et al. (2019) sampled their 
group of study cattle on Day 5, which was the peak day to observe the potential effects of 
the antibiotic; however, they did not observe any resistome differences reflecting 





screened the macrolide resistance genes of ermA and ermX (not ermB) in their sample, and 
failed to identify the common azithromycin resistance genes usually observed in 
Salmonella, such as mphA/mphE, ereA, lnuF, mefB, and msrE genes [32, 182]. 
In our study, isolates were not resistant to azithromycin, ceftiofur or ceftriaxone, 
either before or after either ceftiofur or tulathromycin treatments.  This result was aligned 
with metagenomic data analyses conducted by Weinroth et al. (2018) and Doster et al. 
(2018) but countered the findings of Alali et al. (2009) [41, 46, 47].  These studies 
measured the effect of either ceftiofur or tulathromycin treatment on the microbiome 
or/and resistome of the fecal community of feces in the beef cattle; however, none of the 
studies focused directly on culturable bacteria, let alone Salmonella as the outcome 
bacteria of interest. 
5.6.   Potential public health risks  
In our study, animal-level Salmonella prevalence in lymph nodes was over 80% at 
slaughter; given the high probability these Salmonella were likely to be trimmed into 
ground beef, the public health risks and consequences need to be extensively evaluated.  
Importantly, we isolated S. Newport from cattle lymph nodes at slaughter.  Salmonella 
Newport is a highly virulent serotype that is consistently listed as one of the top three 
Salmonella serotypes causing clinical human salmonellosis [157].  Interestingly, all these 
S. Newport serotypes were recovered from cattle lymph nodes from a single-pen (Pen 53), 
only at slaughter age and all were pan-susceptible to 14 antibiotics.  At first glance, this is 
somewhat unusual for this serotype, especially given its historical association with the 





a public health perspective, since one of the most recent Salmonella outbreaks involved a 
pan-susceptible S. Newport contaminating ground beef products resulting in 403 reported 
salmonellosis cases, 117 hospitalizations and the recall of 5,488 tons of beef products 
(accessed at http://www.outbreakdatabase.com/reports/2018-
2019_JBS_CDC_Marc_22_2019.pdf in August 2019).  
The second most important serotype we isolated from the lymph nodes was S. 
Montevideo, even though this serotype has not been seen as being as virulent as S. 
Newport serotype, it is still one of the ten clinically most important serotypes for human 
infections [157].  We identified this serotype in cattle feces, lymph nodes and hides, and all 
were carrying plasmidal tetracycline resistance and were phenotypically resistant to 
tetracycline. 
In addition to these serotypes, interestingly we isolated a single S. Norwich isolate 
from a single-fecal sample at slaughter.  S. Norwich is also reported as a clinically 
important serotype; however, is not as commonly identified as the other two serotype listed 
above and this serotype is not usually found with an MDR profile [157]. This was the least 
worrying clinically important serotype we found, since only one isolate was identified and 
it was a fecal origin Salmonella. 
Slaughterhouse interventions such as exposing carcasses to steam vacuuming, 
lactic acid, and hot water are highly efficacious at reducing the prevalence of fecal or hide 
origin Salmonella on carcass surfaces.  However, infected lymph nodes are likely to be 
incorporated into ground beef during meat processing, thus contaminating the finished 






A commercially available Salmonella vaccine (Salmonella Newport bacterial 
extract SRP [siderophore receptors and porin proteins] vaccine; Zoetis, LLC) was tested 
previously and was shown to reduce Salmonella carriage in cattle feces and on hide 
samples [237]; however, this hypothesis was tested against the Salmonella carriage in 
lymph nodes in another study that showed no significant effects [296].  Another study 
exploring the effect of a direct-fed microbial supplement on Salmonella carriage in cattle 
lymph nodes reported that Lactobacillus acidophilus and Propionibacterium freudenreichii 
administration to beef cattle during the feeding period can reduce Salmonella carriage in 
sub-iliac lymph nodes [297].  Clearly, to reduce Salmonella colonization in the lymph 
nodes an intervention which can be applied during the feeding period is necessary.  
Therefore, further studies need to be conducted to develop new interventions targeting 
virulent human Salmonella serotypes in cattle lymph nodes. 
5.7.   Population dynamics of Salmonella  
In our study, the most prevalent serotype was S. Lubbock (34.1%), followed by S. 
Anatum (28.3%) and S. Montevideo (17.0%).  In the study by Ohta et al., (2017) 
conducted in 2009 in the same feedlot, the most prevalent serotype was found to be S. 
Mbandaka (ST 413) with 37.9% of prevalence, followed by 19.1% S. Give (ST 654), 
15.2% S. Reading (ST 1628), 13.6% S. Kentucky (ST 198), 13.4% S. Montevideo (ST 
138), and 0.7% S. Anatum (ST 64) [36].  When common serotypes identified in both 
studies were observed, S. Montevideo and S. Anatum shared identical STs whereas S. 





In our study, we did not identify any S. Give, S. Mbandaka, or S. Reading.  In 
contrast, in our study we identify S. Lubbock (ST 413), S. Cerro (ST 367), S. Newport (ST 
118), and S. Norwich (ST 2119).  It is also important note that we purposely used the same 
methods and parameters (with only difference being a shorter TSB incubation time in our 
study) as Ohta et al. (2017) for Salmonella isolation and identification; therefore, these 
results were comparable between the two research projects that were also conducted in the 
same experimental feedlot.  However,  it is important to consider the potential serotype 
selection bias of the methods used, when comparisons are made among studies using 
different isolation methods [74]. 
S. Lubbock is a recently named serotype first isolated from a peripheral cattle 
lymph node and reported in 2015 [307].  Interestingly, the highly prevalent serotype S. 
Mbandaka in 2009 (identified by Ohta et al. [2017]) completely disappeared and was 
replaced by a new serotype S. Lubbock with the same ST (ST 413) in 2016, and in the 
same feedlot.  Evidence of gene recombination events show that serotype S. Mbandaka is 
the most likely ancestor of this new serotype Lubbock [270, 307].  This new serotype is 
believed to have emerged from S. Mbandaka by acquiring the fliC gene operon from S. 
Montevideo [270, 307]. 
 Interestingly, in our phylogenetic tree analyses, S. Lubbock had the highest 
variation of SNPs (84 SNPs/135 isolates), whereas S. Montevideo had lowest (12 SNPs/68 
isolates); this could result from a high mutation frequency that may be observed in S. 
Lubbock isolates, which may explain why the S. Montevideo was more conservative and 





A decade and a half earlier, Purdy et al. (2001 and 2004) isolated and characterized 
Salmonella from playas nearby the feedlots in High Plains in Texas [308, 309].  This study 
discovered varying serotype dynamics from the same playas of different feedlots between 
the winter and summer.  Due to the high prevalence of coliforms and Salmonella found in 
these playas, they suggested not to use retention-pond waters to abate feedyard dust.   
In contrast to these findings, Loneragan et al. (2005) measured effects of retention-
pond use for dust abatement in a cohort study [310].  They used water sprinklers to direct 
retention-pond water at different time intervals on exposed cattle groups and kept the 
remaining cattle as unexposed.  They observed no difference in Salmonella prevalence and 
a non-significant reduction of E. coli 0:157 H:7 prevalence in the exposed group when 
compared to the unexposed group cattle.  In their study, they speculated the presence of 
certain virulence factors in the environment may influence survivability of bacteria.  
Therefore, one of the strongest hypotheses that might explain serotype selection by day, 
time, and location on Salmonella in the environment is the presence of bacteriophages 
[311].   
Bacteriophage treatments are considered as an alternative to antibiotics in order to 
combat AR Salmonella infections and these applications also have reduced Salmonella 
prevalence in rendering facility environments [312, 313].  Xie et al. (2016) characterized 
both Salmonella and Salmonella bacteriophages from soil and feces in Texas feedlots and 
found that bacteriophages that infect one serotype may not affect others [314]. Overall, our 
findings suggest that regardless of the use of antibiotics, Salmonella dynamics fluctuate 
over the feeding period, and were mostly affected by the source of cattle and the pen 





dynamics in the environment.  Therefore, a bacteriophage infection targeting S. Mbandaka 
in the same research feedlot used by study of Ohta et al. (2017) and before this present 
study was performed may be one of the explanations of the evolutionary shift observed in 
the seven-year period between studies where S. Lubbock substituted with S. Mbandaka as 
the dominant serotype.  
In the present study, S. Cerro appeared only at slaughter age and was otherwise 
absent early in the feeding period; perhaps demonstrating the unique temporal dynamics of 
Salmonella.  S. Cerro is known to be a pathogen for at-risk cattle such as dairy cows; 
however, the beef cattle involved this study did not show any clinical signs of 
salmonellosis [59].  In contrast, S. Kentucky was isolated from only one origin/source of 
cattle in the early feeding period and it was not recovered at slaughter age.  In addition, 
according to Salmonella pen and serotype distributions demonstrated in Figure 25, for the 
majority of the pens, a single-dominant serotype was determined to be prevalent on hide 
samples from animals in the same pen at slaughter age. 
In our study, a single-ST was found for each serotype, which would also suggest 
the relatively clonal spread of Salmonella among the days, the sample types and within the 
pens, blocks, and source.  This conclusion is also supported by the phylogenetic analyses 
illustrating the close genotypic relatedness of the isolates; that is, among serotypes that 
were recovered from animals in the same pen, block and origin/source were much more 
closely related when compared to isolates that belonged to other groups (Figure 27). 
Clearly, dominant, and potentially clonal serovars found in feces, lymph nodes, and 
on hides could be attributed to the source (host), environmental (pen) and time-related 





profiles in the pathogens; including the feedlot dust, since a research article published in 
2015 also found bacterial DNA and ARG genes in the particulate matter obtained from 
feedlot dust in the southern United States, suggesting bacteria carrying ARGs genes can 
disperse within and among the feedlots [162].  
To summarize, we speculate that Salmonella serotype and AR selection in cattle 
may be related to pre-existing soil microbiota in the feedlots, seasonal changes, and 
bacteriophages in the environment, and these all may contribute to temporally dynamic 
selection of dominant serotypes of Salmonella [13, 287, 288].  None of these latter points 






Here, we assessed Salmonella population dynamics during the feeding period until 
slaughter following a single-dose antibiotic treatment.  We found no effects of ceftiofur 
and tulathromycin metaphylactic use on resistant ceftriaxone or azithromycin Salmonella 
from the time of treatment until slaughter (up to 141 days later) in cattle feces, lymph 
nodes or hides.  We identified the pen in which cattle are housed as the factor that 
contributed the most to Salmonella serotypes being shared; importantly, the dominant 
strain in each pen changed repeatedly over the entire feeding period.  Clearly, our findings 
suggest that the origin/source (host), the environmental (pen) and time-related factors play 
an important role in the selection of the dominant serotypes and, therefore, for the selection 
of antibiotic resistance.  The ecology of Salmonella within cattle populations is clearly far 
more complex than a proposed simple fecal-oral mode of transmission; thus, supporting 
the idea that origin/source and other ambient environmental factors are likely to be 
involved.  One of the limitations of this study was in not collecting and analyzing prior 
environmental samples to determine the contributions of pre-existing soil microbiota in the 
feedlot pens and other animals (birds, pests) that had contact with cattle, feedlot 
equipment, and bacteriophages in the environment.  Therefore, the environmental factors 
that influenced the temporal dynamic selection of dominant serotypes of Salmonella 
among the pens and the cattle remain unclear.  Further studies are needed to evaluate the 
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